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ABSTRACT 
 
 Small molecules have had a tremendous positive impact on human health and society in 
general. Despite this, small molecule synthesis is still a time and cost intensive process practiced 
primarily by highly trained specialists. Inspired by the impact of general, automated synthesis 
platforms for peptides and other biomolecules, we have pioneered iterative cross coupling (ICC) 
as an analogous platform for small molecules. Enabled by both a building block based synthesis 
strategy and a general purification protocol, our group has designed and built a small molecule 
synthesizer. We have demonstrated the ability of this synthesizer to access a wide variety of 
small molecules, including natural products, pharmaceuticals, and materials components. 
Further, the synthesizer is able to access complex, polycyclic, C(sp
3
) rich natural products 
through the use of the “linear-to-cyclized” strategy wherein linear precursors are prepared on the 
machine in an automated fashion and then manually cyclized. 
 Given the ubiquity of stereogenic C(sp
3
) carbons in natural products, the ability to 
stereospecifically couple secondary alkyl fragments iteratively would be highly enabling. 
However, all currently known methods for such transformations require conditions which 
hydrolyze MIDA boronates (aqueous base, high heat, strong base, etc.). In this thesis I describe 
the development of a second generation iminodiacetic acid ligand for boronic acids which is 
refractory to hydrolysis and has enabled the first examples of coupling unactivated, secondary 
alkyl boronic acids in the context of an iterative cross coupling cycle. 
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CHAPTER 1 
INTRODUCTION 
1.1 ITERATIVE SYNTHESIS METHODS 
 The impact of small molecules on society is vast and, as such, methods which enable 
rapid and flexible access to small molecules are highly impactful. Despite this, small molecule 
syntheses still typically rely on synthetic routes and purification procedures that are developed 
on a de novo basis, requiring time- and cost-intensive efforts of highly trained specialists. In 
contrast, the chemical synthesis of important biological macromolecules like peptides
1
 and 
oligonucleotides
2
 is performed using generalized and automated synthesis platforms. This has 
enabled widespread access to these molecules and shifted the focus away from their synthesis 
and primarily towards their function and application.  
 In solid phase peptide synthesis, an amino acid loaded onto a polymeric support via the 
C-terminus is coupled to a second amino acid protected at its N-terminus as the Fmoc 
carbmamate. This crucial protecting group strategy
3
 prevents random oligomerization of the 
bifunctional amino acid. The use of a solid support allows for very rapid and convenient 
purification between coupling steps via simple washing of the resin and filtration.  Deprotection 
with the mild base piperidine reveals the free amine group, ready to undergo further rounds of 
coupling (Figure 1.1, A). Once the desired peptide is prepared, it is cleaved from the solid 
support, globally deprotected, and purified via traditional chromatographic methods. The 
laboratory synthesis of oligonucleotides is performed in a similar manner, wherein a polymer 
loaded nucleotide is coupled with a bifunctional nucleotide building block protected at the 5’-O 
as the dimethoxytrityl (DMT) ether. After coupling, any unreacted nucleophile is capped using 
acetic anhydride/DMAP, and the newly formed phosphite ester linkage is oxidized to the desired 
2 
 
phosphate ester linkage. Following purification, deprotection with dichloracetic acid (DCL) thus 
reveals the free hydroxyl group ready for further coupling (Figure 1.1, B). An analogous strategy 
for the synthesis of oligosaccharides has also been also been developed more recently by 
Seeberger.
4
  
 
 
 
The development of these automated platforms was enabled primarily by two main 
strategic and tactical advances: (i) generalized, building block-based synthetic methods and (ii) 
purification methods which are agnostic to the specific chemical structure of the corresponding 
intermediates. Building block-based strategies for the synthesis of biopolymers are readily 
apparent due to their inherently modular structure and the iterative nature of their biosynthesis. 
Additionally, common functional group motifs on their building blocks allowed the development 
of efficient strategies for their loading onto and removal from solid supports, a key advance 
which allowed the use of the solid phase purification strategy.  
Figure 1.1. Schematic representations of (A) solid phase peptide synthesis, (B) solid phase oligonucleotide 
synthesis 
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In some select cases, similar strategies have been employed in the synthesis of organic 
polymers and small molecules. Moore and coworkers
5
 demonstrated the controlled synthesis of 
sequence specific phenylacetylene oligomers. In this nonlinear growth strategy, each iterative 
cycle doubles the length of the oligomers by cleaving a portion of the growing polymer from its 
solid support and coupling it to the remaining supported sequence (Figure 1.2, A). While one 
could easily imagine the automation of such chemistry, the coupling reactions used are highly 
customized to these specific Sonogashira couplings, and as such, the scope of motifs which are 
accessible is lacking. Hiyama
6
 also showed that bifunctional [(2-
hydroxymethyl)phenyl]dimethylsilanes could be used to the prepare oligoarenes. In this system, 
treatment with mild base forms the activated pentavalent silicon coupling partner which 
undergoes coupling with the O-protected bifunctional silane (Figure 1.2, B). While the broader 
scope of this method is attractive, Hiyama has only thus far demonstrated the use of aryl and 
heteroaryl coupling partners. Additionally, the challenge of common purification remains in the 
way automation. 
 
  
Figure 1.2. (A) Solid supported iterative synthesis of phenylacetylene polymers using Sonogashira couplings and 
(B) Hiyamas iterative silicon-based couplings to make oligoarenes 
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1.2 ITERATIVE CROSS COUPLING WITH MIDA BORONATES 
 At first glance, small molecule synthesis seems refractory to an automated, generalized 
building block based synthesis platform. Unlike peptides, oligonucleotides, and oligosaccharides, 
small molecules contain no obvious, inherent modularity to lend themselves to building block 
based deconstructions. However, despite their incredibly diverse structures, most small molecule 
natural products are analogously biosynthesized by the iterative assembly of a small set of 
building blocks like malonyl-CoA, isopentenyl pyrophosphate, and pyruvic acid.
7
 Natural 
products containing complex macro- and polycyclic frameworks, which at first seem refractory 
to such a building block-based strategy, are also typically biosynthesized by iterative building 
block assembly of a linear precursor followed by cyclization(s) to yield the final product.
8-10
 In 
addition, many pharmaceuticals and materials components are made up of repeating units of aryl 
and/or heteroaryl motifs.
11
 This latent modularity suggests that a biosynthesis inspired, building 
block-based strategy could enable access to a majority of small molecules. 
 
  
 
Figure 1.3. A general schematic of iterative cross coupling using bifunctional MIDA boronates 
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In this vein, our group has pioneered the use of iterative cross-coupling (ICC) in which 
bifunctional N-methyliminodiacetic acid (MIDA) boronates are sequentially assembled in a 
manner analogous to iterative peptide coupling (Figure 1.3).
12
 The MIDA ligand enables this 
iterative assembly by reversibly attenuating the transmetalation activity of boronic acids in the 
same way that Fmoc attenuates the nucleophilicity of amines in peptide coupling. The mild and 
stereospecific nature of the Suzuki coupling allows for stereochemistry, oxidation states, and 
functional groups to be built into the building blocks and translated faithfully into the products. 
Reflecting the power of this approach, iterative cross-coupling and MIDA boronates have been 
used by our group
12-16
 and others
17-19
 in the syntheses of many different natural products and 
their derivatives (Figure 1.4). In fact, this platform was the basis of a recent study in which our 
group showed that over 75% of all known polyene natural product motifs can be prepared using 
just 12 building blocks and one coupling reaction.
20
 Additionally, around 200 MIDA boronates 
and thousands of halide and boronic acid building blocks are currently commercially available, 
and in at least one case, a MIDA boronate has been used on the process scale to prepare a new 
drug candidate for phase II clinical trials. The widespread use of MIDA boronates can at least 
partially be attributed to their highly desirable physical properties. MIDA Boronates are almost 
universally well behaved crystalline solids which are indefinitely stable to storage under air on 
the benchtop. 
6 
 
 
 
With the ICC synthesis platform in place, our group next aimed to develop a common 
purification protocol for all of the intermediates, an advance which would enable automation. As 
previously discussed in the cases of biopolymers,
1,2,4
 small organic polymers,
5
 and even some 
select small molecules,
6
 this challenge has been overcome through the use of solid-phase 
synthesis. However, small molecules do not generally possess a common functional group 
handle which would allow such an approach to be used. Quite serendipitously, our group 
discovered that MIDA boronates possess nearly universal binary elution properties on standard 
silica gel. Regardless of the polarity, size, or functional groups present in the organic fragments, 
MIDA boronates remain at the baseline when eluting with 1.5% MeOH in Et2O during thin-layer 
chromatography. However, switching the eluent to THF rapidly elutes the same MIDA boronates 
(Figure 1.5). This unique elution profile enabled the development of a new type of catch-and-
Figure 1.4. Select examples of total syntheses which utilized bifunctional MIDA boronate building blocks 
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release purification where a crude reaction mixture is passed over silica gel with MeOH/Et2O 
and any MIDA boronates are retained while excess reagents and byproducts are washed away. 
The clean MIDA boronate product is then obtained by eluting with THF. 
 
 
1.3 SUMMARY 
 Modern laboratory syntheses of large biomolecules like peptides and oligonucleotides are 
accomplished using automated, generalized synthetic platforms. Collectively, these platforms 
have drastically increased the efficiency and flexibility with which researchers can access these 
important classes of molecules. This has led to a shift in the bottleneck in these areas of research 
from their synthesis to the study of their function. The development of these platforms was 
enabled by (i) building block based synthesis strategies and (ii) general purification techniques. 
An analogous platform for the synthesis of small molecules would be highly enabling, but also 
represents significant unique challenges. The latent modularity of small molecule natural 
products,
7-10
 pharmaceuticals, and materials components
11
 suggests that the iterative cross 
Figure 1.5. MIDA boronates uniformly show binary elution properties on silica gel thin-layer chromatography  
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coupling of bifunctional MIDA boronates could access the majority of small molecule chemical 
space. Additionally, despite the lack of a common functional group handle for solid phase 
purification, MIDA boronates exhibit almost universal elution properties on silica gel which has 
allowed the development of a general “catch-and-release” purification protocol, suggesting that a 
solution to automatable purification of intermediates regardless of their structure is possible. 
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CHAPTER 2 
SYNTHESIS OF MANY DIFFERENT TYPES OF ORGANIC SMALL MOLECULES USING 
ONE AUTOMATED PROCESS
‡ 
 
2.1 A SMALL MOLECULE SYNTHESIZER 
With both a common building block–based synthesis platform and a common purification 
method, we designed and built a synthesizer that iteratively assembles MIDA boronate building 
blocks in a fully automated fashion (Figure 2.1, A).
1
 This device comprises three modules that 
sequentially execute the deprotection, coupling, and purification steps required for each cycle 
(Figure 2.1, B). All solutions are automatically transferred via computer controlled syringe 
pumps running custom-designed software. Thus, each automated synthesis simply requires 
placing prepacked cartridges onto the synthesizer and pressing “start.” 
The fully automated synthesis commences at the deprotection module, where THF and 
water are syringed into a cartridge containing the first MIDA boronate building block and solid 
NaOH. Sparging the cartridge with argon from the bottom provides sufficient mixing for the 
system, and upon completion of the deprotection (typically less than 20 minutes), the reaction is 
quenched and diluted with diethyl ether. Aqueous extraction separates the freshly prepared 
boronic acid from the water soluble MIDA ligand, and the ethereal boronic acid solution is dried 
by sequentially passing it over MgSO4 and molecular sieves. Solvent switch to THF and 
concentration to the appropriate volume yields the dry boronic acid solution ready for the 
upcoming reaction. The coupling module then heats and stirs a solution of the next building 
block and the coupling reagents while the synthesizer adds the freshly prepared THF solution of 
boronic acid to the coupling reaction. This slow addition is particularly crucial in the coupling of 
                                                          
‡
 Reproduced with modifications from Li, J.; Ballmer, S.G.; Gillis, E.P.; Schmidt, M.J.; Palazzolo, A.M.E.; 
Lehmann, J.W.; Morehouse, G.F.; Burke, M.D. Science 2015, 347, 1221-1226. Reprinted with permission from 
AAAS. Found online at http://science.sciencemag.org/content/347/6227/1221.abstract 
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boronic acids sensitive to decomposition, such as 2-heterocyclic, vinyl, cyclopropyl, and alkyl 
boronic acids.
2
 At the end of the reaction, the synthesizer filters and transfers the crude reaction 
mixture to the purification module, which executes the catch-and-release purification protocol 
with MeOH:Et2O followed by THF. The THF solution of the purified product is then transferred 
directly into the deprotection module to start the next iteration of the synthesis. 
 
 
 To first test the capacity of this synthesizer to execute one cycle of deprotection, 
coupling, and purification, we subjected a series of commercially available aryl, heteroaryl, and 
vinyl MIDA boronates to automated deprotection and coupling with a model bifunctional 
building block, 4-bromophenyl MIDA boronate 2.3 (Table 2.1). Using a standard set of 
Figure 2.1. (A) A photograph of the small molecule synthesizer and (B) close ups of the deprotection, coupling, and 
purification modules 
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hydrolysis conditions (NaOH, THF:H2O, 23 °C, 20 min) and coupling conditions (PdXPhos, 
K3PO4),
3
 we obtained the desired cross-coupling products in good yields and purities in all cases 
(Table 2.1, entries 1 to 3). The synthesizer was also capable of executing a C(sp
3
) coupling using 
Pd[P(o-tol3)]2 and Ag2O/K2CO3 (Table 2.1, entry 4). Accessing many pharmaceuticals and 
materials requires the flexibility to link building blocks via carbon heteroatom and/or carbon-
carbon bonds. The stability of MIDA boronates toward many reaction conditions
4,5
 and the 
synthetic versatility of boronic acids
6
 allowed us to add carbon-heteroatom bond formations to 
the same platform. The synthesizer successfully executed a series of automated carbon-
heteroatom bond formations, including a Buchwald-Hartwig amination, O-alkylation, and amide 
bond formations (Table 2.2). Despite the different reagents and by-products, the same catch-and-
release process purified all of the corresponding MIDA boronate products.  
 
 Table 2.1. Single cycles of deprotection, coupling, and purification performed by the automated synthesizer 
12 
 
 
 
2.2 AUTOMATED SYNTHESIS OF LINEAR SMALL MOLECULES 
 Having confirmed the capacity to reliably execute single cycles of deprotection, coupling, 
and purification, we next targeted the automated synthesis of a wide range of linear small 
molecules (2.8 to 2.19) via multiple carbon-carbon and/or carbon heteroatom bond formations 
(Figure 2.2). These include natural products from major biosynthetic pathways (2.8, 2.10, 2.11, 
2.13), materials components (2.15, 2.16), and pharmaceuticals and biological probes (2.17 to 
2.19). Most of the corresponding building blocks are commercially available. Similar to 
automated peptide, oligonucleotide, and oligosaccharide syntheses, all of the synthesizer-
generated final products were purified using standard chromatographic techniques, and any 
protecting groups other than MIDA were easily removed in a separate step. In each case, a single 
Table 2.2. Carbon heteroatom bond formations accomplished by the automated synthesizer 
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automated run successfully delivered the targeted small molecule in multimilligram quantities, 
fulfilling the requirements of most functional discovery assays. 
 
 
 
The development of small molecules with optimized functions often requires efficient 
access to many structural derivatives of a parent compound. To test if this platform could enable 
such access, we targeted the automated preparation of many derivatives of the complex 
neolignan natural product ratanhine 2.13. In this experiment, we did not optimize any of the 
deprotection, coupling, or purification conditions used to construct 2.12 (Figure 2.2). We input 
four sets of building blocks representing common substructural elements found throughout the 
neolignan family and/or other pharmaceutically relevant motifs (Figure 2.3). These building 
blocks included variations in oxidation states, methylation patterns, fluorine content, aromatic 
ring identity, and size. They also represent preprogrammed oligomer lengths of 3 to 4 units, 
based on whether the third building block was a bifunctional halo-MIDA boronate or a capping 
halide. In the event, the synthesizer successfully generated 20 out of 20 of the targeted 
derivatives, collectively representing all possible combinations of this four-component matrix of 
building blocks (Figure 2.3). 
Figure 2.2. Automated synthesis of natural products, materials, pharmaceuticals, and biological probes via iterative 
coupling of building blocks indicated by different colors 
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Figure 2.3. Conditions: Deprotection – NaOH, THF:H2O. Coupling – cycle 1: Pd(OAc)2, SPhos, K2CO3, THF, 55 
°C, 16 hours; cycle 2: Pd(OAc)2, XPhos, K3PO4, THF, 55 °C, 14 hours; cycle 3: Pd(OAc)2, SPhos, K3PO4, THF, 55 
°C, 24 hours. Purification – SiO2, MeOH:Et2O; THF. All protecting groups other than MIDA [R: TIPS, TBDPSE, 
TMSE, or Bz] were successfully removed in a separate step 
15 
 
2.3 AUTOMATED SYNTHESIS OF POLYCYCLIC NATURAL PRODUCTS 
Having shown the synthesizers capacity to prepare many different linear small molecule, 
we decided to test whether a wide range of macro- and polycyclic natural products and natural 
product–like cores (Figure 2.4) could be generated using the same automated building block 
assembly process and a strategy dubbed “linear-to-cyclized”. In this strategy, linear precursors 
are prepared in an automated fashion and are then manually cyclized in an enantio- and 
diastereoselective fashion. The macrocyclic natural product citreofuran possesses both C(sp
3
) 
and atropisomerism stereochemical elements (Figure 2.4, entry 1). This complex target can be 
derived from linear precursor 2.53,
7
 which can, in theory, be assembled from building blocks 
2.49 to 2.51. All of the required stereochemical information for citreofuran is preencoded in the 
chiral nonracemic MIDA boronate building block 2.49. On the synthesizer, fully automated 
deprotection of 2.49, C(sp
3
) coupling with 2.50, and purification yielded intermediate 2.52. A 
second round of deprotection and coupling of the resulting 2-furanyl boronic acid with 2.51 
produced linear precursor 2.53. This linear precursor was then deprotected and 
atropdiastereoselectively macrocyclized to generate citreofuran. 
Oblongolide is a norsesquiterpene -lactone natural product containing a 6,6,5-tricyclic 
core with five C(sp
3
) stereogenic centers, one of which is quaternary (Figure 2.4, entry 2). The 
three building blocks 2.55 to 2.57 were automatically assembled via iterative C(sp
2
) and C(sp
3
) 
couplings to produce linear precursor 2.59. After deprotection, the linear precursor was subjected 
to a cascade intramolecular substrate-controlled diastereoselective Diels-Alder reaction and 
lactonization process,
8
 which defined the four contiguous stereogenic centers in oblongolide.  
In cases where no C(sp
3
) stereogenic centers are present in the linear precursors, the 
enantioselectivity of cyclizations can be controlled using a rapidly expanding toolbox of chiral 
16 
 
catalysts.
9
 This approach allows the stereoselective construction of the natural product–like 
hexahydroindene and steroid-like core structures 2.66 and 2.72 using the same linear-to-cyclized 
strategy (Figure 2.4, entries 3 and 4). Specifically, building blocks 2.61 to 2.63, all possessing 
olefins with predefined geometries required for cyclization, were assembled on the synthesizer to 
produce linear precursor 2.65. This precursor was then subjected to deprotection and a chiral 
imidazolidinone-promoted organocatalytic enantio- and diastereoselective Diels-Alder reaction 
to generate 2.66 (Figure 2.4, entry 3).
10
 Similarly, iterative C(sp
3
) coupling of building blocks 
2.67 to 2.69 generated linear precursor 2.71, which then underwent catalyst-promoted enantio- 
and diastereoselective cation- cyclization11 followed by reduction to generate 2.72 (Figure 2.4, 
entry 4). Finally, by simply replacing building block 2.69 with 2.73 and using the same 
automated platform, even the highly complex pentacyclic secodaphnane core ()-2.75 was 
readily prepared (Figure 2.4, entry 5).
12
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Initial difficulties in the synthesis of secodaphnane core 2.75 nicely illustrate the need for 
strategic building block design. A first generation version of building block 2.73 is shown in 
Figure 2.5 (2.76). After many failed efforts to couple 2.76 with dimer 2.70, investigation into 
side reactions revealed two serious issues. The first was that the benzoyl protected allylic alcohol 
formed the -allyl complex due to the leaving group capacity of the benzoate group. Changing to 
a silyl protected alcohol obviated this issue. Second, upon oxidative addition, the alkenyl Pd(II) 
species underwent facile intramolecular Heck reaction to form a kinetically favored 5-membered 
ring. By simply switching the stereochemistry of the vinyl bromide from cis to trans, the 
geometry required for the Heck reaction was no longer present and the reaction was shut down 
Figure 2.4. Modular linear precursors assembled via automated C(sp
2
) and C(sp
3
) couplings are diastereo- and/or 
enantioselectively cyclized 
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entirely. Building block 2.73 underwent smooth Suzuki coupling with dimer 2.70 to provide 
linear precursor 2.74, both on the bench and on the synthesizer. 
 
 
 
 Thus, many different types of small molecules can be synthesized using one automated 
building block assembly platform. This advance was enabled by standardizing the synthesis and 
purification processes used to assemble these structures. Importantly, a majority of the building 
blocks employed herein are already commercially available. Further expanding the scope of this 
automated synthesis platform represents an actionable roadmap toward a general and broadly 
accessible solution to the small-molecule synthesis problem. This roadmap includes creating 
building blocks representing the highly redundant substructural elements found in many small 
molecules,
13
 developing better methods for iteratively coupling those building blocks together, 
and advancing the capacity for biosynthesis inspired cyclizations of linear precursors to yield 
complex natural product frameworks. Achieving these objectives stands to better enable the 
scientific community to bring the substantial power of small-molecule synthesis to bear upon 
many important unsolved problems in society. 
 
Figure 2.5. Strategic design of building block 2.73 enabled synthesis of secodaphnane core 2.75 
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2.4 EXPERIMENTAL SECTION 
General Materials and Methods 
Commercial reagents were purchased from Sigma-Aldrich, EMD Millipore, Fisher 
Scientific, Alfa Aesar, Frontier Scientific, Oakwood Products, or Strem and were used without 
further purification unless otherwise noted. Unless otherwise noted, manual building block 
syntheses were carried out in oven- or flame-dried glassware under a dry inert atmosphere. 
Unless otherwise noted: Celite™ refers to Celite™ 545 filter aid (not acid washed); Darco® 
refers to activated carbon, Darco
®
 G-60, -100 mesh, powder; and K3PO4 and K2CO3 were both 
anhydrous and were freshly and finely ground in a 120 °C mortar and pestle. XPhos 2
nd
 
generation palladacycle refers to chloro(2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-
biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II) (741825, Sigma-Aldrich). Solvents were 
purified via passage through packed columns as described by Pangborn and coworkers
14
 (THF, 
Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexanes, benzene, toluene: dry neutral alumina and 
Q5 reactant; DMSO, DMF: activated molecular sieves. Water was deionized. 
Thin layer chromatography (TLC) was performed using the indicated eluent on E. Merck 
silica gel 60 F254 plates (0.25 mm). Compounds were visualized by exposure to a UV lamp (λ = 
254 and/or 366 nm) and/or a basic solution of KMnO4 followed by brief heating with a 
Varitemp
®
 heat gun. Flash chromatography was performed as described by Still and coworkers 
(35) using EM Merck silica gel 60 (230-400 mesh). 
1
H NMR spectra were recorded at room 
temperature on one of the following instruments: Varian Unity 500, Varian VXR 500, or Varian 
Unity Inova 500NB. Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (CDCl3, δ = 7.26; 
(CD3)2CO, δ = 2.05, center line; CD2Cl2, δ = 5.32, center line; (CD3)2SO, δ = 2.50, center line). 
20 
 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, sept = septet, m = multiplet, br = broad, app = apparent, dd = doublet of 
doublets, dt = doublet of triplets, dq = doublet of quartets), coupling constant (J) in Hertz (Hz), 
and integration. 
13
C NMR spectra were recorded at room temperature on one of the following 
instruments: Varian Unity 500 or Varian VXR 500. Chemical shifts (δ) are reported in ppm 
downfield from tetramethylsilane and referenced to carbon resonances in the NMR solvent 
(CDCl3, δ = 77.16, center line; (CD3)2CO, δ = 29.84, center line; CD2Cl2, δ = 53.84; (CD3)2SO, δ 
= 39.52, center line). High resolution mass spectra (HRMS) were performed by Furong Sun and 
Elizabeth Eves at the University of Illinois School of Chemical Sciences Mass Spectrometry 
Laboratory. 
 
 
 
 
 
 
Figure 2.6. Photograph of the automated synthesizer 
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Design of the Deprotection Module 
 
 
The deprotection module consists of two J-KEM
®
 Scientific V6 programmable syringe 
pumps (part # SYR-1400PC). Both are fitted with a 10-mL glass/PTFE syringe (part # SPGS-
10000) and an 8-port distribution valve (part # SPDV-8). One pump (the Primary Pump) is 
utilized as the organic liquid handling pump and the other (the Wet Pump) is used exclusively as 
the aqueous liquid handling pump. The module utilizes an additional five 8-port distribution 
valves (part # SPDV-CS8) housed in four separate quad stack KEM select distribution modules 
(part # SYR-CS4) for liquid handling. A source of dry nitrogen and dry argon are used for liquid 
handling and deoxygenation/concentration processes. Connections between valves are made with 
FEP tubing (1/16’’ OD, 0.030’’ ID).  
To the Deprotection Cartridge, the Primary Pump adds THF and the Wet Pump adds 
water. The reaction is then agitated with pulses of argon gas. The Wet Pump then adds a 
quenching reagent (either pH=6 phosphate buffer or saturated NH4Cl) and the Primary Pump 
Figure 2.7. Photograph of the deprotection module 
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adds Et2O. The resulting biphasic system is agitated with pulses of nitrogen gas and the aqueous 
layer is drawn off and disposed of by the Wet Pump. The Wet Pump adds 50% saturated aqueous 
NaCl. The resulting biphasic system is agitated with pulses of nitrogen and the aqueous layer is 
drawn off and disposed of by the Wet Pump. The Primary Pump transfers the wet organic 
solution to a Predrying Cartridge (if applicable), and subsequently Drying Cartridge, containing 
drying agents and agitates the mixture by repeatedly withdrawing/injecting the solution. The 
Primary Pump transfers the dried organic solution to a Concentration/Deoxygenation Cartridge 
and concentrates/deoxygenates the solution with pulses of argon gas. 
Design of the Coupling Module 
 
 
 The coupling module consists of one J-KEM
®
 Scientific V6 programmable syringe pump 
(part # SYR-1400PC), the Primary Pump described above. The module utilizes one additional 8-
port distribution valve (part # SPDV-CS8) housed in one separate quad stack KEM select 
distribution module (part # SYR-CS4) for liquid handling (shared with the deprotection module). 
A source of dry nitrogen and dry argon are used for liquid handling and deoxygenation processes 
Figure 2.8. Photograph of the coupling module 
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(shared with the deprotection module). Two IKA
®
 RET control visc IKAMAG
®
 safety control 
heating stir plates (part # 3364001) and one IKA
®
 RCT basic IKAMAG
®
 safety control heating 
stir plate (part # 3810001) are used for reaction stirring and temperature control. Connections 
between valves are made with FEP tubing (1/16’’ OD, 0.030’’ ID).  
The Reaction Cartridge, agitated with a magnetic stir bar, is typically deoxygenated with 
pulses of argon gas. The Primary Pump adds THF to the reaction cartridge and then slowly adds 
the dried/deoxygenated THF solution of boronic acid. After the addition, the reaction is allowed 
to agitate. 
Design of the Purification Module 
 
 
The purification module consists of two J-KEM
®
 Scientific V6 programmable syringe 
pumps (part # SYR-1400PC). One is the Primary Pump described above. The other pump (the 
Auxillary Pump) is used exclusively as the column eluent and waste handling pump. The module 
utilizes an additional six 8-port distribution valves (part # SPDV-CS8) housed in three separate 
quad stack KEM select distribution modules (part # SYR-CS4) for liquid handling. Five of these 
Figure 2.9. Photograph of the purification module 
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distribution valves are shared with the deprotection and coupling modules. Two IKA
®
 RET 
control visc IKAMAG
®
 safety control heating stir plates (part # 3364001), shared with the 
coupling module, and one IKA
®
 RCT basic IKAMAG
®
 safety control heating stir plate (part # 
3810001) are used. Connections between valves are made with FEP tubing (1/16’’ OD, 0.030’’ 
ID).  
The Auxillary Pump adds hexanes to the Precipitation Cartridge, agitated with a magnetic 
stir bar. The Primary Pump adds portions of the crude reaction solution to the Precipitation 
Cartridge. The Auxillary Pump then withdraws the solvent through the Silica gel Plug. This 
process is repeated until the Reaction Cartridge is empty. The Primary Pump then adds 1.5% 
MeOH in Et2O to the Precipitation Cartridge and then the Auxillary Pump withdraws the solvent 
through the Silica Gel Plug. The Primary Pump then adds Et2O to the Precipitation Cartridge and 
then the Auxillary Pump withdraws the solvent through the Silica Gel Plug. The Auxillary Pump 
then adds THF to the Precipitation Cartridge and the Primary Pump removes the resulting 
solution and transfers it to the next Deprotection Cartridge. 
Description of software 
The synthesizer is controlled remotely on a Windows-based computer by a custom 
software program written in VB.NET (based on code written for the J-KEM
®
 Scientific V6 
programmable syringe pumps). The software program is designed to interpret instructions to the 
synthesizer written in a simple custom scripting language. Pre-set series of instructions enable all 
of the steps required for a synthesis to be executed in a fully automated fashion after the operator 
simply presses “Start.” 
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Single-Step C-C Bond Formation (Table 2.1) (Automated Procedure I) 
Unless otherwise noted, “cartridge” refers to a 12-g Luknova column capped with a 12-g 
Luknova column screw cap. 
Automated Procedure I – Cartridge Preparation 
First Deprotection Cartridges contain solid NaOH and the starting MIDA boronate. 
Predrying Cartridges contain Celite™ (800 mg) and anhydrous MgSO4 (2.1 g). These 
solids are mixed thoroughly and a plastic 5-mL syringe plunger is placed on top of the mixed 
solids. This is topped with an aluminum foil cover. 
Drying Cartridges contain Celite™ (300 mg) with 4 Å molecular sieves (activated, 
powder, -325 mesh) (3.6 g) layered on top. A plastic 5-mL syringe plunger is placed on top of 
the layered solids.  
Concentration/Deoxygenation Cartridges are empty.  
First Reaction Cartridges contain a PTFE-coated magnetic stir bar, coupling partner, 
catalyst and ligand, and base. For this cartridge, the factory-supplied fiber frit has been removed 
and a medium porosity glass frit installed. The cap is pierced with a 1.5-inch 18 G needle and 
topped with an empty 4-g Luknova column (capped with a 4-g Luknova column screw cap). This 
cap is tethered to another cap PTFE tubing (1/16-inch I.D., 1/8-inch O.D.). This additional cap, 
pierced with a 1.5-inch 18 G needle, is attached to the Reaction Filtration Cartridge. The PTFE 
tubing is adjusted to place the end of the tubing approximately 5 mm above the frit of the First 
Reaction Cartridge and approximately 20 mm below the screw cap of the Reaction Filtration 
Cartridge. The luer ports of both screw caps are packed with a small ball of rolled Kimberly-
Clark
®
 Kimwipes™. 
26 
 
Reaction Filtration Cartridges contain a PTFE-coated magnetic stir bar and a mixture 
of Celite™ (2.5 g) and Florisil® (1.25 g). This is tethered to the First Reaction Cartridge as 
described above. 
Precipitation Cartridges contain a PTFE-coated magnetic stir bar, Celite™ (150 mg), 
and 3-aminopropyl functionalized silica gel (250 mg). Hexanes (10 mL) is added and the 
cartridge is swirled vigorously to suspend and homogenize the mixture of solids. The stir bar and 
solids are allowed to settle over 30 seconds and the supernatant hexanes is pushed out of the 
cartridge with an overhead pressure of air. The stir bar is now embedded in the mixture of solids 
wet with hexanes. 
Silica Gel Plugs contain silica gel, tightly packed, and topped with a 4-g Luknova 
column frit. This is capped with a 4-g Luknova column screw cap, using four layers of PTFE 
tape on the sealing insert to ensure a leak-free seal. 
Automated Procedure I - Experimental Procedure 
Deprotection In the deprotection module, to a Deprotection Cartridge containing starting 
MIDA boronate 2.1 (1.0 mmol) and NaOH (3.0 mmol, 120 mg) is added 12 mL THF followed 
by 3 mL water.  This solution is then agitated by bubbling argon through the solution for 20 
minutes at room temperature.  After agitation, 3 mL aqueous potassium phosphate buffer (pH=6, 
0.5 M) and 5 mL Et2O are added.  The layers are briefly mixed (again, via argon sparging) 
before being allowed to separate.  Then, the Wet Pump disposes of the aqueous layer before 
adding 3 mL 50% saturated aqueous NaCl, mixing the layers, and allowing them to separate.  
Again, the Wet Pump disposes of the aqueous layer.  The THF/Et2O solution of boronic acid is 
then dried using the Predrying and Drying Cartridges.  This is accomplished by the repeated 
injection and withdrawal of the solution into the cartridges (20 repetitions for the Predrying 
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Cartridge, followed by 20 repetitions for the Drying Cartridge).  The solution is then passed into 
the Concentration/Deoxygenation Cartridge before washing the contents of the Predrying and 
Drying Cartridges with 6 mL THF and adding the wash to the Concentration/Deoxygenation 
Cartridge.  This organic solution is then concentrated to 10 mL (evaporating most of the Et2O) 
before washing the drying agents with a further 6 mL THF.  The organic solution (now only 
THF) is concentrated to 9 mL.  This deoxygenated, dry solution is used directly in the 
subsequent coupling reaction. 
Coupling In the coupling module, a First Reaction Cartridge is charged with bifunctional 
MIDA boronate 2.3 (0.33 mmol), XPhos 2
nd
 generation palladacycle (0.017 mmol, 13.1 mg, 5 
mol%), and K3PO4 (3.0 mmol, 637 mg) and warmed to 55 °C before being deoxygenated by 
flushing with argon for 10 minutes.  To this cartridge is added 3 mL THF with stirring.  The THF 
solution of boronic acid 2.2 is added over 4 hours (0.0375 mL/min).  At the end of the addition, 
the reaction is stirred for an additional 12 hours. 
Purification In the purification module, the crude reaction mixture is added to a Reaction 
Filtration Cartridge and 12 mL hexanes is added to the Precipitation Cartridge/Silica Gel Plug.  
Then, a 3 mL portion of the filtered crude reaction mixture is added to the Precipitation Cartridge 
and the solvent is removed from the cartridge, loading any crude reaction product onto the Silica 
Gel Plug (“catch”).  This process is performed a total of 10 times, using 3 mL THF to wash the 
Reaction and Reaction Filtration Cartridges for each cycle.  Then, 12 mL of 1.5% MeOH in Et2O 
are added and the solvent is removed three times (36 mL total).  Then, 12 mL of Et2O are added 
and the solvent is removed 3 times (36 mL total).  Finally, 12 mL THF are added and slowly 
removed (to increase residence time in the column), giving a purified solution of MIDA boronate 
2.4.  
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Automated Procedure I was followed using 251.7 mg (1.02 mmol) aryl MIDA boronate 
2.1a and 104.0 mg (0.333 mmol) bifunctional MIDA boronate 2.3. The conversion for the 
deprotection step was 99% and the conversion for the coupling step was 98%. The desired aryl 
MIDA boronate 2.4a was obtained as a white solid of >95% purity (65.3 mg, 0.202 mmol, 61% 
yield). TLC (20% MeCN in Et2O): Rf = 0.37, visualized by UV and KMnO4 stain; 
1
H-NMR (500 
MHz, DMSO-d6:D2O, 95:5): δ 7.64 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 8.5 Hz, 2H), 7.48 (s, 1H), 
7.45 (dd, J = 7.5, 0.5 Hz, 1H), 7.34 (t, J = 7.5 Hz, 1H), 7.17 (dd, J = 7.5, 0.5 Hz, 1H), 4.34 (d, J 
= 17.5 Hz, 2H), 4.13 (d, J = 17 Hz, 2H), 2.54 (s, 3H), 2.37 (s, 3H); 
13
C-NMR (125 MHz, DMSO-
d6:D2O, 95:5): δ 169.1, 140.7, 140.1, 138.0, 132.9, 128.7, 128.0, 127.2, 125.9, 123.7, 61.8, 47.6, 
21.0; HRMS (EI+) calculated for C18H18BNO4 [M]
+ 
m/z 323.13289, found 323.13253. 
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Automated Procedure I was followed using 325.4 mg (1.01 mmol) aryl MIDA boronate 
2.1b and 104.4 mg (0.335 mmol) bifunctional MIDA boronate 2.3. The conversion for the 
deprotection step was 99% and the conversion for the coupling step was 99%. The desired aryl 
MIDA boronate 2.4b was obtained as an off-white solid of >95% purity (110.9 mg, 0.278 mmol, 
83% yield). TLC (20% MeCN in Et2O): Rf = 0.46, visualized by UV and KMnO4 stain; 
1
H-NMR 
(500 MHz, DMSO-d6:D2O, 95:5): δ 7.43 (d, J = 8 Hz, 2H), 7.33 (dd, J = 3, 1.5 Hz, 1H), 7.30 (d, 
J = 8.5 Hz, 2H), 6.26 (t, J = 3.5 Hz, 1H), 6.23 (dd, J = 3, 1.5 Hz, 1H), 4.34 (d, J = 17 Hz, 2H), 
4.13 (d, J = 17 Hz, 2H), 2.54 (s, 3H), 1.28 (s, 9H); 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5): δ 
30 
 
169.7, 149.1, 134.7, 134.4, 132.0, 128.2, 123.0, 114.7, 111.2, 83.9, 62.1, 47.9, 27.3; HRMS 
(ESI+) calculated for C20H24BN2O6 [M+H]
+ 
m/z 399.1727, found 399.1723. 
 
  
 
Automated Procedure I was followed using 265.9 mg (1.00 mmol) aryl MIDA boronate 
2.1c and 105.6 mg (0.339 mmol) bifunctional MIDA boronate 2.3. The conversion for the 
deprotection step was 98% and the conversion for the coupling step was 99%. The desired aryl 
MIDA boronate 2.4c was obtained as an off-white solid of >95% purity (77.7 mg, 0.228 mmol, 
67% yield). TLC (20% MeCN in Et2O): Rf = 0.44, visualized by UV and KMnO4 stain; 
1
H-NMR 
(500 MHz, DMSO-d6:D2O, 95:5): δ 7.35 (s, 4H), 6.34 (d, J = 16.5 Hz, 1H), 6.25 (dd, J = 16.5, 7 
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Hz, 1H), 4.31 (d, J = 17 Hz, 2H), 4.08 (d, J = 17 Hz, 2H), 2.47 (s, 3H), 2.13-2.06 (m, 1H), 1.74-
1.68 (m, 4H), 1.63-1.60 (m, 1H), 1.31-1.23 (m, 2H), 1.18-1.11 (m, 3H); 
13
C-NMR (125 MHz, 
DMSO-d6:D2O, 95:5): δ 169.6, 138.1, 136.8, 132.7, 127.3, 125.4, 61.9, 47.7, 40.6, 32.6, 25.8, 
25.6; HRMS (EI+) calculated for C19H24BNO4 [M]
+ 
m/z 341.17984, found 341.18030. 
 
 
 
 
Automated Procedure I was followed with modifications: 268.4 mg (0.997 mmol) octyl 
MIDA boronate 2.1d, 105.2 mg (0.337 mmol) p-bromophenyl MIDA boronate 2.3, an increased 
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catalyst loading of 25.6 mg (10 mol%) Pd[P(o-tol)3]2, and 237.6 mg Ag2O (1.03 mmol) and 
277.7 mg K2CO3 (2.01 mmol) were used. The conversion for the deprotection step was 99% and 
the conversion for the coupling step was 99%. The desired aryl MIDA boronate 2.4d was 
obtained as an off-white solid of 80% purity (68.9 mg, 0.200 mmol, 59% yield). TLC (50% 
acetone/hexanes) Rf = 0.48, visualized by UV and KMnO4 stain; 
1
H-NMR (500 MHz, DMSO-
d6:D2O, 95:5): δ 7.32 (d, J = 7.6 Hz, 2H), 7.16 (d, J = 7.7 Hz, 2H), 4.29 (d, J = 17.3 Hz, 2H), 
4.07 (d, J = 17.3 Hz, 2H), 2.57-2.52 (m, 2H), 2.47 (s, 3H), 1.54 (quint, J = 7.4 Hz, 2H), 1.29-
1.19 (m, 10H), 0.83 (t, J = 6.8 Hz, 3H); 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5): δ 169.8, 
134.8, 132.9, 128.4, 128.1, 62.3, 57.5, 42.6, 35.8, 31.9, 31.4, 29.4, 29.3, 22.7, 14.6.; HRMS 
(ESI+) calculated for C19H29BNO4 [M+H]
+
 m/z 346.2190, found 346.2180. 
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Single-Step C-X Bond Formation (Table 2.2) (Automated Procedure II) 
Unless otherwise noted, “cartridge” refers to a 12-g Luknova column capped with a 12-g 
Luknova column screw cap.  
Automated Procedure II – Cartridge Preparation 
Drying Cartridges contain 4.2 g Na2SO4, topped with the plunger from a 5 mL syringe. 
Concentration/Deoxygenation Cartridges are empty.  
First Reaction Cartridges are the 40 mL reaction vials described above, and contain a 
PTFE-coated magnetic stir bar, coupling partner, coupling reagent (where applicable) and base.  
These cartridges have no frit at their base.  The Luer port at the bottom is packed with a small 
piece of Kimwipe (so that solids are retained in the vial during weighing).  The top of the vial is 
capped with a screw-top rubber septum cap.  This septum is pierced with a 1.5 inch 18 G needle 
which is connected to an empty 4 g Luknova column (capped with a 4 g Luknova column screw 
cap connected to a source of dry nitrogen).  Additionally, the cap is tethered to the screw cap 
topping the Reaction Filtration Cartridge via PTFE tubing (1/16-inch I.D., 1/8-inch O.D.)  This 
tubing is adjusted in such a way to be ~5 mm above the base of the reaction vessel, and is used to 
transfer the crude reaction mixture to the Reaction Filtration Cartridge. 
Reaction Filtration Cartridges contain 1.0 g Celite™ and 0.5 g Florisil® which have 
been thoroughly mixed. This is tethered to the First Reaction Cartridge as described above. 
Precipitation Cartridges contain a PTFE-coated magnetic stir bar, Celite™ (150 mg), 
and 3-aminopropyl functionalized silica gel (250 mg). Hexanes (10 mL) is added and the 
cartridge is swirled vigorously to suspend and homogenize the mixture of solids. The stir bar and 
solids are allowed to settle over 30 seconds and the supernatant hexanes is pushed out of the 
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cartridge with an overhead pressure of air. The stir bar is now embedded in the mixture of solids 
wet with hexanes. 
Silica Gel Plugs contain silica gel, tightly packed, and topped with a 4-g Luknova 
column frit. This is capped with a 4-g Luknova column screw cap, using four layers of PTFE 
tape on the sealing insert to ensure a leak-free seal. 
Automated Procedure II - Experimental Details 
Coupling The First Reaction Cartridge is charged with all solid reagents (MIDA 
boronates, coupling reagents, etc.) before sealing, placing into an appropriately warmed heating 
block, and flushing with argon (10 minutes).  To this is added THF (12 mL, unless otherwise 
noted) with stirring.  After stirring briefly, any necessary liquid reagents are added via syringe 
through the septum cap.  The reaction is then stirred in an appropriately warmed heating block 
until complete, at which point it is transferred to the Reaction Filtration Cartridge before 
workup/purification. 
Purification After filtration, the crude reaction mixture is added to the 
Extraction/Workup Cartridge.  To this cartridge is then added 5 mL 50% saturated aqueous 
NaCl. The layers are mixed via argon sparging (60 seconds) before removing and disposing of 
the aqueous layer.  This is repeated twice more, for a total of three aqueous washes before the 
organic layer is dried in the Predrying Cartridge.  This is accomplished through the repeated 
injection and withdrawal of the solution into the cartridge (20 repetitions).  Then, a 3 mL portion 
of the filtered and washed crude reaction mixture is added to the Precipitation Cartridge and the 
solvent is removed from the Precipitation Cartridge, loading any crude reaction product onto the 
Silica Gel Plug (“catch”).  This process is performed a total of 10 times, washing the Predrying 
Cartridge with 2 mL THF for the final two repetitions.  Then, 12 mL of 1.5% MeOH in Et2O are 
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added and the solvent is removed 3 times (36 mL total).  Then, 12 mL of Et2O are added and the 
solvent is removed 3 times (36 mL total).  Finally, 12 mL THF are added and slowly removed (to 
increase residence time in the column), giving a purified solution of the product MIDA boronate.  
In the case of a single-step coupling experiment this solution is added to an empty Deprotection 
Cartridge where it can be retrieved for analysis or further use.  In the case of multi-step 
experiments, the solution is moved to a Deprotection Cartridge containing NaOH, concentrated 
to 10 mL, and another cycle of deprotection begins. 
 
Automated Procedure II was followed using 95 µL aniline 2.5a (1.04 mmol), 105.2 mg 
(0.337 mmol) p-bromophenyl MIDA boronate 2.3, 638.4 mg K3PO4 (3.01 mmol), and 13.5 mg 
(5 mol%) 2
nd
 generation XPhos palladacycle.  The reaction was run at 55°C for 16 h.  The 
desired aryl MIDA boronate 2.7a was obtained as an off-white solid (82.3 mg, 0.254 mmol, 75% 
yield) of 88% purity. 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5): δ 7.27 (d, J = 8.3 Hz, 2H), 7.22 
(dd, J = 8.5 and 7.2 Hz, 2H), 7.08 (d, J = 7.3 Hz, 2H), 7.05 (d, J = 8.5 Hz, 2H), 6.82 (t, J = 7.2 
Hz, 1H), 4.27 (d, J = 17.2 Hz, 2H), 4.05 (d, J = 17.2 Hz, 2H), 2.50 (s, 3H). 
13
C-NMR (125 MHz, 
DMSO-d6:D2O, 95:5): δ 169.6, 144.3, 143.1, 133.5, 129.3, 120.1, 117.2, 115.8, 61.7, 47.6; 
HRMS (ESI+) calculated for C17H18BN2O4 [M+H]
+
 m/z 325.1360, found 325.1358.   
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Automated Procedure II was followed using 82.9 mg (0.333 mmol) p-hydroxyphenyl 
MIDA boronate 2.6a, 120 µL benzyl bromide 2.5b (1.01 mmol), and 416.4 mg (3.01 mmol) 
K2CO3.  After automated addition of THF (8.4 mL), MeCN (3.6 mL) was added as a co-solvent.  
The reaction was run at 60 °C for 16 h.  The desired aryl MIDA boronate 2.7b was obtained as a 
solid (93.5 mg, 0.276 mmol, 83% yield) of >95% purity.  
1
H-NMR (500 MHz, DMSO-d6:D2O, 
95:5): δ 7.46 – 7.42 (m, 2H), 7.41 – 7.36 (m, 2H), 7.36 – 7.30 (m, 3H), 6.99 (d, J = 8.4 Hz, 2H), 
5.08 (s, 2H), 4.28 (d, J = 17.2 Hz, 2H), 4.06 (d, J = 17.2 Hz, 2H), 2.47 (s, 3H); 
13
C-NMR (125 
MHz, DMSO-d6:D2O, 95:5): δ 169.7, 159.3, 137.3, 134.0, 128.7, 128.1, 127.9, 114.4, 69.2, 61.8, 
47.7; HRMS (ESI+) calculated for C18H19NO5B [M+H]
+
 m/z 340.1356, found 340.1355. 
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Automated Procedure II was followed using 82.2 mg (0.331 mmol) p-aminophenyl 
MIDA boronate  2.6b, 60.7 mg (0.497 mmol) benzoic acid 2.5c, 170.7 mg (0.532 mmol) TATU, 
and 90 µL (0.517 mmol) DIPEA.  After automated addition of THF (8.4 mL), MeCN (3.6 mL) 
was added as a co-solvent.  The reaction was run at 40 °C for 13 h.  The desired aryl MIDA 
boronate 2.7c was obtained as an off-white solid (93.7 mg, 0.266 mmol, 80% yield) of 90% 
purity.  
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5): δ 10.27 (s, 1H), 7.96 – 7.92 (m, 2H), 7.78 – 
7.74 (m, 2H), 7.62 – 7.57 (m, 1H), 7.55 – 7.50 (m, 2H), 7.40 (d, J = 8.3 Hz, 2H), 4.31 (d, J = 
17.2 Hz, 2H), 4.10 (d, J = 17.2 Hz, 2H), 2.51 (s, 3H); 
13
C-NMR (125 MHz, DMSO-d6:D2O, 
95:5): δ169.6, 165.8, 139.8, 135.0, 132.9, 131.8, 128.6, 127.8, 119.7, 61.9, 47.7; HRMS (ESI+) 
calculated for C18H18N2O5B [M+H]
+
 m/z 353.1309, found 353.1310. 
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Automated Procedure II was followed using 91.7 mg (0.331 mmol) p-carboxyphenyl 
MIDA boronate 2.6c, 55 µL (0.345 mmol) p-(tert-butyl)aniline, 118.3 mg (0.367 mmol) TATU, 
and 60 µL (0.344 mmol) DIPEA.  After automated addition of THF (8.4 mL), MeCN (3.6 mL) 
was added as a co-solvent.  The reaction was run at room temperature for 1 h.  The desired aryl 
MIDA boronate 2.7d was obtained as an off-white solid (118.7 mg, 0.291 mmol, 88% yield) of 
90% purity. 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5): δ 10.19 (s, 1H), 7.92 (d, J = 8.2 Hz, 
2H), 7.66 (d, J = 8.7 Hz, 2H), 7.57 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.7 Hz, 2H), 4.35 (d, J = 17.3 
Hz, 2H), 4.14 (d, J = 17.2 Hz, 2H), 2.52 (s, 3H), 1.27 (s, 9H); 
13
C-NMR (125 MHz, DMSO-
d6:D2O, 95:5): δ169.6, 165.7, 146.4, 136.7, 135.5, 134.2, 132.6, 127.0, 125.4, 120.5, 62.1, 47.9, 
34.3, 31.4; HRMS (ESI+) calculated for C22H26BN2O5 [M+H]
+
 m/z 409.1935, found: 409.1931. 
39 
 
 
 
Syntheses Involving Multiple ICC Cycles (Figure 2.2) (Automated Procedure III) 
 
Automated Procedure III - Cartridge Preparation 
For multi-step syntheses, cartridges are prepared in the same manner as outlined in 
Automated Procedure I (for C-C coupling reactions) and Automated Procedure II (for C-X 
bond forming reactions).  Each ICC cycle requires one set of the above described cartridges. 
Automated Procedure III - Experimental Details  
Automated Procedures I and II are followed with the following addendums:  
For two-step syntheses, after eluting the product from the Silica Gel Plug with 12 mL 
THF, the purified MIDA boronate solution is added to the Second Deprotection Cartridge which 
already contains solid NaOH (1.0 mmol, 40 mg).  The Second Reaction Cartridge contains the 
capping building block (0.11 mmol), XPhos 2
nd
 generation palladacycle (0.0056 mmol, 4.4 mg, 5 
mol%), and K3PO4 (1.0 mmol, 212 mg).  The coupling reactions are run at the concentrations 
noted in the following procedures. This cartridge is identical to a First Reaction Cartridge, but is 
not tethered to a Reaction Filtration Cartridge. 
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For three-step syntheses, the Third Deprotection Cartridge contains NaOH (0.33 mmol, 
13.3 mg) and no Drying Cartridge is used for the third reaction. The Third Reaction Cartridge is 
a 7-mL glass vial containing a PTFE-coated magnetic stir, the capping building block (0.037 
mmol), XPhos 2
nd
 generation palladacycle (0.00185 mmol, 1.5 mg, 5 mol%), and K3PO4 (0.33 
mmol, 71 mg). The coupling reactions are run at the concentrations noted in the following 
procedures.  The vial is sealed under argon with a septum-top screw cap.   
At the end of the synthesis, the crude reaction mixture is purified by either silica gel 
chromatography or preparative HPLC. 
 
 
Automated Procedure III was followed with the following modifications: The first 
coupling reaction was run at room temperature for 24 hours. The second deprotection reaction 
was run for 10 minutes, and the second coupling reaction was run in a 20-mL glass vial at room 
temperature using aqueous NaOH as the base for 40 minutes. The procedure was also conducted 
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under subdued light conditions to protect against isomerization of the polyene framework. 2.8 
was afforded as a fluorescent solid (18.3 mg, 0.0662 mmol, 56% yield). 
1
H NMR indicated a 
10:1 mixture of the desired β-parinaric acid (2.8):9-(Z)-parinaric acid (arising from 10:1 E:Z 
mixture of starting material vinyl iodide 2.8-3). TLC (50% Et2O in hexanes): Rf = 0.13, 
visualized by UV; HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-
302), 25 mL/min, gradient: A = water, B = acetonitrile, 0 min: 95% A, 5% B; 2 min: 95% A, 5% 
B; 15 min: 0% A, 100% B; 30 min: 0% A, 100% B): 23.7 min; 
1
H-NMR (500 MHz, CDCl3): δ 
6.21-6.05 (m, 6H), 5.76-5.63 (m, 2H), 2.34 (t, J = 7 Hz, 2H), 2.15-2.07 (m, 4H), 1.66-1.60 (m, 
2H), 1.43-1.26 (m, 8H), 1.01 (t, J = 7.5 Hz, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 179.2, 136.7, 
135.1, 132.6, 132.6, 131.0, 131.0, 130.8, 129.8, 34.0, 33.0, 29.4, 29.2, 29.1, 29.1, 26.0, 24.8, 
13.7; HRMS (ESI+) calculated for C18H29O2 [M+H]
+ 
m/z 277.2168, found 277.2175. 
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Automated Procedure III was followed with the following modifications: In the first 
coupling reaction, SPhos was used as the ligand and the reaction was run for 14 hours at room 
temperature. Both deprotection reactions were run for 10 minutes. The second coupling reaction 
was run in a 7-mL glass vial at 40 °C for 6 hours using Cs2CO3 as the base. The procedure was 
also conducted under subdued light conditions to protect against isomerization of the polyene 
framework. Crude 2.9 was purified via silica gel chromatography (100% hexanes to 30% EtOAc 
in hexanes) to afford 2.9 as a single stereoisomer and a yellow oil (18.2 mg, 0.0491 mmol, 74% 
yield). TLC (petroleum ether: ether 4:1): Rf = 0.86, stained by KMnO4; 
1
H-NMR (500 MHz, 
CDCl3): δ 6.66 (dd, J = 14.8, 11.2 Hz, 1H), 6.27 (d, J = 15.2 Hz, 1H), 6.19-6.08 (m, 3H), 5.54 (d, 
J = 6 Hz, 1H), 5.21 (d, J = 6.4 Hz, 1H), 3.66 (d, J = 11.2 Hz, 2H), 3.53 (d, J = 10.8 Hz, 2H), 2.01 
(t, J = 6.4 Hz, 2H), 1.95 (s, 3H), 1.91 (s, 3H), 1.70 (s, 3H), 1.62-1.59 (m, 2H), 1.47-1.44 (m, 2H), 
1.23 (s, 3H), 1.01 (s, 6H), 0.75 (s, 3H); 
13
C-NMR (125 MHz, CDCl3):δ 139.3, 137.8, 137.6, 
136.6, 135.8, 130.0, 129.3, 127.2, 127.0, 126.2, 109.8, 98.8, 39.6, 34.2, 33.0, 30.0, 28.9, 23.0, 
22.0, 21.7, 19.2, 13.4, 12.7; HRMS (ESI+) calculated for C25H39O2 [M+H]
+ 
m/z 371.2950, found 
371.2950. 
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A 7-mL vial charged with 2.9 (18.2 mg, 0.049 mmol, 1.0 equiv.) was sealed with a 
PTFE-lined cap and purged with N2 and THF (1.0 mL, 0.05M) was added to afford a clear 
yellow solution. The vial was cooled to 0 
°
C in an ice bath for 5 minutes. Aqueous HCl (1M, 0.5 
mL) was added dropwise to the reaction vial and the reaction mixture was allowed to warm to 23 
°
C with stirring over 30 minutes. After 30 minutes, the reaction mixture was transferred to a 
separatory funnel containing aqueous saturated NaHCO3 (5 mL), rinsing with diethyl ether (10 
mL) and the phases were separated. The aqueous layer was back-extracted with diethyl ether (5 
mL) and the combined organic layers were dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo to afford a yellow-orange oil. The resulting crude material (4:1 ratio of all-
trans retinal (2.10):13-cis-retinal) was adsorbed onto Celite™ from an acetone solution and 
purified by silica gel chromatography (32:1 hexanes: EtOAc) to afford 2.10 as an orange solid 
(8.9 mg, 0.0313 mmol, 64% yield). 
1
H-NMR (500 MHz, CDCl3):δ 10.11 (d, J = 8 Hz, 1H), 7.14 
(dd, J = 15, 11.5 Hz, 1H), 6.37 (d, J =15 Hz, 1H), 6.34 (d, J = 15 Hz, 1H), 6.19 (d, J = 9.5 Hz, 
1H), 6.16 (d, J = 16 Hz, 1H), 5.97 (d, J = 8.5 Hz, 1H), 2.33 (d, J = 1 Hz, 3H), 2.04-2.02 (m, 2H), 
2.03 (s, 3H), 1.72 (s, 3H), 1.63-1.60 (m, 2H), 1.49-1.46 (m, 2H), 1.03 (s, 6H). 
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Automated Procedure III was followed with the following modifications: In the first 
coupling reaction, P(o-tol)3 was used as the ligand and K2CO3 and Ag2O were used as the base 
and the reaction was run for 8 hours. Both deprotection reactions were run for 10 minutes. The 
second coupling reaction was run for 18 hours in a 7-mL glass vial. Crude 2.11 was purified via 
silica gel chromatography (40% EtOAc in hexanes to 50% EtOAc in hexanes) to afford 2.11 as 
an off-white solid (14.5 mg, 0.0406 mmol, 61% yield). TLC (20% EtOAc in hexanes): Rf = 0.08, 
visualized by UV; 
1
H-NMR (500 MHz, CDCl3): δ 7.39 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7 Hz, 
2H), 7.23 (t, J = 7 Hz, 1H), 6.56 (d, J = 16.5 Hz, 1H), 6.17-6.01 (m, 3H), 5.63 (s, 1H), 5.38 (br s, 
2H), 4.08 (dd, J = 7.5, 1 Hz, 1H), 3.54 (s, 3H), 3.32 (s, 3H), 3.19 (dd, J = 10, 2 Hz, 1H), 2.56-
2.53 (m, 1H), 2.25 (d, J = 1 Hz, 3H), 1.56-1.52 (m, 1H), 1.19 (d, J = 7 Hz, 3H), 0.84 (d, J = 7 
Hz, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 169.4, 149.7, 137.2, 136.8, 134.1, 132.1, 129.3, 128.7, 
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127.7, 126.5, 119.7, 86.5, 81.1, 61.6, 56.6, 42.7, 40.2, 18.9, 13.9, 9.8; HRMS (ESI+) calculated 
for C22H32NO3 [M+H]
+ 
m/z 358.2382, found 358.2392. 
 
 
Automated Procedure III was followed with the following modifications: The first 
coupling reaction was run using SPhos (10 mol%), Pd(OAc)2
 
(5 mol%)  and K2CO3 as the base. 
The second and third deprotection reactions were run for 10 and 30 minutes, respectively. The 
second coupling reaction was run for 14 hours and the third coupling reaction was run for 24 
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hours using SPhos as the ligand. 2.12 was isolated as a colorless oil (4.7 mg, 36% yield), the 
1
H 
NMR of which contained small amounts of hydrocarbon impurities presumed to represent some 
leaching from the HPLC column. HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product 
number: 413910-302), 25 mL/min, gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 
20% B; 5 min: 0% A, 100% B; 50 min: 0% A, 100% B): 13.4 min; 
1
H-NMR (500 MHz, acetone-
d6): δ 7.67 (s, 1H), 7.64-7.62 (m, 4H), 7.54 (d, J = 9 Hz, 2H), 7.50 (s, 1H), 7.45-7.43 (m, 8H), 
7.25 (d, J = 2 Hz, 1H), 7.21 (d, J = 8.5 Hz, 1H), 7.10 (d, J = 8.5 Hz, 1H), 6.95 (d, J = 1 Hz, 1H), 
6.56 (dd, J = 16, 2 Hz, 1H), 6.51-6.46 (m, 3H), 6.38 (dq, J = 15.5, 6.5 Hz, 1H), 6.35 (s, 1H), 6.26 
(dq, J = 15.5, 6.5 Hz, 1H), 5.46 (s, 2H), 3.86-3.83 (m, 2H), 3.81 (s, 3H), 3.57-3.54 (m, 2H), 1.91 
(dd, J = 6.5, 1.5 Hz, 3H), 1.88 (dd, J = 5, 1.5 Hz, 3H), 1.20-1.17 (m, 2H), 0.99 (s, 9H), 0.89-0.86 
(m, 2H), 0.02 (s, 9H); HRMS (ESI+) calculated for C59H65O6Si2 [M+H]
+ 
m/z 925.4320, found 
925.4316. 
 
 
To a 1-mL Reacti-vial
™
 containing 2.12 and a PTFE-coated magnetic stir bar was added 
CsF (8.2 mg, 0.054 mmol) and 18-crown-6 (1.1 mg, 0.00416) followed by DMSO (0.15 mL) in a 
glovebox. The vial was sealed with a cap and stirred at 50 C for 14 hours. The reaction was then 
cooled to room temperature, diluted with 8 mL EtOAc and washed with a solution of 1:1 
47 
 
saturated aqueous NH4Cl/H2O (8 mL). The aqueous layer was extracted with 4 mL EtOAc. The 
combined organic layers were washed with H2O (2 × 4 mL), then with brine (8 mL). The organic 
phase was dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude product 
was purified by silica gel chromatography to afford 2.13 as an off-white solid (0.2 mg, 0.00036 
mmol, 7% yield). TLC (40% EtOAc/pentane): Rf = 0.44, visualized by shortwave UV; 
1
H-NMR 
(500 MHz, acetone-d6): δ 7.83 (dt, J = 9.0, 2.0 H, 2H), 7.77 (s, 1H), 7.53 (s, 1H), 7.43 (dd, J = 
8.5, 2.0 Hz, 1H), 7.37 (d, J = 8.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 1H), 7.28 (d, J = 8.0, 1.0 Hz, 1H), 
7.17 (d, J = 8.5 Hz, 1H), 7.14 (s, 1H), 6.83 (dt, J = 8.5, 2.0 Hz, 2H), 6.55 (s, 1H), 6.50 (dd, J = 
15.5, 1.5 Hz, 1H), 6.44 (dd, J = 16.0, 1.5 Hz, 1H), 6.31-6.21 (m, 2H), 5.61 (d, J = 1.5 Hz, 1H), 
5.57 (d, J = 2.0 Hz, 1H), 3.96 (s, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 1.84 (dd, J = 6.5, 1.5 Hz, 
3H); HRMS (ESI+) calculated for C36H31O6 [M+H]
+ 
m/z 559.2121, found 559.2128. 
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Automated Procedure III was followed with the following modifications: In the second 
coupling reaction, the addition of the boronic acid was performed over 1 minute and the coupling 
was run in a 7-mL glass vial. 2.14 was afforded as a yellow solid (44.1 mg, 0.0945 mmol, 84% 
yield). TLC (40% DCM in hexanes): Rf = 0.31, visualized by UV; 
1
H-NMR (500 MHz, CDCl3): 
δ 8.06 (d, J = 8 Hz, 2H), 7.59-7.54 (m, 6H), 7.41-7.39 (m, 3H), 7.23 (d, J = 16.5 Hz, 1H), 7.22 
(d, J = 16 Hz, 1H), 7.15 (d, J = 15.5 Hz, 1H), 7.12 (d, J = 16 Hz, 1H), 4.40 (q, J = 7 Hz, 2H), 
1.42 (t, J = 7.5 Hz, 3H), 1.40 (s, 18H); 
13
C-NMR (125 MHz, CDCl3): δ 166.5, 151.2, 141.9, 
137.8, 136.5, 136.0, 130.9, 130.2, 130.1, 129.3, 127.5, 127.4, 127.3, 127.0, 126.4, 122.4, 121.0, 
61.0, 35.0, 31.6, 14.5; HRMS (ESI+) calculated for C33H39O2 [M+H]
+ 
m/z 467.2950, found 
467.2943.  
 
 
To a solution of ethyl ester 2.14 (44.1 mg, 0.0945 mmol) in MeOH/THF 1:1 (2 mL) was 
added LiOH solution (18 mg, 0.752 mmol in 0.4 mL H2O) in one portion. The mixture was 
stirred vigorously at 45 C for 3.5 hours. The reaction was cooled briefly in an ice-water bath 
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and 0.2 mL of 2 N HCl was added. The mixture was diluted with 5 mL H2O and extracted with 
EtOAc (10 mL, then 2 × 5 mL). The combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude product was purified by 
recrystallization from hot toluene. A second crop was obtained by precipitation from 
toluene/hexanes and combined with the first crop to afford 2.15 as a bright yellow solid (20.5 
mg, 0.047 mmol, 50% yield). 
1
H-NMR (500 MHz, DMSO-d6): δ 12.88 (s, 1H), 7.92 (d, J = 8 
Hz, 2H), 7.70 (d, J = 8.5 Hz, 2H), 7.64 (s, 3H), 7.43 (d, J = 1.5 Hz, 2H), 7.40 (d, J = 16.5 Hz, 
1H), 7.34 (d, J = 16.5 Hz, 1H), 7.32 (d, J = 17 Hz, 1H), 7.30 (s, 2H), 7.26 (d, J = 16.5 Hz, 1H), 
1.31 (s, 18 H); 
13
C-NMR (125 MHz, DMSO-d6): δ 167.0, 150.5, 141.5, 137.2, 136.2, 135.7, 
130.6, 129.7 (2C), 129.4, 127.2, 127.1, 126.8, 126.4, 121.6, 120.8, 34.5, 31.2; HRMS (EI+) 
calculated for C31H34O2 [M]
+ 
m/z 438.25588, found: 438.25538. 
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Automated Procedure III was followed. Crude 2.16 was purified via silica gel 
chromatography (100% hexanes to 20% EtOAc in hexanes) to afford 2.16 as a red/orange solid 
(7.5 mg, 0.0194 mmol, 50% yield). TLC (20% EtOAc in hexanes): Rf = 0.29, visualized by 
longwave UV; 
1
H-NMR (500 MHz, CDCl3): δ 9.81 (s, 1H), 7.54 (s, 1H), 7.24 (d, J = 3.5 Hz, 
1H), 7.17 (m, 3H), 7.06 (d, J = 3.5 Hz, 1H), 6.90 (d, J = 5.0 Hz, 1H), 2.48 (s, 3H), 2.43 (s, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 182.6, 141.6, 140.6, 139.7, 139.2, 136.7, 135.8, 134.8, 134.5, 
134.2, 131.7, 130.7, 128.2, 126.2, 124.8, 124.2, 123.8, 16.1, 15.7; HRMS (EI+) calculated for 
C19H14OS4 [M]
+ 
m/z 385.99277, found 385.99217. 
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Automated Procedure III was followed with the following modifications: In the second 
coupling reaction: 1.11 mmol of K3PO4 were used, the addition of the boronic acid was 
performed over 1 minute, and the coupling was run in a 7-mL glass vial. 2.17 was afforded as a 
colorless solid (6.6 mg, 0.0218 mmol, 20% yield). TLC (EtOAc): Rf = 0.30, visualized by UV; 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = acetonitrile, 0 min: 95% A, 5% B; 20 min: 5% A, 95% B): 17.5 min; 
1
H-NMR (500 MHz, acetone-d6): δ 8.63 (br s, 2H), 8.12 (t, J = 1 Hz, 1H), 7.97 (dd, J = 9.5, 1 
Hz, 1H), 7.96 (d, J = 2.5 Hz, 1H), 7.93 (dd, J = 9, 2.5 Hz, 1H), 7.87 (dd, J = 9.5, 1.5 Hz, 1H), 
7.74 (app d, J = 6 Hz, 2H), 7.35 (d, J = 9 Hz, 1H), 3.98 (s, 3H); 
13
C-NMR (125 MHz, DMSO-
d6): δ 157.3, 150.1, 149.3, 148.1, 146.1, 142.2, 135.8, 129.8, 129.1, 129.0, 128.2, 120.9, 114.9 
(2C), 112.7, 56.1; HRMS (ESI+) calculated for C18H14N3O2 [M+H]
+ 
m/z 304.1086, found 
304.1081. 
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Automated Procedure III was followed. Crude 2.18 was purified via silica gel 
chromatography (50% hexanes in EtOAc to 100% EtOAc) to afford 2.18 as a tan-orange solid 
(12.9 mg, 0.0318 mmol, 28% yield). TLC (EtOAc): Rf = 0.25, visualized by UV; 
1
H-NMR (500 
MHz, CDCl3): δ 9.31 (br s, 1H), 9.19 (s, 2H), 8.58 (d, J = 5 Hz, 1H), 8.16 (d, J = 8 Hz, 1H), 8.10 
(s, 1H), 8.05 (s, 1H), 7.95 (d, J = 8.5 Hz, 1H), 7.87-7.81 (m, 2H), 7.74 (d, J = 5.5 Hz, 1H), 7.68-
7.60 (m, 2H), 7.56 (br s, 1H), 1.44 (s, 9H); 
13
C-NMR (125 MHz, CDCl3): δ 171.2, 152.5, 151.6, 
148.5, 143.2, 140.9, 136.9, 135.9, 135.2, 133.2, 132.7, 130.8, 128.9, 128.6, 127.2, 126.8, 126.3, 
125.6, 121.9, 120.6, 118.2, 39.0, 29.9; HRMS (ESI+) calculated for C26H24N5 [M+H]
+ 
m/z 
406.2032, found 406.2031. 
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Automated Procedure III was followed with the following modifications: In the first 
coupling reaction, N,N’-dicyclohexylcarbodiimide (DCC) was used as a coupling agent. The 
DCC, carboxylic acid 2.19-1, and amine MIDA boronate 2.19-2 all began in the First Reaction 
Cartridge and the coupling was run at room temperature for 4 hours. In the second coupling 
reaction, 0.167 mmol of pyrazole 2.19-3, 0.33 mmol of pyridine, 0.25 mmol of Cu(OAc)2, and 
125 mg of activated 4 Å powdered molecular sieves were used, the addition of the boronic acid 
was performed over 1 minute, and the coupling was run at room temperature for 48 hours in a 7-
mL glass vial. 2.19 was afforded a colorless solid (6.7 mg, 0.0159 mmol, 9% yield). TLC (20% 
EtOAc in hexanes): Rf = 0.22, visualized by UV; HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm 
(product number: 413910-302), 25 mL/min, gradient: A = water, B = MeCN, 0 min: 95% A, 5% 
B; 10 min: 5% A, 95% B; 15 min: 5% A, 95% B; 15.5 min: 95% A, 5% B; 20.5 min: 95% A, 5% 
B): 11.6 min; TLC (20% EtOAc in hexanes): Rf = 0.22, visualized by UV. 
1
H-NMR (500 MHz, 
acetone-d6): δ 10.15 (br s, 1H), 8.01 (d, J = 9.0 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 7.52 (s, 1H), 
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2.92 (s, 3H); 
13
C-NMR (125 MHz, acetone-d6): δ 160.8, 159.0, 144.5, 143.1 (JC-F = 39.2 Hz), 
141.1, 135.2, 135.1 (JC-F = 40.1 Hz), 127.7, 121.7, (JC-F = 268.6 Hz), 121.5, 120.1 (JC-F = 269.6 
Hz), 108.3, 13.6; HRMS (ESI+) calculated for C15H10N5OSF6 [M+H]
+ 
m/z 422.0510, found 
422.0504. 
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Library Synthesis (Figure 2.3) 
General Scheme for Automated Synthesis of Library Members 2.30 to 2.41 
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Automated Procedure III as modified for 2.12 was followed to give 2.30 (27.8 mg, 
75% yield). TLC (50% DCM in hexanes): Rf = 0.51, stained by KMnO4; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.82 (d, J = 8.5 Hz, 1H), 7.74-7.71 (m, 4H), 7.53 (d, J = 1.5 Hz, 1H), 7.47-7.42 
(m, 6H), 7.39 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 1.5 Hz, 1H), 7.17 (d, J = 1 Hz, 1H), 6.52-
6.46 (m, 3H), 6.24 (dq, J = 15.5, 6.5 Hz, 1H), 4.14-4.11 (m, 2H), 3.93 (s, 3H), 1.88-1.84 (m, 
5H), 1.09 (s, 9H); 
13
C-NMR (125 MHz, acetone-d6): δ 161.3, 158.8, 153.8 (2C), 136.7, 134.8, 
134.0, 132.2, 131.2, 130.3, 128.7, 128.3, 124.5, 122.8, 118.7, 112.8, 111.2, 106.6, 105.0, 100.0, 
66.2, 55.9, 28.1, 18.6, 18.5, 12.6; HRMS (ESI+) calculated for C36H39O3Si [M+H]
+ 
m/z 
547.2668, found 547.2673.  
 
Automated Procedure III as modified for 2.12 was followed to give 2.31 (27.9 mg, 
72% yield). TLC (50% DCM in hexanes): Rf = 0.23, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.84 (dd, J = 8, 0.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.47-7.43 (m, 6H), 7.14 (s, 1H), 
7.10 (d, J = 1.5 Hz, 1H), 6.93 (d, J = 1.5 Hz, 1H), 6.50-6.45 (m, 3H), 6.24 (dq, J = 15.5, 6.5 Hz, 
1H), 4.14-4.10 (m, 2H), 4.01 (s, 3H), 3.93 (s, 3H), 1.87-1.84 (m, 5H), 1.09 (s, 9H); 
13
C-NMR 
(125 MHz, acetone-d6): δ 161.3, 158.7, 153.7, 145.9, 143.0, 136.7, 135.0, 134.8, 132.6, 132.5, 
130.3, 128.7, 128.3, 124.6, 112.8, 111.6, 106.6, 105.2 (2C), 100.0, 66.2, 56.3, 56.0, 28.1, 18.5 
(2C) 12.6; HRMS (ESI+) calculated for C37H41O4Si [M+H]
+ 
m/z 577.2774, found 577.2767. 
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Automated Procedure III as modified for 2.12 was followed to give 2.32 (25.9 mg, 
54% yield). TLC (50% DCM in hexanes): Rf = 0.49, stained by KMnO4; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.83 (d, J = 8.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.61 (d, J = 1.5 Hz, 1H), 7.47-7.42 
(m, 7H), 7.35 (dd, J = 8.5, 2 Hz, 1H), 7.19 (d, J = 0.5 Hz, 1H), 6.77 (dt, J = 16, 1.5 Hz, 1H), 
6.51-6.47 (m, 2H), 6.35 (dt, J = 15.5, 5 Hz, 1H), 4.47 (dd, J = 4.5, 1.5 Hz, 2H), 4.14-4.11 (m, 
2H), 3.94 (s, 3H), 1.88-1.84 (m, 2H), 1.22-1.08 (m, 30H); 
13
C-NMR (125 MHz, acetone-d6):δ 
161.4, 158.8, 154.1, 154.0, 136.7, 134.8, 133.2, 131.3, 130.3, 130.2, 128.8, 128.7, 128.3, 123.3, 
119.3, 112.8, 111.3, 106.7, 105.0, 100.0, 66.2, 64.8, 56.0, 28.1, 18.6, 18.4, 12.8, 12.6; HRMS 
(ESI+) calculated for C45H59O4Si2 [M+H]
+ 
m/z 719.3952, found 719.3925. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.33 (29.2 mg, 
57% yield). TLC (50% DCM in hexanes): Rf = 0.40, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6):δ 7.84 (app d, J = 9 Hz, 1H), 7.74-7.71 (m, 4H), 7.48-7.43 (m, 6H), 7.17 (d, J = 1 
Hz, 1H), 7.16 (s, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.73 (dt, J = 15.5, 1.5 Hz, 1H), 6.50 (s, 1H), 
6.50--6.48 (m, 1H), 6.36 (dt, J = 16, 4.5 Hz, 1H), 4.47 (dd, J = 5, 1.5 Hz, 2H), 4.14-4.11 (m, 2H), 
4.02 (s, 3H), 3.93 (s, 3H), 1.88-1.84 (m, 2H), 1.20-1.09 (m, 30H); 
13
C-NMR (125 MHz, acetone-
d6): δ 161.3, 158.7, 153.8, 146.0, 143.2, 136.7, 143.7, 134.2, 132.7, 130.5, 130.3, 128.8, 128.7, 
128.3, 112.8, 112.3, 106.6, 105.5, 105.2, 100.0, 66.2, 64.8, 56.3, 55.9, 28.1, 18.6, 18.4, 12.8, 
12.6; HRMS (ESI+) calculated for C46H61O5Si2: [M+H]
+ 
m/z 749.4058, found 749.4056.  
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Automated Procedure III as modified for 2.12 was followed to give 2.34 (9.9 mg, 56% 
yield). TLC (20% EtOAc in hexanes): Rf = 0.28, stained by KMnO4; 
1
H-NMR (500 MHz, 
acetone-d6): δ 8.37 (dd, J = 3, 0.5 Hz, 1H), 7.89 (dd, J = 8.5, 0.5 Hz, 1H), 7.63 (dd, J = 2 Hz, 
1H), 7.50 – 7.48 (m, 2H), 7.39 (dd, J = 8.5, 2 Hz, 1H), 7.31 (d, J = 1 Hz, 1H), 6.53 (dd, J = 16, 
1.5 Hz, 1H), 6.29 (dq, 15.5, 6.5 Hz, 1H), 3.95 (s, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H); 
13
C-NMR 
(125 MHz, acetone-d6):δ 157.0, 156.6, 155.2, 142.5, 139.2, 134.5, 132.0, 130.4, 125.1, 123.7, 
121.2, 120.9, 119.3, 111.9, 103.6, 56.2, 18.6; HRMS (ESI+) calculated for C17H16NO2 [M+H]
+ 
m/z 266.1181, found 266.1180. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.35 (6.9 mg, 35% 
yield). TLC (20% EtOAc in hexanes): Rf = 0.23, stained by KMnO4; 
1
H-NMR (500 MHz, 
acetone-d6): δ 8.36 (dd, J = 3, 0.5 Hz, 1H), 7.89 (dd, J = 8.5, 0.5 Hz, 1H), 7.49 (dd, J = 8.5, 3.0 
Hz, 1H), 7.28 (s, 1H), 7.19 (d, J = 1.5 Hz, 1H), 7.01 (d, J = 1.5 Hz, 1H), 6.50 (d, J = 15.5, 1.5 
Hz, 1H), 6.29 (dq, J = 16, 6.5 Hz, 1H), 4.05 (s, 3H), 3.95 (s, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H); 
13
C-NMR (125 MHz, acetone-d6): δ 156.9, 156.6, 146.3, 144.5, 142.5, 139.2, 135.5, 132.3, 
131.8, 125.1, 121.2, 120.8, 112.0, 105.8, 103.9, 56.3, 56.2, 18.5; HRMS (ESI+) calculated for 
C18H18NO3 [M+H]
+ 
m/z 296.1287, found 296.1282. 
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 Automated Procedure III as modified for 2.12 was followed to give 2.36 (5.6 mg, 19% 
yield). TLC (20% EtOAc in hexanes): Rf = 0.33, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 8.37 (dd, J = 3, 1 Hz, 1H), 7.89 (dd, J = 9, 1 Hz, 1H), 7.71 (d, J = 1.5 Hz, 1H), 
7.52 (d, J = 8.5, 1H), 7.49 (dd, J = 8.5, 3 Hz, 1H), 7.46 (dd, J = 8.5, 1H), 7.34 (d, J = 1 Hz, 1H), 
6.80 (dt, J = 15.5, 2 Hz, 1H), 6.40 (dt, J = 15.5, 5 Hz, 1H), 4.50 (dd, J = 4.5, 2 Hz, 2H), 3.96 (s, 
3H), 1.22-1.10 (m, 21H); HRMS (ESI+) calculated for C26H36NO3Si [M+H]
+ 
m/z 438.2464, 
found 438.2468. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.37 (8.5 mg, 26% 
yield). TLC (20% EtOAc in hexanes): Rf = 0.26, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 8.36 (dd, J= 3, 0.5 Hz, 1H), 7.90 (dd, J = 9, 0.5 Hz, 1H), 7.49 (dd, J = 8.5, 3 Hz, 
1H), 7.30 (s, 1H), 7.26 (d, J = 1.5 Hz, 1H), 7.08 (d, J = 1.5 Hz, 1H), 6.76 (dt, J = 15.5, 2 Hz, 
1H), 6.41 (dt, J = 16, 4.5 Hz, 1H), 4.49 (dd, J = 5, 2 Hz, 2H), 4.06 (s, 3H), 3.95 (s, 3H), 1.21-
1.11 (m, 21H); 
13
C-NMR (125 MHz, acetone-d6):δ 157.0, 156.6, 146.4, 144.7, 142.5, 139.2, 
134.8, 131.9, 130.2, 129.3, 121.2, 120.8, 112.8, 106.0, 103.9, 64.7, 56.4, 56.2, 18.4, 12.8; HRMS 
(ESI+) calculated for C27H38NO4Si [M+H]
+ 
m/z 468.2570, found 468.2572. 
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Automated Procedure III as modified for 2.12 was followed to give 2.38 (27.8 mg, 
69% yield). TLC (20% DCM in hexanes): Rf = 0.27, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.94 (d, J = 9 Hz, 1H), 7.74-7.72 (m, 4H), 7.62 (d, J = 1.5 Hz, 1H), 7.48-7.42 (m, 
7H), 7.37 (dd, J = 8.5, 1.5 Hz, 1H), 7.10 (d, J = 0.5 Hz, 1H), 6.91 (dd, J = 9, 2.5 Hz, 1H), 6.82 
(quint, J = 1.5 Hz, 1H), 6.51 (dd, J = 16, 2 Hz, 1H), 6.27 (dq, J = 16, 7 Hz, 1H), 4.17-4.14 (m, 
2H), 1.90-1.87 (m, 2H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H), 1.10 (s, 9H); 
13
C-NMR (125 MHz, 
acetone-d6): δ 160.7, 154.2, 151.7, 147.0, 136.7, 134.6, 134.5, 132.0, 130.4, 130.3, 129.8, 128.7, 
125.1, 123.8, 121.5 (JC-F = 257 Hz), 119.2, 116.8, 114.2, 111.6, 109.0, 105.7, 67.0, 28.1, 18.6 
(2C), 12.4; HRMS (ESI+) calculated for C36H36F3O3Si [M+H]
+ 
m/z 601.2386, found 601.2386. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.39 (32.2 mg, 
76% yield). TLC (20% DCM in hexanes): Rf = 0.09, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.94 (d, J = 9 Hz, 1H), 7.74-7.72 (m, 4H), 7.48-7.42 (m, 6H), 7.18 (d, J = 1.5 Hz, 
1H), 7.07 (s, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.92 (dd, J = 9, 2.5 Hz, 1H), 6.81 (quint, J = 2 Hz, 
1H), 6.48 (dd, J = 16, 2 Hz, 1H), 6.27 (dq, J = 16, 6.5 Hz, 1H), 4.17-4.14 (m, 2H), 4.03 (s, 3H), 
1.90-1.86 (m, 2H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H), 1.09 (s, 9H); 
13
C-NMR (125 MHz, acetone-
d6): δ 160.7, 151.5, 146.9, 146.1, 143.6, 136.7, 135.5, 134.6, 132.3, 131.9, 130.3, 129.7, 128.7, 
125.1, 121.5 (JC-F = 257 Hz), 116.8, 114.2, 111.8, 109.0, 105.9 (2C), 67.0, 56.4, 28.1, 18.6, 18.5, 
12.4; HRMS (ESI+) calculated for C37H38O4F3Si [M+H]
+ 
m/z 631.2491, found 631.2488. 
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Automated Procedure III as modified for 2.12 was followed to give 2.40 (21.6 mg, 
42% yield). TLC (10% DCM in hexanes): Rf = 0.11, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.95 (d, J = 9 Hz, 1H), 7.74-7.70 (m, 5H), 7.50-7.41 (m, 8H), 7.13 (d, J = 0.5 Hz, 
1H), 6.92 (dd, J = 9, 2.5 Hz, 1H), 6.82 (quint, J = 1.5 Hz, 1H), 6.79 (dt, J = 16, 1.5 Hz, 1H), 6.39 
(dt, J = 16, 4.5 Hz, 1H), 4.48 (dd, J = 5, 2 Hz, 2H), 4.18-4.14 (m, 2H), 1.90-1.87 (m, 2H), 1.21-
1.08 (m, 30H); HRMS (ESI+) calculated for C45H54F3O4Si2 [M+H]
+ 
m/z 771.3513, found 
771.3550. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.41 (35.7 mg, 
65% yield). TLC (20% DCM in hexanes): Rf = 0.11, visualized by UV; 
1
H-NMR (500 MHz, 
acetone-d6): δ 7.95 (d, J = 8.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.46-7.42 (m, 6H), 7.26 (d, J = 1.5 
Hz, 1H), 7.09 (s, 1H), 7.06 (d, J = 1 Hz, 1H), 6.93 (dd, J = 8.5, 2.5 Hz, 1H), 6.81 (quint, J = 1.5 
Hz, 1H), 6.79 (dt, J = 15.5, 2 Hz, 1H), 6.39 (dq, J = 16, 4.5 Hz, 1H), 4.47 (dd, J = 4.5, 1.5 Hz, 
2H), 4.17-4.14 (m, 2H), 4.04 (s, 3H), 1.90-1.86 (m, 2H), 1.20-1.09 (m, 30H); 
13
C-NMR (125 
MHz, acetone-d6): δ 160.7, 151.6, 146.9, 146.2, 143.8, 136.7, 134.8, 134.6, 132.0, 130.3, 130.2, 
129.8, 129.3, 128.7, 121.5 (JC-F = 257 Hz), 116.8, 114.2, 112.6, 109.0, 106.2, 106.0, 67.0, 64.7, 
56.4, 28.1, 18.5, 18.4, 12.8, 12.4; HRMS (ESI+) calculated for C46H57F3O5Si2Na [M+H]
+ 
m/z 
825.3594, found 825.3600. 
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General Scheme for Automated Synthesis of Library Members 2.12 and 2.42 to 2.48 
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Automated Procedure III as modified for 2.12 was followed to give 2.42 (3.7 mg, 34% 
yield). HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 
mL/min, gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 
100% B; 50 min: 0% A, 100% B): 17.1 min; 
1
H-NMR (500 MHz, acetone-d6): δ 7.71 (s, 1H), 
7.68-7.61 (m, 6H), 7.60 (d, J = 2.5 Hz, 1H), 7.50 (d, J = 1.5 Hz, 1H), 7.47-7.41 (m, 7H), 7.36 (d, 
J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 1.5 Hz, 1H), 7.17-7.13 (m, 2H), 7.10-7.06 (m, 2H), 6.95 (d, J 
= 1 Hz, 1H), 6.56 (dd, J = 16, 2 Hz, 1H), 6.51 (dd, J = 16, 1.5 Hz, 1H), 6.38 (dq, J = 16, 6.5 Hz, 
1H), 6.34 (s, 1H), 6.25 (dq, J = 15.5, 7 Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 5.49 (d, J = 2 Hz, 1H), 
3.88-3.86 (m, 2H), 3.79 (s, 3H), 1.90 (dd, J = 6.5, 1.5 Hz, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 
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1.27-1.23 (m, 2H), 0.99 (s, 9H); HRMS (ESI+) calculated for C54H53O5Si [M+H]
+ 
m/z 809.3662, 
found 809.3658. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.43 (5.1 mg, 44% 
yield). HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 
mL/min, gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 
100% B; 50 min: 0% A, 100% B): 14.3 min; TLC (70% DCM in hexanes): Rf = 0.5, visualized 
by UV; 
1
H-NMR (500 MHz, acetone-d6): δ 7.75 (s, 1H), 7.68-7.63 (m, 6H), 7.59 (d, J = 2.5 Hz, 
1H), 7.47-7.41 (m, 8H), 7.17-7.14 (m, 2H), 7.10-7.07 (m, 3H), 6.93 (s, 1H), 6.55 (dd, J = 16, 1.5 
Hz, 1H), 6.48 (dd, J = 16, 1.5 Hz, 1H), 6.38 (dq, J = 16, 6.5 Hz, 1H), 6.34 (s, 1H), 6.26 (dq, J = 
15.5, 6.5 Hz, 1H), 5.51 (d, J = 2 Hz, 1H), 5.50 (d, J = 2 Hz, 1H), 4.00 (s, 3H), 3.88-3.85 (m, 2H), 
3.78 (s, 3H), 1.90 (dd, J = 6.5, 1.5 Hz, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 1.27-1.23 (m, 2H), 
0.99 (s, 9H); HRMS (ESI+) calculated for C55H55O6Si [M+H]
+ 
m/z 839.3768, found 839.3772. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.44 (0.6 mg, 5% 
yield). HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 
mL/min, gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 
100% B; 50 min: 0% A, 100% B): 48.3 min; 
1
H-NMR (500 MHz, acetone-d6): δ 7.71 (s, 1H), 
7.67-7.58 (m, 7H), 7.47-7.37 (m, 10H), 7.16-7.14 (m, 2H), 7.10-7.07 (m, 2H), 6.97 (s, 1H), 6.78 
(app d, J = 16 Hz, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.41-6.36 (m, 2H), 6.35 (s, 1H), 5.51 (d, 
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J = 1.5 Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 4.50 (dd, J = 5, 2 Hz, 2H), 3.88-3.85 (m, 2H), 3.79 (s, 
3H), 1.91 (dd, J = 6.5, 1.5 Hz, 3H), 1.29-1.07 (m, 23H), 0.94 (s, 9H); HRMS (ESI+) calculated 
for C63H73O6Si2 [M+H]
+ 
m/z 981.4946, found 981.4949. 
 
Automated Procedure III as modified for 2.12 was followed to give 2.45 (3.0 mg, 23% 
yield). Library member 2.45 was isolated as a colorless oil (3.0 mg), the 
1
H NMR of which 
contained small amounts of hydrocarbon impurities presumed to represent some leaching from 
the HPLC column. HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-
302), 25 mL/min, gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 
0% A, 100% B; 50 min: 0% A, 100% B): 33.4 min; TLC (50% DCM in hexanes): Rf = 0.18, 
visualized by UV; 
1
H-NMR (500 MHz, acetone-d6):δ 7.75 (s, 1H), 7.69-7.62 (m, 6H), 7.60 (d, J 
= 2.5 Hz, 1H), 7.47-7.40 (m, 7H), 7.17-7.13 (m, 3H), 7.10-7.06 (m, 2H), 7.00 (d, J = 1.5 Hz, 
1H), 6.95 (s, 1H), 6.76 (dt, J = 15.5, 1.5 Hz, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.40-6.35 (m, 
2H), 6.34 (s, 1H), 5.52 (d, J = 1.5 Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 4.49 (dd, J = 5, 2 Hz, 2H), 
4.02 (s, 3H), 3.88-3.85 (m, 2H), 3.78 (s, 3H), 1.90 (dd, J = 6.5, 2.5 Hz, 3H), 1.29-1.23 (m, 2H), 
1.23-1.08 (m, 21H), 0.99 (s, 9H); HRMS (ESI+) calculated for C64H74O7Si2Na [M+Na]
+ 
m/z 
1033.4871, found 1033.4895. 
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Automated Procedure III as modified for 2.12 was followed to give 2.46 (3.5 mg, 26% 
yield). HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 
mL/min, gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 
100% B; 50 min: 0% A, 100% B): 12.2 min; 
1
H-NMR (500 MHz, acetone-d6): δ 7.71 (s, 1H), 
7.64-7.62 (m, 4H), 7.56-7.53 (m, 2H), 7.46-7.41 (m, 8H), 7.10 (d, J = 8 Hz, 1H), 7.08 (d, J = 1 
Hz, 1H), 6.94 (d, J = 1.5 Hz, 1H), 6.93 (s, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.51-6.47 (m, 
3H), 6.38 (dq, J = 15.5, 6.5 Hz, 1H), 6.34 (s, 1H), 6.27 (dq, J = 15.5, 6.5 Hz, 1H), 5.46 (s, 2H), 
4.02 (s, 3H), 3.87-3.84 (m, 2H), 3.80 (s, 3H), 3.56 (app t, J = 8 Hz, 2H), 1.90 (dd, J = 6.5, 1.5 
Hz, 3H), 1.88 (dd, J = 6.5, 1.5 Hz, 3H), 1.23-1.20 (m, 2H), 0.98 (s, 9H), 0.91-0.88 (m, 2H), 0.03 
(s, 9H); HRMS (ESI+) calculated for C60H67O7Si2 [M+H]
+ 
m/z 955.4425, found 955.4437. 
 
 
Automated Procedure III as modified for 2.12 was followed to give 2.47 (1.3 mg, 4% 
yield). HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 
mL/min, gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 
100% B; 50 min: 0% A, 100% B): 26.8 min; 
1
H-NMR (500 MHz, acetone-d6): δ 7.69 (s, 1H), 
7.64-7.61 (m, 5H), 7.57 (s, 1H), 7.55 (d, J = 9 Hz, 2H), 7.46-7.34 (m, 9H), 7.10 (d, J = 8.5 Hz, 
1H), 6.97 (s, 1H), 6.80 (dt, J = 16, 1.5 Hz, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.49 (d, J = 7 Hz, 
2H), 6.41-6.34 (m, 3H), 5.46 (s, 2H), 4.51 (dd, J = 5, 2 Hz, 2H), 3.90-3.85 (m, 2H), 3.81 (s, 3H), 
3.58 (app t, J = 8 Hz, 2H), 1.91 (dd, J = 6.5, 1 Hz, 3H), 1.24-1.17 (m, 5H), 1.15-1.12 (m, 18H), 
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0.99 (s, 9H), 0.88 (m, 2H), 0.03 (s, 9H); HRMS (ESI+) calculated for C68H85O7Si3 [M+H]
+ 
m/z 
1097.5603, found 1097.5591 
 
Automated Procedure III as modified for 2.12 was followed to give 2.48 (4.0 mg, 26% 
yield). Library member 2.48 was isolated as a colorless oil (4.0 mg), the 
1
H NMR of which 
contained small amounts of hydrocarbon impurities presumed to represent some leaching from 
the HPLC column. HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-
302), 25 mL/min, gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 
0% A, 100% B; 50 min: 0% A, 100% B): 22.3 min; 
1
H-NMR (500 MHz, acetone-d6): δ 7.72 (s, 
1H), 7.64-7.62 (m, 5H), 7.55 (d, J = 8.5 Hz, 2H), 7.46-7.41 (m, 7H), 7.14 (d, J = 1 Hz, 1H), 7.10 
(d, J = 8 Hz, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.95 (s, 1H), 6.76 (dt, J = 15.5, 1.5 Hz, 1H), 6.56 (dd, 
J = 16, 2 Hz, 1H), 6.49 (d, J = 8.5 Hz, 2H), 6.42-6.34 (m, 3H), 5.44 (d, J = 2 Hz, 1H), 5.43 (d, J 
= 2 Hz, 1H), 4.50 (dd, J = 5, 2 Hz, 2H), 4.03 (s, 3H), 3.88-3.82 (m, 2H), 3.80 (s, 3H), 3.59 (app t, 
J = 8 Hz, 2H), 1.91 (dd, J = 6.5, 1.5 Hz, 3H), 1.24-1.17 (m, 5H), 1.15-1.13 (m, 18H), 0.99 (s, 
9H), 0.91-0.88 (m, 2H), 0.03 (s, 9H); HRMS (ESI+) calculated for C69H86O8Si3Na [M+Na]
+ 
m/z 
1149.5528, found 1149.5552. 
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Semi-Automated Synthesis of Cyclic Targets (Figure 2.4) Using Automated Procedures III and 
IV 
 
Automated Procedure IV - Cartridge Preparation 
Unless otherwise noted, “cartridge” refers to a 12-g Luknova column capped with a 12-g 
Luknova column screw cap.  Additionally, the Second-Generation procedure makes use of 
custom 40 mL reaction vials which are fitted at their bottom with ground-glass joints designed to 
fit into a Luer lock and at their tops with threads to allow for sealing with septum-top screw caps. 
First Deprotection Cartridges are the 40 mL reaction vials described above.  They 
contain solid starting MIDA boronate and solid NaOH. 
Second and Third Deprotection Cartridges are the 40 mL reaction vials described 
above.  They contain solid NaOH. 
Predrying Cartridges are not used in Automated Procedure IV.       
Drying Cartridges contain 4.2 g Na2SO4, topped with the plunger from a 5 mL syringe. 
Concentration/Deoxygenation Cartridges are empty.  
First Reaction Cartridges are the 40 mL reaction vials described above, and contain a 
PTFE-coated magnetic stir bar, coupling partner, catalyst, ligand, and base.  These cartridges 
have no frit at their base.  The Luer port at the bottom is packed with a small piece of Kimwipe 
(so that solids are retained in the vial during weighing).  The top of the vial is capped with a 
screw-top rubber septum cap.  This septum is pierced with a 1.5 inch 18 G needle which is 
connected to an empty 4 g Luknova column (capped with a 4 g Luknova column screw cap 
connected to a source of dry nitrogen).  Additionally, the cap is tethered to the screw cap topping 
the Reaction Filtration Cartridge via PTFE tubing (1/16-inch I.D., 1/8-inch O.D.)  This tubing is 
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adjusted in such a way to be ~5 mm above the base of the reaction vessel, and is used to transfer 
the crude reaction mixture to the Reaction Filtration Cartridge. 
Reaction Filtration Cartridges contain 1.0 g Celite™ and 0.5 g Florisil® which have 
been thoroughly mixed. This is tethered to the First Reaction Cartridge as described above. 
Second and Third Reaction Cartridges contain a PTFE-coated magnetic stir bar, 
coupling partner, catalyst and ligand, and base. 
Precipitation Cartridges contain a PTFE-coated magnetic stir bar, Celite™ (150 mg), 
and 3-aminopropyl functionalized silica gel (250 mg). Hexanes (10 mL) is added and the 
cartridge is swirled vigorously to suspend and homogenize the mixture of solids. The stir bar and 
solids are allowed to settle over 30 seconds and the supernatant hexanes is pushed out of the 
cartridge with an overhead pressure of air. The stir bar is now embedded in the mixture of solids 
wet with hexanes. 
Silica Gel Plugs contain silica gel, tightly packed, and topped with a 4-g Luknova 
column frit. This is capped with a 4-g Luknova column screw cap, using four layers of PTFE 
tape on the sealing insert to ensure a leak-free seal. 
Automated Procedure IV - Experimental Details 
Deprotection In the deprotection module, to a Deprotection Cartridge containing starting 
MIDA boronate (1.0 mmol) and NaOH  (3.0 mmol, 120 mg) is added 3 mL THF followed by 3 
mL water.  This solution is then agitated by bubbling argon through the solution for 20 minutes 
at room temperature while open to the air.  After the reaction is completed, argon is then 
continually bubbled through the solution for 1 hour to remove THF, leaving a primarily aqueous 
solution of what is presumed to be the trihydroxyborate salt.  After concentration, sat. NH4Cl (3 
mL) is added to quench the reaction, causing a white precipitate to form.  After briefly agitating, 
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diethyl ether (4 mL) is added to extract the boronic acid from the aqueous layer.  This biphasic 
mixture is then agitated via argon sparging (60 seconds) before removing the aqueous layer from 
the Deprotection Cartridge.  The organic layer is then moved to the Drying Cartridge via the 
primary pump.  The aqueous layer is then replaced into the Deprotection Cartridge.  The ether 
extraction procedure is repeated twice more (12 mL total) before disposing of the aqueous layer.  
The ethereal boronic acid solution is then dried in the Drying Cartridge via the repeated injection 
and withdrawal of the solution (20 repetitions).  The solution is then passed into the 
Concentration/Deoxygenation Cartridge before washing the contents of the Drying Cartridge 
with 2 mL diethyl ether.  The solution is then concentrated to ~2 mL before solvent switching by 
adding THF (4 mL) and then concentrating to ~2 mL.  Another portion of THF (4 mL) is added 
before concentrating to the volume required for the subsequent coupling reaction.  
Coupling In the coupling module, a Reaction Cartridge is charged with bifunctional 
halo-MIDA boronate or capping halide building block, ligand and/or catalyst in a glovebox.  The 
Cartridge is warmed to the appropriate temperature before having the THF solution of boronic 
acid added in a single portion. 
Purification In the purification module, the crude reaction mixture is added to a Reaction 
Filtration Cartridge and 12 mL hexanes is added to the Precipitation Cartridge/Silica Gel Plug.  
Then, a 3 mL portion of the filtered crude reaction mixture is added to the Precipitation Cartridge 
and the solvent is removed from the cartridge, loading any crude reaction product onto the Silica 
Gel Plug (“catch”).  This process is performed a total of ten times, using 3 mL THF to wash the 
Reaction and Reaction Filtration Cartridges for each cycle.  Then, 12 mL of 1.5% MeOH in Et2O 
are added and the solvent is removed three times (36 mL total).  Then, 12 mL of Et2O are added 
and the solvent is removed three times (36 mL total).  Finally, 12 mL THF are added and slowly 
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removed (to increase residence time in the column), giving a purified solution of MIDA 
boronate. The solution is then moved to an empty Concentration/Deoxygenation Cartridge and 
concentrated to 3 mL before being added to the next Deprotection Cartridge. 
 
 
Automated Procedure III was followed with the following modifications: In the first 
deprotection reaction, 4 mmol of NaOH were used and the reaction was run for 30 minutes. In 
the first coupling reaction, the concentration was 0.05 M with respect to 2.50, 1 mmol of Ag2O, 2 
mmol of K2CO3, and 25 mol% of Pd[P(o-tol)3]2 were used, the addition of the boronic acid was 
performed over 1 minute, and the reaction was run at 60 °C for 14 hours. In the second 
deprotection reaction, 0.3 mmol of NaOH were used. In the second coupling reaction, the 
concentration was 0.02 M with respect to 2.51, 0.3 mmol of K3PO4 and 10 mol% of 2
nd
 
generation XPhos palladacycle were used, and the reaction was run for 6 hours in a 7-mL glass 
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vial.   For the purification steps, the Et2O:MeOH eluent (1.5% MeOH in Et2O) was diluted 50% 
with hexanes. This automated cycle was performed 6 times to accumulate 2.53 as a slightly 
yellow residue (88.4 mg total; average of 14.7 mg, 0.020 mmol, 39% yield).  HPLC (Agilent 
Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, gradient: A = 
MeCN, B = EtOAc, 0 min: 100% A, 0% B; 1 min: 100% A, 0% B; 10 min: 90% A, 10% B; 25 
min: 90% A, 10% B; 25.5 min: 100% A, 0% B): 18.5 min; 
1
H-NMR (500 MHz, acetone-d6): δ 
7.50-7.48 (m, 2H), 7.43-7.39 (m, 4H), 7.37-7.32 (m, 3H), 7.31-7.28 (m, 1H), 6.77 (d, J = 2.5 Hz, 
1H), 6.68 (d, J = 2.5 Hz, 1H), 6.37 (d, J = 3.0 Hz, 1H), 6.10 (d, J = 3.0 Hz, 1H), 5.14 (s, 2H), 
5.13 (s, 2H), 4.14-4.08 (m, 3H), 3.64 (d, J = 1.5 Hz, 2H), 2.75 (t, J = 8.0 Hz, 2H), 1.92-1.80 (m, 
2H), 1.24 (d, J = 6.5 Hz, 3H), 1.09-1.08 (m, 21H), 0.98-0.95 (m, 2H), 0.03 (s, 9H); 
13
C-NMR 
(125 MHz, acetone-d6): δ171.6, 160.2, 158.8, 155.8, 148.1, 138.2, 138.1, 137.1, 129.3, 129.1, 
128.7, 128.5, 128.4, 128.0, 115.4, 112.0, 110.2, 106.6, 100.3, 70.9, 70.6, 68.7, 63.0, 40.9, 38.8, 
24.5, 23.8, 18.6, 18.5, 17.9, 13.2, -1.5 ; HRMS (ESI+) calculated for C44H63O6Si2 [M+H]
+ 
m/z 
743.4163, found 743.4166. 
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A 7 mL vial containing protected seco acid 2.53 (85.6 mmol, 0.115 mmol, 1 equiv) and a 
stir bar was charged with TBAF·3H2O (185 mg, 0.586 mmol, 5.1 equiv) in the glovebox. The 
vial was sealed with a septum cap and brought out of the glovebox. DMSO (2.3 mL) was added 
via syringe and the reaction was stirred at 50 °C for 70 min in a heating block. The reaction was 
cooled to room temperature, then partitioned between H2O (20 mL) and Et2O (20 mL). After 
mixing thoroughly and separating the phases (both phases should become clear), the aqueous 
layer was extracted with Et2O (20 mL, then with 10 mL). The combined organics were washed 
with brine, dried over MgSO4, filtered and concentrated to ~ 5mL. Celite was added to the 
solution and the crude product was adsorbed onto celite in vacuo. The celite pad was loaded onto 
a florisil column (5 cm length, 2 cm diameter) equilibrated with 60% EtOAc/hexanes. The 
impurities were eluted with 80% EtOAc/hexanes + 0.1% AcOH. The product was eluted with 
80% EtOAc/hexanes + 0.2% AcOH. The fractions containing the product were concentrated to ~ 
5 mL and then azeotroped with n-heptane to remove residual AcOH. After complete removal of 
solvent, the residue was triturated with 1:5 DCM:pentane, causing an off-white solid to 
precipitate. The suspension was then concentrated in vacuo and dried under high vacuum to give 
an off-white fluffy solid as the product 2.53-1 (41 mg, 73%).  
1
H-NMR matches literature data.
15 
 
The following procedure is modified from a known literature procedure.
15
 A dry 40 mL 
vial equipped with a stir bar was charged with PPh3 (99.2 mg, 0.378 mmol, 5.05 equiv). The vial 
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was sealed with a septum cap, evacuated and filled with N2 (×3). THF (2.5 mL) was added, 
followed by PhMe (5 mL). A dry 7 mL vial was charged with seco acid 2.53-1 (36.4 mg, 0.0748 
mmol, 1 equiv), sealed with a septum cap, evacuated and filled with N2 (×3). THF (0.4 mL) and 
PhMe (2 mL) was added. Diethyl azodicarboxylate solution (40 wt% in PhMe, 0.17 mL, 0.374 
mmol, 5 equiv) was then added to the 40 mL vial via syringe, giving a very light yellow solution. 
A 3 mL syringe was charged with 1.2 mL of the seco acid solution, which was added to the 40 
mL vial over 6 h with the aid of a syringe pump. The reaction was then stirred for another 1 h. 
Another portion of PPh3 (99.2 mg, 0.378 mmol, 5.05 equiv) was added as a solid. The vial was 
flushed briefly with N2 and re-sealed with a septum cap. Another portion of diethyl 
azodicarboxylate solution (40 wt% in PhMe, 0.17 mL, 0.374 mmol, 5 equiv) was added. The 3 
mL syringe was then charged with the remaining seco acid solution and added to the reaction 
over 5 h. The reaction was then stirred for another 5 h. THF (0.3 mL) was used to rinse out the 7 
mL vial, adding the rinse to the reaction over 1h. The reaction was stirred for another 3.5 h, then 
transferred to a recovery flask, rinsing with EtOAc. Celite was added and the crude product 
adsorbed in vacuo. The crude product was purified by silica gel column (hexanes to 5% to 10% 
to 15% EtOAc/hexanes) to give an off-white solid as the pure product 2.53-2 (12.4 mg, 35%). 
TLC (30% Et2O/hexanes): Rf = 0.28, visualized by short wave UV; 
1
H-NMR matches literature 
data.
15
 Supplementary 
1
H-NMR: (500 MHz, CDCl3): δ 7.43-7.38 (m, 4H), 7.35-7.31 (m, 4H), 
7.29-7.27 (m, 2H), 6.55 (d, J = 2.5 Hz, 1H), 6.57 (d, J = 2.0 Hz, 1H), 6.31 (d, J = 3.0 Hz, 1H), 
6.09 (d, J = 3.0 Hz, 1H), 5.30-5.24 (m, 1H), 5.09 (d, J = 11.5 Hz, 1H), 5.05 (d, J = 12.5 Hz, 1H), 
5.04 (d, J = 11.5 Hz, 1H), 5.00 (d, J = 12.0 Hz, 1H), 3.28 (dd, J = 17.0, 14.5 Hz, 2H), 2.83 (ddd, 
J = 15.5, 6.5, 2.5 Hz, 1H), 2.73 (ddd, J = 15, 11.5, 2.5 Hz, 1H), 2.07-2.03 (m, 1H), 1.86-1.79 (m, 
1H), 1.27 (d, J = 6.5 Hz, 3H). 
75 
 
 
In an unoptimized procedure, a solution of the dibenzyl ether 2.53-2 (12.1 mg, 0.0258 
mmol) in a 7 mL vial was charged with 10% Pd/C (2 mg) The vial was sealed with a septum cap 
and H2 gas was bubbled through the stirring suspension for 8 min from a balloon. The outlet 
needle was removed and the reaction was stirred under H2 atmosphere at room temperature. 
After 1 h, another portion of 10% Pd/C (1.4 mg) was added to the reaction. The vial was flushed 
with H2 for 3 min, then left to stir. After another 2 h, a third portion of 10% Pd/C (5 mg) was 
added and the reaction was left to stir for another 25 min. The reaction was then purged with N2 
for 5 min, then filtered through celite, rinsing with EtOAc. The filtrate was concentrated in 
vacuo, azeotroping once with CH2Cl2. The crude product was purified by silica gel 
chromatography (20% to 30% to 40% EtOAc/pentane) to give a mixture of citreofuran and the 
tetrahydrofuran side product arising from reduction of the furan ring. The pure product 2.54 
(0.99 mg, 13%) was obtained after HPLC purification (Agilent Prep-C18, 10 µm, 30 x 150 mm, 
product number: 413910-302, 25 mL/min, gradient: 40% to 70% EtOH/H2O in 25 min) 
1
H-NMR 
matches literature data.
15
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Automated Procedure III was followed with the following details/modifications:  In the 
first coupling reaction, the concentration was 0.05 M with respect to building block 2.56 (0.33 
mmol), 5 mol% of Pd(OAc)2, 10 mol% of dppf, 1 mmol of Ag2O, and 2 mmol of K2CO3 were 
used, the addition of the boronic acid was performed over 1 minute, and the reaction was run at 
45 °C for 12 hours.  In the second deprotection reaction, 0.58 mmol of NaOH was used and the 
reaction was run for 30 minutes.  In the second coupling reaction, 25 mol% of Pd[P(o-tol)3]2, 
0.195 mmol of Ag2O, and 0.389 mmol of K2CO3 were used.  The addition of the boronic acid 
was performed over <1 minute, and the reaction was run at 60 °C for 12 hours.  The crude 
reaction mixture was purified by two rounds of column chromatography (10% Et2O/hexanes; 
20% to 30% to 35% to 45% DCM/hexanes).  This automated procedure was performed 2 times 
to accumulate 2.59 as a slightly yellow residue (19.4 mg total, average 9.7 mg, 0.022 mmol, 21% 
average yield).  TLC (40% CH2Cl2/hexanes): Rf = 0.25, visualized by UV, stained by KMnO4; 
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1
H-NMR (500 MHz, CDCl3): δ 6.64 (dt, J = 7.5, 1.5 Hz, 1H), 6.32-6.27 (m, 1H), 6.13-6.08 (m, 
1H), 5.72-5.64 (m, 2H), 4.31 (app d, J = 4.5 Hz, 2H), 2.25-2.10 (m, 3H), 2.01-1.95 (m, 1H), 1.76 
(d, J = 1.5 Hz, 3H), 1.57 (sextet, J = 6.5 Hz, 1H), 1.50-1.43 (m, 10 H), 1.30-1.24 (m, 1H), 1.14-
1.06 (m, 21H), 0.92 (d, J = 7.0 Hz, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 167.6, 141.2, 132.3, 
131.2, 130.5, 129.7, 129.0, 79.9, 63.7, 40.0, 35.2, 33.0, 28.1, 26.3, 19.4, 18.0, 12.3, 12.0; HRMS 
(ESI+) calculated for C27H50O3SiNa [M+Na]
+ 
m/z 473.3427, found 473.3430. 
 
 
To a polyethylene vial containing a solution of 2.59 in THF (0.4 mL) was added 
HF·pyridine (0.09 mL), followed by THF (0.3 mL). The vial was capped and stirred at room 
temperature for 3 h. The reaction was quenched with the dropwise addition of saturated aqueous 
NaHCO3 (5 mL). The mixture was stirred for 5 min, then transferred to a separatory funnel 
saturated aqueous NaHCO3 (3 mL), rinsing with Et2O (8 mL). After mixing and phase 
separation, the aqueous layer was extracted with Et2O (4 mL × 2). The combined organics were 
washed with H2O, brine, dried over MgSO4, filtered and concentrated in vacuo, azeotroping once 
with CH2Cl2. The crude product was purified by silica gel chromatography (30% to 40% 
Et2O/pentane) to give a colorless liquid as the product 2.59-1 (7.3 mg, 60%). TLC (50% 
Et2O/hexanes): Rf = 0.32, visualized by UV, stained by KMnO4; 
1
H-NMR (500 MHz, CDCl3): δ 
6.63 (td, J = 7.5, 1.5 Hz, 1H), 6.23 (dd, J = 15.0, 10.0 Hz, 1H), 6.04 (dd, J = 15.0 Hz, 10.5 Hz, 
1H), 5.73 (dt, J = 15.5 Hz, 6.0 Hz, 1H), 5.67 (dt, J = 15.0, 7.5 Hz, 1H), 4.17 (app d, J = 5.5 Hz, 
1H), 2.20-2.08 (m, 3H), 1.99-1.93 (m, 1H), 1.78 (d, J = 1.0 Hz, 3H), 1.56-1.41 (m, 11H), 1.33 (t, 
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J = 9.5 Hz, 1H), 1.27-1.21 (m, 1H), 0.89 (d, J = 6.5 Hz, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 
167.6, 141.2, 133.7, 131.9, 130.8, 129.6, 129.0, 79.9, 63.5, 40.0, 35.2, 32.9, 28.1, 26.3, 19.4, 
12.3; HRMS (ESI+) calculated for C18H30O3Na [M+Na]
+ 
m/z 317.2093, found 317.2096. 
 
The following procedure is modified from a known literature procedure:
16
 A Schlenk 
bomb containing alcohol 2.59-1 (7.3 mg, 0.0248 mmol) and a stir bar was charged with 1,2-
dichlorobenzene (2.5 mL) under a stream of N2. Methlyene blue (~ 1 mg) was added, forming a 
blue solution. The solution was degassed with 6 freeze-pump-thaw cycles. The flask was sealed 
under vacuum, then warmed to room temperature and placed in a sand bath and warmed to ~150 
°C. The reaction temperature was allowed to equilibrate for another 15 min before introducing 
N2 gently into the reaction vessel. The vessel was sealed again and stirred at 200-210 °C (bath 
temperature). The reaction was stirred for a total of 68 h at that temperature. The reaction was 
cooled to room temperature, then transferred to a 15 mL rbf, rinsing with CH2Cl2. The CH2Cl2 
was removed by rotary evaporation. The remaining solvent was removed by distillation under 
vacuum, giving a blue residue. The crude product was loaded onto a silica gel column 
equilibrated with 10% Et2O/pentane. The product was eluted with 20% Et2O/pentane. This semi-
purified product was purified on a second silica gel column (100% CH2Cl2) to give oblongolide 
2.60 as a white solid (1.3 mg, 24%) in 85-90% purity. 
1
H-NMR matches literature data.
16
 
Supplementary data: 
1
H-NMR (500 MHz, CDCl3): δ 5.61 (d, J = 10.0 Hz, 1H), 5.55 (ddd, J = 
10.0, 4.5, 2.5 Hz, 1H), 4.39 (t, J = 9.0 Hz, 1H), 3.83 (dd, J = 11.0, 8.5 Hz, 1H), 2.75-2.70 (m, 
1H), 1.96-1.74 (m, 3H), 1.52-1.45 (m, 1H), 1.35-1.21 (m, 3H), 1.14 (s, 3H), 0.97-0.84 (m, 4H), 
0.79 (q, J = 12.3 Hz, 1H) 
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Automated Procedure III was followed with the following modifications:  In the first 
coupling reaction, the concentration was 0.05 M with respect to 2.62, 1 mmol of Ag2O, 3 mmol 
of K2CO3, 5 mol% of Pd(OAc)2, and 20 mol% of P(o-tol)3 were used, the addition of the boronic 
acid was performed over 1 minute, and the reaction was run at 55 °C for 14 hours.  In the second 
deprotection reaction, 0.7 mmol NaOH were used and the reaction was run for 30 minutes.  In 
the second coupling reaction, vinyl iodide 2.63 was weighed into a clean, dry 7 mL vial in a 
glove box, sealed and removed immediately prior to the reaction, and was then washed into the 
reaction vial using THF (1 mL) in an automated fashion.  The concentration was 0.05 M with 
respect to 2.63 (0.233 mmol), 0.233 mmol of Ag2O, 0.699 mmol of K2CO3, and 25 mol% of 
Pd[P(o-tol)3]2 were used, the addition of the boronic acid was performed over <1 minute, and the 
reaction was run at 55 °C for 13 hours in a 7-mL glass vial.  For the purification steps, the 
Et2O:MeOH eluent (1.5% MeOH in Et2O) was diluted 50% with hexanes.  This automated cycle 
was performed 9 times to give 48.9 mg of crude linear precursor 2.65 as a slightly yellow 
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residue.  This was purified by two rounds of column chromatography (5% to 10% to 20% 
Et2O/hexanes; 5% acetone/hexanes) to yield 18.8 mg of linear precursor 2.65. TLC (80% 
CH2Cl2/hexanes): Rf = 0.35, visualized by UV, stained by KMnO4; 
1
H-NMR (500 MHz, CDCl3): 
δ 7.37 (app d, J = 8 Hz, 2H), 7.30 (app t, J = 7.5 Hz, 2H), 7.19 (t, J = 7.0 Hz, 1H), 6.74 (dd, J = 
15.5, 10.5 Hz, 1H), 6.44 (d, J = 16 Hz, 1H), 6.21 (dd, J = 15, 10.5 Hz, 1H), 5.93 (dt, J = 15.5, 7.0 
Hz, 1H), 5.80 (dt, J = 15.5, 7.0 Hz, 1H), 5.59 (ddt, J = 16.0, 5.5, 1.0 Hz, 1H), 4.85 (d, J = 5.0 Hz, 
1H), 3.65 (d, J = 11.5 Hz, 2H), 3.50 (d, J = 10.5 Hz, 2H), 2.17 (q, J = 7.0 Hz, 2H), 2.12 (q, J = 
7.0 Hz, 2H), 1.55 (quint, J = 7.5 Hz, 2H), 1.22 (s, 3H), 0.74 (s, 3H); 
13
C-NMR (125 MHz, 
CDCl3): δ 137.8, 135.6, 135.3, 131.0, 130.3, 129.5, 128.7, 127.3, 127.2, 126.3, 101.4, 77.4, 32.4, 
31.7, 30.2, 28.3, 23.1 22.1; HRMS (ESI+) calculated for C21H29O2 [M+H]
+ 
m/z 313.2168, found 
313.2156. 
 
 
To a solution of ketal 2.65 (18.8 mg, 0.0602 mmol) in THF (2 mL) in a 7 mL vial was 
added 2N HCl (1 mL) dropwise under ambient atm at 0 °C. The addition was completed in less 
than 1 min. The vial was capped with a PTFE-lined cap and stirred at 0 °C for 2 h 10 min. The 
reaction was quenched with the slow addition of saturated aqueous NaHCO3 (2 mL) at the same 
temperature. The mixture was stirred vigorously until bubbling ceased. The mixture was then 
transferred to a separatory funnel containing saturated aqueous NaHCO3 (5 mL) and Et2O (5 
mL), rinsing with Et2O (5 mL). After mixing and phase separation, the aqueous layer was 
extracted with Et2O (2 × 5 mL). The combined organics were washed with brine, dried over 
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MgSO4, filtered and concentrated in vacuo at room temperature. The crude product was taken up 
in a minimum amount of 60% DCM/pentane and loaded onto a silica gel column equilibrated 
with 60% DCM/pentane. The crude product was purified by silica gel chromatography (60% to 
70% DCM/pentane) to afford the product 2.65-1 as a single isomer (8.5 mg, 62%). 
1
H-NMR 
matches literature data
 
(32). Supplementary 
1
H-NMR (500 MHz, CDCl3): δ 9.52 (d, J = 8.0 Hz, 
1H), 7.38 (app d, J = 8.0 Hz, 2H), 7.31 (app t, J = 7.5 Hz, 2H), 7.21 (d, J = 7.5 Hz, 1H), 6.86 (dt, 
J = 15.5, 6.5 Hz, 1H), 6.75 (dd, J = 15.5, 10.0 Hz, 1H), 6.47 (d, J = 15.5 Hz, 1H), 6.23 (dd, J = 
15.0, 10.5 Hz, 1H), 6.14 (ddt, J = 15.5, 6.5, 1.0 Hz, 1H), 5.79 (dt, J = 15.0, 7.5 Hz, 1H), 2.38 
(app q, J = 7.0 Hz, 2H), 2.22 (app q, J = 8.0 Hz, 2H), 1.67 (quint, J = 7.5 Hz, 1H). 
 
The following procedure is modified from a published procedure:
17
 A solution of 
imidazolidinone catalyst (29.4 mg, 0.118 mmol) in MeCN (1.2 mL) in a 7 mL vial was cooled to 
-35 °C in a dry ice/ethylene glycol/EtOH bath with stirring. TFA (9 µL, 0.118 mmol) and H2O 
(24 µL) were added. The solution was stirred for 5 min at the same temperature. 75 µL of this 
solution was then added to the 2 mL vial containing aldehyde 2.65-1. The vial was capped with a 
PTFE-lined cap and left to stand in a -18 °C freezer for 39 h.  The reaction was then warmed to 
room temperature and loaded directly onto a silica gel column equilibrated with 5% 
EtOAc/pentane, rinsing with  a small amount of the same solvent mixture. The product was 
eluted with 5% EtOAc/pentane. The fractions containing the product were concentrated in vacuo 
at room temperature to give the product 2.66 as a crystalline solid (6.7 mg, 79% yield). The d.r. 
was determined to be 17:1 
1
H-NMR. The e.r. was determined to be 95.5:4.5 by chiral HPLC 
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(Chiralcel-OD-H, 15% IPA/hexane isocratic elution, flow rate = 0.75 mL/min, tr (minor) = 5.33 
min, tr (major) = 5.85 min).  
1
H-NMR matches reported literature data.
17 
 
 
Automated Procedure III was followed with the following modifications: In the first 
coupling reaction, 0.33 mL of a freshly prepared solution of 2.67 in DMF (~2.5 M) was added 
manually to the First Reaction Cartridge, the concentration was 0.05 M with respect to 2.68, 3 
mol% of PdCl2(PPh3)2 was used, and the reaction was run at 45 °C for 14 hours. Furthermore, 
the Reaction Filtration Cartridge contained only 300 mg of Celite™ and after filtration, the crude 
reaction underwent an automated aqueous quench (6 mL saturated aqueous NH4Cl + 1 mL 
water) followed by an automated drying process before being purified. In the second 
deprotection reaction, 0.84 mmol of NaOH were used and the reaction was run for 30 minutes. In 
the second coupling reaction, 0.168 mmol of Ag2O, 0.336 mmol of K2CO3, and 25 mol% of 
Pd[P(o-tol)3]2 were used, the addition of the boronic acid was performed over 1 minute, and the 
reaction was run at 60 °C in a 7-mL glass vial.  For the purification steps, the Et2O:MeOH eluent 
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(1.5% MeOH in Et2O) was diluted 50% with hexanes. This automated cycle was performed 4 
times to accumulate 2.71 as a slightly yellow residue (14.8 mg total; average of 3.7 mg, 0.013 
mmol, 23% yield). TLC (hexanes): Rf = 0.31, visualized by UV, stained with KMnO4; HPLC 
(Sunfire Prep-C18, 5 µm, 30 x 150 mm (product number: 186002797), 25 mL/min, gradient: A = 
water, B = MeCN, 0 min: 50% A, 50% B; 15 min: 5% A, 95% B; 25 min: 5% A, 95% B; 25.5 
min: 50% A, 50% B): 19.5 min; 
1
H-NMR (500 MHz, CDCl3): δ 6.36 (d, J = 2.5 Hz, 2H), 6.30 (t, 
J = 2.5 Hz, 1H), 5.18 (tq, J = 7.0, 1.5 Hz, 1H), 5.09 (tdt, J = 6.0, 1.9, 1.0 Hz, 1H), 3.78 (s, 6H), 
2.58 (dd, J = 9.1, 6.7 Hz, 2H), 2.29 (q, J = 8.0 Hz, 2H), 2.09-1.96 (m, 4H), 1.68 (d, J = 1.0 Hz, 
3H), 1.60 (s, 3H), 1.58 (s, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 160.8, 145.0, 135.9 131.5, 124.4, 
123.7, 106.6, 97.8, 55.4, 39.9, 36.6, 29.9, 26.9, 25.8, 17.8, 16.2; HRMS (ESI+) calculated for 
C19H29O2 [M+H]
+ 
m/z 289.2168, found 289.2175. 
 
 
To an oven-dried 20 mL vial equipped with a magnetic stir bar was added Hg(OTf)2 
(28.2 mg, 0.057 mmol, 1.1 equiv.) and ligand (28.2 mg, 0.063 mmol, 1.2 equiv.). The vial was 
purged with Ar thrice and charged with CH2Cl2 (4.7 mL). The catalyst solution was then allowed 
to stir vigorously at room temperature for 20 min at which point it was cooled to -78 °C in an 
IPA/dry ice bath. After 7 min, linear precursor 2.71 (14.8 mg, 0.051 mmol, 1.0 equiv.) in CH2Cl2 
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(0.5 mL) was added to the reaction mixture dropwise via syringe over 3 min, giving a bright 
yellow solution. The reaction mixture was allowed to stir at -78 °C for 1 h at which point the 
IPA/dry ice bath was replaced with a water/ice bath. The reaction mixture was allowed to slowly 
warm to 0 °C with stirring over 2 h then quenched with the addition of a pre-mixed solution of 
sat. NaBr (aq): sat. NaHCO3 (aq) : H2O (5 mL, 1:2:2) at 0 °C. The ice bath and Ar inlet were 
removed and reaction mixture was allowed to warm to room temperature with stirring over 45 
min. The mixture was transferred to a 40 mL vial, rinsing with CH2Cl2 and H2O. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined organics 
were dried over Na2SO4, filtered, and concentrated in vacuo to afford a pale yellow solid which 
was loaded onto Celite as a CH2Cl2 slurry and purified by SiO2 chromatography (hexanes to 4:1 
hexanes:EtOAc) to afford organomercury bromide 2.71-1 as a white crystalline solid (23.1 mg; 
79% yield). Enhancement of ee by recrystallization was achieved by dissolving the solid 
organomercury bromide in warm EtOAc (5 mL) and diluting with warn hexanes (50 mL), and 
storing at -20 °C for 24 h. The resulting mother liquor was concentrated in vacuo to afford 
enantioenriched 2.71-1 (16.7 mg; 57% yield). TLC (4:1 Hexanes:EtOAc): Rf = 0.50, visualized 
by UV, stained with CAM; 
1
H-NMR matches literature data.
18
 Supplementary 
1
H-NMR (500 
MHz, CDCl3): δ 6.27 (d, J = 2.7 Hz, 1H), 6.18 (d, J = 2.7 Hz, 1H), 3.75 (s, 6H), 3.18 (dt, J = 
13.5, 3.6 Hz, 1H), 2.92 – 2.78 (m, 3H), 2.27 (qd, J = 13.7, 3.4 Hz, 1H), 1.97 (dq, J = 14.0, 3.8 
Hz, 1H), 1.81 (dd, J = 12.9, 5.7 Hz, 1H), 1.67 – 1.57 (m, 1H), 1.38 (d, J = 11.6 Hz, 1H), 1.31 (s, 
3H), 1.20 (td, J = 13.4, 3.7 Hz, 1H), 1.15 (s, 3H), 1.13 (s, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 
159.6, 158.1, 138.7, 129.2, 104.8, 97.7, 56.5, 55.3, 55.1, 40.2, 39.8, 38.9, 37.2, 33.6, 29.9, 27.6, 
26.5, 20.9, 19.9; HRMS (ESI+) calculated for C19H28O2BrHg [M+H]
+ 
m/z 569.0979, found 
569.0980. 
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To an oven-dried 2 mL vial containing organomercury bromide 2.71-1 (16.7 mg, 29.5 
μmol, 1.0 equiv), equipped with a magnetic stir bar, and purged with Argon thrice was added 
CH2Cl2
 (147 μL) and EtOH (147 μL). NaBH4 (4.4M in 14M NaOH, 33.4 μL; 5.0 equiv) was 
added dropwise via syringe at room temperature causing the reaction mixture to turn dark gray. 
The reaction mixture was allowed to stir at room temperature for 2 hours at which point it was 
diluted with Et2O and transferred to a 40 mL vial rinsing with H2O and Et2O. The layers were 
separated and aqueous layers extracted with Et2O (2 × 10 mL). The combined organics were 
washed with brine (2 × 10 mL), dried over Na2SO4, filtered and concentrated in vacuo to afford a 
yellow oil with white precipitate. This crude material was loaded onto Celite as a CH2Cl2 slurry 
and purified by SiO2 chromatography (hexanes to 2.5% EtOAc in hexanes) to afford 2.72 as a 
white solid (3.5 mg; 41% yield, 90:10 e.r.) (36). The e.r. was determined by chiral HPLC 
(Chiralcel OD-H, tr = 17.70 min (major); 18.97 min (minor); flow rate = 0.3 mL/min, 0.3% IPA 
in Hexanes for 30 min. Detected at λ= 254 nm.). TLC (5% EtOAc in hexanes): Rf = 0.31, 
visualized by UV, stained with CAM; 
1
H-NMR (500 MHz, CDCl3): δ 6.28 (d, J = 2.6 Hz, 1H), 
6.19 (d, J = 2.6 Hz, 1H), 3.75 (s, 6H), 3.09 – 3.01 (app dt, J = 13.2, 3.2 Hz, 1H), 2.89 – 2.77 (m, 
2H), 1.79 (app dd, J = 6.0, 13.2 Hz, 1H), 1.70 (qt, J = 13.5, 3.6 Hz, 1H), 1.60 – 1.40 (m, 3H), 
1.27 (s, 3H), 1.33-1.25 (m, 1H), 1.18 (dtd, J = 30.0, 13.0, 3.9 Hz, 2H), 0.95 (s, 3H), 0.92 (s, 3H); 
13
C-NMR (125 MHz, CDCl3): δ 159.8, 157.9, 139.0, 130.5, 104.9, 97.7, 55.2 (2C), 53.5, 41.7, 
39.2, 36.9, 34.0, 33.9, 33.7, 22.3, 20.2, 19.6, 19.1; HRMS (ESI+) calculated for C19H29O2 
[M+H]
+ 
m/z 289.2162, found 289.2168. 
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Automated Procedure IV was followed with the following modifications: In the first 
coupling reaction, 1.0 mL of a freshly prepared solution of 2.67 in DMF (2.5 M, 2.5 mmol) was 
added manually to the First Reaction Cartridge, the concentration was 0.05 M with respect to 
2.68 (1 mmol), 3 mol% of PdCl2(PPh3)2 and 5.2 eq LiBr was used, and the reaction was run at 60 
°C for 6 hours. Furthermore, the Reaction Filtration Cartridge contained only 300 mg of Celite™ 
and after filtration, the crude reaction underwent an automated aqueous quench (6 mL saturated 
aqueous NH4Cl + 1 mL water) followed by an automated drying process before being purified. 
In the second deprotection reaction, 3 mmol of NaOH were used and the reaction was run for 30 
minutes. In the second coupling reaction, 0.402 mmol of Ag2O and 10 mol% of Pd[P(o-tol)3]2 
were used, the addition of the boronic acid was performed over 1 minute, and the reaction was 
run at 60 °C for 14 hours in a 7-mL glass vial. This automated cycle was performed 3 times to 
accumulate 2.74 as a slightly yellow residue (37.5 mg total; average of 12.5 mg, 0.025 mmol, 
28% yield). TLC (40% CH2Cl2/hexanes): Rf = 0.47, visualized by UV, stained with KMnO4; 
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1H-NMR (500 MHz, CDCl3): δ 5.83 (t, J = 7.5 Hz, 1H), 5.18 (dt, J = 7.0, 1.0 Hz, 1H), 5.12-5.08 
(m, 2H), 4.23 (s, 2H), 4.20 (q, J = 7.3 Hz, 2H), 2.44 (q, J = 7.5 Hz, 2H), 2.26 (t, J = 7.0 Hz, 1H), 
2.14-2.04 (m, 6H), 1.97 (app t, J = 8.5 Hz, 2H), 1.77 (d, J = 1.0 Hz, 3H), 1.68 (s, 3H), 1.60 (s, 
3H), 1.58 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H), 1.14-1.05 (m, 21H); 13C-NMR (125 MHz, CDCl3): δ 
168.0, 141.1, 135.9, 135.7, 132.2, 131.3, 125.0, 124.3, 123.3, 62.0, 60.0, 39.7, 34.7, 29.8, 27.7, 
27.4, 26.7, 25.7, 18.3, 17.7, 16.0, 14.3, 12.0 ; HRMS (ESI+) calculated for C31H57O3Si 
[M+H]+ m/z 505.4077, found 505.4077. 
 
In the glovebox, the 7 mL vial containing 2.74 (34.6 mg, 0.0685 mmol, 1 equiv) and a 
stir bar was charged with Mg turnings (70.5 mg, 2.90 mmol, 42.3 equiv). The vial was sealed 
with a septum cap and brought out of the glovebox and placed under N2. MeOH (1.4 mL) was 
added via syringe and the mixture was sonicated for 2 min, then stirred at rt with an N2 inlet 
needle. Note: an exotherm formed as the Mg turnings dissolved, but the reaction was not cooled. 
The reaction was stirred for 16 h, then quenched with the addition of sat. aq. NH4Cl (2 mL). The 
mixture was transferred to a separatory funnel, rinsing with Et2O (10 mL) and H2O (5 mL). After 
mixing and phase separation, the aqueous layer was extracted with Et2O (2 x 5 mL). The 
combined organics were washed with H2O (10 mL), brine, dried over Na2SO4, filtered and 
concentrated in vacuo. The residue was taken up in CH2Cl2, filtered through a pad of Na2SO4 and 
concentrated in vacuo. After drying under high vacuum, the material was re-subjected to the 
above reaction conditions to consume the remaining starting material. After the same work-up 
procedure described above, the desired reduced product 2.74-1 was obtained as a 4:1 mixture of 
ethyl:methyl ester (29.1 mg, 84% yield). This material was used without further purification. 
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TLC (40% CH2Cl2/hexanes): Rf = 0.47, stained by KMnO4; 1H-NMR (500 MHz, CDCl3): δ 
5.15 (t, J = 7.0 Hz, 1H), 5.10-5.07 (m, 2H), 4.21 (s, 2H), 4.13 (q, J = 7.1 Hz, 2H), 3.66 (s, 3H for 
methyl ester), 2.31 (tt, J = 9.0. 5.55 Hz, 1H), 2.08-2.04 (m, 2H), 2.01 (m, 6H), 1.76 (app s, 3H), 
1.68 (app s, 3H), 1.68-1.60 (m, 1H), 1.60 (s, 3H), 1.57 (s, 3H), 1.58-1.55 (m, 1H), 1.48-1.40 (m, 
2H), 1.30 (quint, J = 7.8 Hz, 2H), 1.26 (t, J = 7.0 Hz, 3H), 1.14-1.05 (m, 21H); 13C-NMR (125 
MHz, CDCl3): δ 176.3, 135.8 (Me), 135.7, 135.5, 131.3, 125.6, 125.5 (Me), 124.3, 123.6, 123.5 
(Me), 61.9, 60.0, 51.3 (Me), 45.2, 45.1 (Me), 39.7, 32.4, 32.1, 27.8 (Me), 27.7, 26.6, 25.8, 25.7, 
21.0, 18.0, 17.7, 15.9, 14.3, 12.0; HRMS (ESI+) calculated for C31H59O3Si [M+H]+ m/z 
507.4233, found 507.4231. Note: (Me) = peaks corresponding to the methyl ester. 
 
The 7 mL vial containing ester 2.74-1 (27.6 mg, 0.0544 mmol, 1 equiv) was charged with 
a stir bar and sealed with a septum cap. The vial was vac-filled with N2 (× 3). THF (1.1 mL) was 
added via syringe and the solution cooled to -25 °C in a dry ice/ethylene glycol/ethanol bath. 
DIBAl-H (1M in hexanes, 0.27 mL, 0.27 mmol, 4.96 equiv) was added dropwise. The reaction 
was stirred at – 20 °C for 2 h. The reaction was quenched by adding sat. Rochelle’s salt solution 
(1.5 mL) was dropwise at -20 °C. Et2O (1.5 mL) was then added. The mixture was stirred 
vigorously for 10 min, then H2O (1 mL) and Et2O (1mL) were added. After stirring for another 
10 min, the mixture was transferred to a separatory funnel, rinsing with H2O (8mL) and Et2O (8 
mL). After mixing and phase separation, the aqueous layer was extracted with Et2O (2 x 5 mL). 
The combined organics were washed with H2O, brine, dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by silica gel chromatography (5% to 10% 
to 20% Et2O/hexanes) to give the product 2.74-2 as a colorless oil (22.5 mg, 89% yield). TLC 
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(20% Et2O/hexanes): Rf = 0.24, stained by KMnO4; 1H-NMR (500 MHz, CDCl3): δ 5.19 (app 
dt, = 7.0, 1.0 Hz, 1H), 5.11-5.07 (m, 2H), 4.22 (d, J = 12.5 Hz, 1H), 4.21 (d, J = 12.5 Hz, 1H), 
3.54 (dd, J = 5.5, 1.5 Hz, 2H), 2.11-1.94 (m, 8H), 1.77 (d, = 1.0 Hz, 3H), 1.68 (s, 3H), 1.60 (s, 
6H), 1.50-1.25 (m, 7H), 1.15-1.06 (m, 21H); 13C-NMR (125 MHz, CDCl3): δ 135.3, 135.1, 
131.3, 126.0, 124.5, 124.3, 65.6, 62.0, 40.1, 39.7, 30.9, 30.5, 27.9, 27.2, 26.7, 25.7, 25.2, 21.0, 
21.0, 18.0, 17.7, 16.0; HRMS (ESI+) calculated for C29H57O2Si [M+H]+ m/z 465.4128, found 
465.4126. 
 
To a solution of 2.74-2 (22.3 mg, 0.048 mmol) in THF (0.75 mL) and pyridine (0.25 mL) 
in a polyethylene vial equipped with a stir bar was added HF·pyridine (0.18 mL) dropwise at 0 
°C. The vial was purged with N2, and sealed with a screw cap. The reaction was gradually 
warmed to rt. After 5 h, another portion of HF·pyridine (0.05 mL) was added to the reaction at rt. 
The reaction was then stirred for another 1.5 h, then quenched by the slow addition of sat. 
aqueous NaHCO3 (3 mL). The mixture was transferred to a separatory funnel containing sat. aq. 
NaHCO3 (10 mL), rinsing with Et2O (10 mL). After mixing and phase separation, the aqueous 
layer was extracted with Et2O (3 × 5 mL). The combined organics were washed with H2O, brine, 
dried over Na2SO4, filtered and concentrated. The crude product was purified by silica gel 
chromatography (20% to 30% to 40% EtOAc/hexanes) to give the pure product 2.74-3 as a 
colorless oil (13.7 mg, 93% yield). TLC (40% EtOAc/hexanes): Rf = 0.25, stained by KMnO4; 
1H-NMR (500 MHz, CDCl3): δ 5.29 (app t, J = 7.5 Hz, 1H), 5.12-5.07 (m, 2H), 4.16 (d, J = 11.5 
Hz, 1H), 4.10 (d, J = 11.5 Hz, 1H), 3.58 (dd, J = 10.5, 5.0 Hz, 1H), 3.51 (dd, J = 11.0, 6.0 Hz, 
1H), 2.10-1.97 (m, 8 H), 1.80 (d, J = 1.3 Hz, 3H), 1.68 (d, J = 1.0 Hz, 3H), 1.60 (s, 6H), 1.50-
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1.25 (m, 9H) 13C-NMR (125 MHz, CDCl3): δ 135.2, 134.4, 131.3, 128.5, 124.4, 124.3, 65.5, 
61.5, 39.7 (2C), 30.9, 30.2, 27.6, 26.9, 26.7, 25.7, 25.2, 21.3, 17.7, 16.0; HRMS (ESI+) 
calculated for C20H37O2 [M+H]+ m/z 309.2794, found 309.2794. 
 
The following procedure was modified from a published procedure: To a Schlenk tube 
sealed with a rubber septum and vac-filled with N2 (3×) was added CH2Cl2 (0.3 mL) followed by 
DMSO (30 µL, 0.386 mmol, 8.7 equiv). The solution was cooled to -78 °C in a dry ice/acetone 
bath. Oxalyl chloride (2.0 M in CH2Cl2, 90 µL, 0.18 mmol, 4.05 equiv) was added dropwise via 
syringe. The resulting solution was stirred at -78 °C for 30 min. A solution of diol 2.74-3 (13.7 
mg, 0.0444 mmol, 1.0 equiv) in CH2Cl2 (0.3 mL) in a 7 mL vial was added dropwise to the 
reaction flask via syringe, rinsing with CH2Cl2 (0.3 mL). The solution was stirred for 20 min at – 
78 °C, then NEt3 (45 µL, 0.32 mmol, 7.25 equiv) was added into the reaction dropwise. The 
reaction was stirred for 5 min at the same temperature, then the cold bath was removed and the 
reaction stirred at room temperature for another 45 min. TLC showed complete conversion of the 
diol. The reaction was cooled to 0 °C in an ice/water bath. Dry MeNH2 gas was then passed 
above the reaction solution over 4 min via an inlet needle with an outlet needle, causing an 
increase in reaction volume and dissolution of the solids. The reaction was stirred for 4 h, 
gradually warming to room temperature in the ice/water bath. The flask was then opened to the 
Schlenk line, causing evaporation of the dissolved MeNH2. The solvent was removed under a 
stream of N2, giving a yellow oily solid. The rubber septum was quickly replaced with a new 
septum under positive N2 flow, and the residue was dried under high vacuum overnight. The 
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flask was filled with N2. Dry AcOH (0.7 mL) was added to dissolve the brown residue. The 
solution was stirred at 80 °C (oil bath temperature) for 8.5 h. The reaction was cooled to room 
temperature and transferred to an Erlenmeyer flask equipped with a stir bar, rinsing with CH2Cl2 
(10 mL). The solution was cooled to 0 °C in an ice/water bath. 3N NaOH was added dropwise 
with stirring until pH>10 (approx. 4.4 mL). The mixture was transferred to a separatory funnel, 
rinsing with CH2Cl2 (5 mL). After phase separation the pH was adjusted to 14 with 2 drops of 
3N NaOH. The aqueous phase was then extracted with CH2Cl2 (2 × 3 mL). The combined 
organics were washed with saturated NaHCO3 (aq), dried over Na2SO4, filtered and concentrated 
in vacuo. The crude product was purified by silica gel column chromatography (20-40% 
EtOAc/pentane) to give the product as a colorless oil (6.0 mg, 47% yield). 1H-NMR (500 MHz, 
CDCl3): δ 2.89 (s, 1H), 2.54 (d, J = 4.5, 1H), 1.89 (t, J = 5.0 Hz, 1H), 1.74-1.38 (m, 15H), 1.17 
(dd, J = 9.5, 3.0, 1H) 0.98-0.92 (m, 1H), 0.88 (d, J = 6.5, 3H), 0.87 (d, J = 7.0, 3H), 0.74 (s, 3H), 
0.70 (s, 3H); 13C-NMR (125 MHz, CDCl3): δ 60.3, 54.8, 50.4, 49.7, 47.3, 43.4, 39.4, 38.6, 36.4, 
35.6, 34.5, 28.6, 27.8, 26.6, 22.8, 21.1 (2C), 21.0, 18.4, 21.1 (3C), 21.0; HRMS (ESI+) 
calculated for C20H34N [M+H]+ m/z 288.2691, found 288.2697. 
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CHAPTER 3 
 
DESIGN AND SYNTHESIS OF A MORE HYDROLYTICALLY STABLE MIDA 
BORONATE 
 
3.1 BACKGROUND 
Small molecule natural products serve as potent sources of new pharmaceutical agents.
1-3
 
The coevolution of secondary metabolites with the targets they affect serves as natures “pre-
optimization” of these compounds, and while some of these natural compounds serve as 
medicines themselves, they often require derivatization and/or optimization.
4,5
 In fact, 42% of all 
new chemical entities approved as drugs from 1981 to 2006 are natural products, derivatives of 
natural products, or have pharmacophores derived from natural products.
6
 Recognizing this, 
there have been a number of synthetic strategies developed towards rapidly and efficiently 
preparing compounds or libraries of compounds which more closely match the structural 
complexity, number of stereogenic centers, and C(sp
3
) richness of many natural products.
7-9
 
Despite this, synthesis still stands as a major bottleneck in fully utilizing the functional potential 
of small molecule natural products. The advent of general and automated iterative synthesis 
platforms has largely removed this bottleneck in the case of peptides,
10
 oligonucleotides,
11
 and 
increasingly, oligosaccharides.
12
 As described in Chapters 1 and 2, our group has pioneered the 
use of iterative cross coupling as an analogous approach to broadly enable the potential of small 
molecules. While the coupling of organoboron reagents is well developed and robust in the case 
of coupling C(sp
2
) fragments, the general use of C(sp
3
) boronates is still a major challenge. Due 
to the ubiquity of stereogenic C(sp
3
) centers in small molecule natural products, the development 
of the stereospecific coupling of chiral non-racemic C(sp
3
) boronates in a manner compatible 
with ICC stands to be a highly enabling advance. 
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In the past decade, a number of important advances have been made towards the 
development of such methods (Figure 3.1). The first major advance came in 2009 when 
Crudden
13
 reported the stereoretentive coupling of chiral non-racemic secondary benzylic 
pinacol boronates. Similarly, Molander
14
 later reported the stereoretentive coupling of 1-
(benzyloxy)alkyltrifluoroborate salts. Molander
15
 and Hall
16
 also separately reported the 
stereoinvertive coupling of secondary boronates which contain pendant carbonyl groups (amides 
and esters). These Lewis basic groups are believed to coordinate to the boron center and thus 
influence the mechanism by which they transmetalate. In 2011, Suginome
17
 showed in a similar 
system containg pendant Lewis basic groups that different acidic additives can influence which 
transmetalation pathway is dominant. Addition of the Lewis acid Zn(OiPr)4∙iPrOH interrupts the 
intramolecular amide coordination, leading to the retentive pathway being dominant. 
Alternatively, addition of phenol leads to H-bonding with an oxygen of the pinacol ester, leading 
to stronger amide coordination and invertive transmetalation as the dominant pathway. While all 
of these results show major progress towards coupling secondary boronates, they all require 
pendant activating/directing for the reactions to work efficiently. In an ideal version of the ICC 
platform, building blocks have all functional groups and stereocenters preinstalled, so the 
requirement for such groups is inherently limiting. Excitingly, our group has discovered the first 
stereoretentive coupling of unactivated secondary boronic acids,
18,19
 while Biscoe and 
coworkers
20
 more recently demonstrated the stereoinvertive coupling of unactivated secondary 
trifluoroborate salts. All of these methods, both stereoretentive and invertive, would be highly 
impactful if they were incorporated with the ICC platform, allowing for secondary alkyl 
fragments to be used as building blocks.  
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One major challenge lies in the way of the utilization of these methods: all of them are 
currently incompatible with the MIDA boronate functional group. Most notably, the use of 
biphasic, aqueous basic conditions leads to deprotection of the MIDA boronate to the 
corresponding boronic acid. The use of high temperatures, strong bases, and long reaction times, 
even in rigorously anhydrous conditions, leads to similar decomposition. In addition, challenging 
C(sp
2
) couplings that require long reaction times and/or high temperatures, while achievable, 
have been shown to be accompanied by undesired MIDA hydrolysis. Access to complex building 
blocks from simple MIDA boronate precursors
21
 can also be hindered by such competitive 
Figure 3.1. A collection of stereoretentive and stereoinvertive methods for the coupling of secondary alkyl boron 
fragments 
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hydrolysis during reactions and/or purification. To collectively address these challenges, I aimed 
to develop a more hydrolytically stable derivative of the MIDA boronate framework. 
 
3.2 THE MECHANISMS OF MIDA BORONATE HYDROLYSIS 
To rationally design a MIDA boronate derivative which is refractory to hydrolysis, 
understanding the mechanism of the hydrolysis reaction is critical. Our group has collaborated 
with the groups of Lloyd-Jones and Houk
22
 to probe this mechanism utilizing a combination of 
kinetic isotope effects in the MIDA framework (including 
13
C, 
15
N, and 
11
B), 
18
O labeling of 
water and hydroxide, rapid injection kinetics, and computation. The results reveal that MIDA 
boronates hydrolyze by two distinct mechanisms depending upon the reaction conditions—
“basic” (or “fast release”) hydrolysis and “neutral” (or “slow release”) hydrolysis. 
 
Figure 3.2. Basic hydrolysis mechanism of MIDA boronates (“fast release”) 
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 Primarily basic hydrolysis (Figure 3.2) occurs when MIDA boronates are treated with 
aqueous NaOH in THF at room temperature. Upon addition of the aqueous base to the organic 
solution, a metastable emulsion is formed between the two layers and hydrolysis occurs rapidly 
in this medium. At concentrations tested (0.01 to 0.1 M), this emulsion separates into a neutral 
organic upper layer and a basic aqueous lower layer within minutes. Hydrolysis occurs so 
quickly that full conversion is typically observed prior to phase separation; however, if 
hydrolysis is incomplete at this point, the mechanism switches over to the much slower neutral 
hydrolysis in the organic layer (vide infra). The fast, basic hydrolysis begins with rate-limiting 
attack of hydroxide at the carbonyl carbon of MIDA which is followed by subsequent attacks at 
boron to liberate the free ligand. In support of this, a significant 
12/13
C KIE of 1.049 was 
observed, while no such KIEs were observed upon labeling of boron or nitrogen. Additionally, 
when 
18
O-labelled water and NaOH were used, the MIDA ligand recovered from the hydrolysis 
reaction showed 98% incorporation of a single 
18
O atom, consistent with initial attack at carbon 
followed solely by attack at boron. 
 In contrast, primarily neutral hydrolysis (Figure 3.3) occurs when MIDA boronates are 
treated with aqueous K3PO4 (7.5 equivalents) in THF at elevated temperatures (55 to 60 °C). 
These are conditions based upon those initially developed by our group for the slow release cross 
coupling of MIDA boronates as surrogates for unstable boronic acids.
23
 Much like in the case of 
basic hydrolysis, upon addition of the aqueous K3PO4 to the THF boronate solution, an emulsion 
is formed which quickly separates into layers; however, unlike the basic hydrolysis, less than 3% 
of hydrolysis is observed prior to phase separation. The majority of hydrolysis occurs via a 
water-mediated process in the organic layer post-separation. This neutral hydrolysis was 
independently confirmed by rate measurements of aqueous THF mixtures containing no base (ie. 
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no phase separation). Attempts to determine an overall rate law for this process, however, were 
complicated by the non-ideal behavior of THF/water mixtures, and required introduction of a 
term for the thermodynamic activity of water (aw) to account for an apparent plateau in rate with 
respect to the formal concentration of water ([H2O]). The rate law thus obtained (presented in 
Figure 3.3), along with a negative entropy of activation (∆S‡ = 16 e.u.), is consistent with attack 
by a neutral cluster of water molecules, (H2O)n, with an average n = 2.8. The site of attack by 
such a water cluster was elucidated through KIE experiments similar to those performed for the 
basic hydrolysis, showing significant KIEs at boron (
10/11
B KIE = 1.032) and nitrogen (
14/15
N 
KIE = 1.017) while showing no KIE at carbon. Collectively, these data are consistent with slow 
release hydrolysis beginning with rate-limiting attack of a cluster of between two and three 
neutral water molecules at the N-B bond to open the MIDA “cage”, followed by subsequent 
attacks at boron to liberate the free ligand. The use of 
18
O-labelled water in the neutral hydrolysis 
reaction led to no incorporation of 
18
O in the MIDA ligand recovered, again consistent with no 
direct attack of water at the carbonyl carbons of the MIDA framework. Given the divergent 
nature of these 
18
O-labelling experiments, percentage 
18
O incorporation in recovered MIDA 
ligand can serve as a powerful mechanistic readout when undesired hydrolysis is observed in any 
given reaction. 
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3.3 DEVELOPMENT OF A NEW IMINODIACETIC ACID LIGAND 
 With a clear mechanistic picture of MIDA boronate hydrolysis in hand, we set out to 
design a more hydrolytically stable iminodiacetic acid framework. Given that both of the above 
mechanisms involve rate determining attack of a nucleophile, it stands to reason that increase of 
steric bulk around the center(s) of attack would decrease the rate of hydrolysis. Towards this 
goal, I became interested in preparing and testing derivatives of MIDA which have (i) alkyl 
groups appended to the α-carbon of the acetate groups and (ii) larger alkyl groups appended to 
the nitrogen. Modifications at the α-methylenes of the MIDA framework seem particularly 
attractive, as they are proximal to both sites of nucleophilic attack. As shown in Figure 3.4, 
MIDA boronate derivatives in which the N-Me group had been replaced with cyclohexyl (3.1) 
Figure 3.3. Basic hydrolysis mechanism of MIDA boronates (“fast release”) 
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and isopropyl (3.2) groups had been previously synthesized by former graduate student Dr. Eric 
Gillis and quantities sufficient for hydrolysis studies were already on hand. In conjunction with 
undergraduate student Robert Pipal, I then synthesized a collection of α-substituted derivatives 
(R = Me, Et, nBu, Ph, 3.3 to 3.6). Double SN2 displacement of the appropriate α-bromo esters 
followed by deprotection and complexation with p-tolylboronic acid under standard Dean-Stark 
azeotrope conditions gave the desired boronates as mixtures of the “out-out” and “in-out” 
diastereomers which were easily separable by column chromatography. Finally, a piperidine-
derived ligand in which the two α-substituents were tethered into a 6-membered ring was 
Figure 3.4. Synthetic routes towards new iminodiacetic acid ligand frameworks 
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prepared from 2,6-dipicolinic acid. Hydrogenation with Pd/C yielded the desired cis 
diastereomer of the resulting piperidine which was then methylated using the Eschweiler-Clarke 
reaction. Again, standard Dean-Stark azeotrope conditions yielded the desired boronate 3.7. 
 To test these new derivatives, an assay was developed based upon our previously 
reported slow release cross coupling conditions.
23
 In this assay, a THF-d8 solution of the p-
tolylboronate (0.067 M) is treated with a D2O solution of K3PO4 (3.0 M, 7.5 eq) and stirred for 
between 0 and 6 hours at 60 °C. At the indicated time point, the reaction vessel is briefly cooled 
under a stream of air before being diluted with DMSO-d6 containing an internal standard. Proton 
NMR is then immediately obtained and integration gives the amount of boronate remaining 
relative to the initial time point. 
A number of useful and surprising trends emerged from this data set. First, in opposition 
to what was expected, boronates with more sterically bulky N-substituents (N-Cy, 3.1 and N-iPr, 
3.2) hydrolyze more quickly than the parent MIDA boronate (Figure 3.5). One possible 
mechanistic explanation for this trend is that steric clash between the bulky N-substituents and 
the organic group on boron results in lengthening and weakening of the N-B bond. Given that 
attack of water at the N-B bond is the rate determining step under slow release conditions, a 
longer/weaker N-B would be more susceptible to attack. While faster hydrolysis was not the 
initial goal of this study, a collection of boronates with hydrolysis rates that are tunable to be 
both faster and slower could prove useful in the context of selectively coupling polyborylated 
building blocks. 
Previous studies by former graduate student Greg Morehouse had shown that the α-
dimethyl substituted derivative of p-bromophenyl MIDA boronate (analogous to compound 3.3) 
hydrolyzed more slowly than the parent compound under slow release conditions. To confirm 
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this data, I prepared diastereomerically pure samples of the “out-out” and “in-out” 
dimethylMIDA boronates 3.3 and repeated the hydrolysis experiment with both yielding the 
same result—they hydrolyzed slightly over one order of magnitude slower than the 
corresponding parent MIDA boronate. While the slowed hydrolysis was welcome and expected, 
the identical rate profiles of the two diastereomers was intriguing, as it was expected that the “in-
out” diastereomer would have less protective capacity towards the rate-determining nucleophilic 
attack. A closer look at the NMR spectra of these two experiments revealed that these 
compounds rapidly equilibrated to a thermodynamic mixture of the two diastereomers (<30 
minutes), presumably through an enol or enolate intermediate as shown in Figure 3.6. The “in-
out” diastereomer was actually preferred by a factor of 8, which was also a surprising result as 
this isomer was presumed to have more unfavorable steric interactions in the internal cavity of 
the MIDA framework.  
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Figure 3.5. Slow release hydrolysis studies of MIDA boronate derivatives. Data points represent the average of 
two duplicate runs, except in the case of N-Cy and N-iPr MIDA where n = 1. Ar = p-tolyl 
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Encouraged by these results, I then measured the hydrolysis rates of the diethyl- and 
dibutylMIDA boronates (3.4 and 3.5). Given that the dimethylMIDA boronate had slowed 
hydrolysis rates, it was expected that increasing the size of the alkyl groups attached to the 
backbone would result in even slower rates. Quite surprisingly, the opposite trend was observed 
(Figure 3.5). Of the compounds in this series, dibutylMIDA boronate 3.5 hydrolyzed the fastest, 
followed by diethylMIDA boronate 3.4 and then the aforementioned dimethylMIDA boronate 
3.3. The current leading hypothesis stems from the fact that the rate of slow release hydrolysis is 
dependent on the concentration (or, more formally, the activity) of neutral water in the organic  
Figure 3.6. Both diastereomers of dimethylMIDA boronate 3.3 rapidly equilibrate to a thermodynamic mixture 
of the two isomers 
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phase post phase separation. As hydrolysis proceeds, free ligand is released into the reaction 
mixture and likely primarily exists in the aqueous layer as the dicarboxylate salt. This free ligand 
can then act as a surfactant that increases the concentration of water in the organic layer, and thus 
increases the rate of neutral hydrolysis (Figure 3.7, A). With this in mind, the observed trend 
begins to make sense—ligands with longer alkyl chains appended would be more lipophilic and 
would therefore be more efficient surfactants, ultimately leading to faster neutral hydrolysis. The 
Figure 3.7. (A) Surfactant/phase transfer hypothesis for increasing hydrolysis rate with increasing alkyl chain 
length (B) Adding free dibutylMIDA ligand to the hydrolysis of dimethylMIDA results in a drastic increase in 
rate 
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structural similarity of the free ligands to molecules known to act as surfactants (that is, 
molecules with distinct hydrophilic and hydrophobic regions such as phospholipids) provides 
further support. In support of this hypothesis, addition of one equivalent of the free dibutylMIDA 
ligand to the slow release hydrolysis of dimethylMIDA boronate resulted in a nearly 10-fold 
increase in rate (Figure 3.7, B). 
 Having shown that simply increasing the length of alkyl chains on the MIDA backbone 
actually has detrimental effects on its hydrolytic stability, we next became interested in the effect 
of permethylating the backbone. There are two primary rationales for this interest. First, 
increasing the number of alkyl groups attached to the alpha carbons of simple alkyl esters results 
in reduced rates of basic hydrolysis, while simply increasing the length of alkyl chains has a far 
lesser effect.
24
 Our boronate esters have thus far followed a similar trend, so by analogy, we 
expected tetramethylMIDA (TIDA) to have a decrease in hydrolysis rate relative to 
dimethylMIDA. Second, epimerization of the dimethylMIDA boronates results in mixtures of 
diastereomers that would complicate the isolation and characterization of building blocks and 
synthetic intermediates. Permethylation of the α carbons would remove this complication 
entirely. TIDA was synthesized in a manner analogous to dimethylMIDA—double SN2 
displacement of tert-butyl 2-bromopropionate yielded protected dimethylMIDA which was 
treated with 2.2 eq of LDA followed by trapping with excess methyl iodide. Treatment of the 
resulting material with formic acid yielded tetramethylMIDA (TIDA) in 55% yield over 3 steps 
(Figure 3.8, A). Despite their sterically congested nature, TIDA boronates are easily prepared 
from the corresponding boronic acids using previously discussed Dean-Stark conditions. 
Excitingly, hydrolysis of p-tolylTIDA boronate (Figure 3.8, B) proceeded much slower than the 
corresponding MIDA boronate under these conditions. More detailed rate studies will be 
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required to accurately determine their relative rates. This result represented the first MIDA 
derivative which has the potential to have the broadened synthetic utility we initially sought, so 
we decided to further investigate the physical and chemical properties of TIDA boronates. 
 
 
The first noticeable difference between p-tolyl TIDA boronate and its MIDA counterpart 
was its reduced solubility in THF. Despite sonication, extended stirring, and warming, a solution 
of the TIDA boronate in THF that was sufficiently concentrated (0.08 M) for the hydrolysis 
assay wasn’t able to be obtained. In addition to necessitating the boronate to be delivered as a 
THF slurry (a potential source of experimental error), we recognized that insolubility could be 
the primary factor behind the lack of hydrolysis observed. To address this concern, I synthesized 
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Figure 3.8. (A) Synthesis of tetramethylMIDA (B) Hydrolysis studies of a collection of MIDA boronate 
derivatives representing a wide range of tunable rates. Ar = p-tolyl 
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octyl TIDA boronate which proved to be completely soluble in THF at the concentration utilized 
in the hydrolysis reaction. Gratifyingly, no loss of boronate or generation of the corresponding 
boronic acid was observed by 
1
H NMR over the course of 6 hours. More detailed studies will be 
required in the future to fully understand how the nature of the organic fragment on boron affects 
both the kinetic and thermodynamic solubility of TIDA boronates. Satisfyingly, large transparent 
crystals of octylTIDA boronate were easily obtained by slow evaporation from THF, allowing 
the structure to be unambiguously determined by x-ray crystallography. Interestingly, the 
sterically congested nature of the TIDA boronate causes it to skew away from the symmetrical 
structure seen in MIDA boronates. As seen in Figure 3.9, one of the α carbons (in this case, the 
right hand carbon) dips down and inward toward the boron atom, while the other (the left hand 
carbon) shifts up and out away from the boron atom. These boronates exist as pairs of 
conformers which rapidly interconvert at room temperature as evidenced by the coalescence of 
the α-methyl peaks in the 1H NMR spectrum, leading to two singlets (one each for the internal 
and external sets of methyl groups).  
 
 
Figure 3.9. X-ray crystal structure of octylTIDA boronate 
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I then became interested in testing the capacity of the TIDA boronate functional group to 
withstand conditions previously incompatible with the ICC platform. Excitingly, our groups 
anhydrous conditions developed for coupling secondary, unactivated boronic acids were 
successfully used to couple boronic acid 3.9 with 3-iodo-5-trifluoromethylphenylTIDA boronate 
3.10 in a modest 14% isolated yield (Figure 3.10, A). With a successfully coupled intermediate, 
we next looked at conditions for deprotection of the TIDA boronates to allow iteration. 
Treatment with aqueous NaOH at room temperature, the conditions used to deprotect MIDA 
boronates, TIDA boronates tested saw no conversion. Increasing the temperature to 60 °C led to 
full conversion after 60 minutes. Interestingly, it was found that addition of MeOH to the 
reaction mixture greatly increased the rate of deprotection. Treatment of TIDA intermediate 3.11 
with MeOH and aqueous NaOH led to complete, clean deprotection in 15 minutes at 45 °C. 
Finally, this boronic acid was taken on and coupled with benzyl 4-bromobenzoate to give the 
final product in 73% isolated yield. This is the first complete cycle of iterative cross coupling 
which utilized a secondary alkyl boronic acid coupling partner successfully. 
Finally, I tested the capacity of TIDA boronates to survive aqueous, biphasic coupling 
conditions. Coupling of p-tolylboronic acid with TIDA boronate 3.10 under conditions 
developed for slow release cross coupling
23
 gave 50% isolated yield of the desired product. 
Additionally, coupling of either potassium 2-butyltrifluoroborate or 2-butylMIDA boronate with 
metachlorophenylTIDA boronate 3.13 gave the desired coupling products in 48% and 25% 
isolated yields respectively. These are the first successful couplings of a benchtop stable 
boronate with a bifunctional TIDA boronate, representing a major step forward for the iterative 
cross-coupling platform. 
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 In summary, we have developed a second generation iminodiacetic acid based ligand 
which is substantially more stable to hydrolysis relative to MIDA. Initial results show that these 
boronates are also much more stable to a range of conditions for cross coupling. These new 
conditions will enable unique disconnections to be used with the iterative cross coupling 
platform, namely in the coupling of unactivated secondary boronates. Given the prevalence of 
Figure 3.10. (A) A complete iterative cross coupling cycle using an unactivated secondary boronic acid (B) 
TIDA boronates survive aqueous biphasic coupling conditions in synthetically useful yields 
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stereogenic C(sp
3
) centers in small molecule natural products, these disconnections stand to 
enable the ICC platform to access new and important chemical space. 
 
3.4 EXPERIMENTAL SECTION 
General Methods and Materials 
Commercial reagents were purchased from Sigma-Aldrich, TCI America, Alfa Aesar, 
Strem Chemicals Inc., Fisher Scientific, or Combi Blocks and used without further purification 
unless otherwise noted.  Solvents were purified via passage through packed columns as described 
by Pangborn and coworkers
25
 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, 
benzene, and toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated molecular 
sieves).  All water was deionized prior to use. 
All reactions were performed in flame- or oven (125 °C)-dried glassware under an 
atmosphere of dry nitrogen or argon unless otherwise stated.  Organic solutions were 
concentrated via rotary evaporation under reduced pressure with a bath temperature of 30-40 °C.  
Reactions were monitored by analytical thin layer chromatography (TLC) on Merck silica gel 60 
F254 plates (0.25 mm) using the indicated solvent system.  Compounds were visualized by 
exposure to UV light (254 nm), or by treatmeant with a basic potassium permanganate (KMnO4) 
solution followed by brief heating with a Varitemp heat gun.  MIDA boronates are compatible 
with standard silica gel chromatography, include standard loading techniques.  Column 
chromatography was performed on silica gel (Merck Grade 938, pore size 60 Å, 230-400 mesh 
particle size, Ald. #227196) with indicated solvent systems). 
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Ligand Synthesis 
 
Under ambient atmosphere, methylamine hydrochloride (3.76 g, 55.7 mmol), potassium 
carbonate (38.48 g, 278.5 mmol), and MeCN (80 mL) were charged into a 250 mL roundbottom 
flask containing a stir bar. Tert-butyl 2-bromopropionate (25.62 g, 122.5 mmol) was then 
weighed into a small beaker and poured into the flask, rinsing with further 20 mL of MeCN. The 
flask was then fit with a rubber septum and flushed with dry nitrogen for 10 minutes. The flask 
was then stirred in 60 °C oil bath overnight while under a positive pressure of nitrogen. The next 
day, the crude reaction mixture was filtered through a ~2 cm silica gel plug, rinsing with EtOAc 
(~50 mL) and acetone (~20 mL). The solvent was then removed in vacuo to give 17.13 g of a 
yellow oil which was primarily product as a ~1:1 mixture of diastereomers. For large scale 
preparation, this crude material was taken onto the next step without further purification, 
although purified material can be obtained by column chromatography (10% EtOAc/hexanes). 
1
H-NMR (500 MHz, CDCl3): δ 3.43 (app dq, 2H), 2.40 (app d, 3H), 1.45 (app d, 18H), 1.27 (app 
dd, 6H). Note: This spectrum is that of the 1:1 mixture of diastereomers—all peaks appear to 
split as “doublets” but its really just the two diastereomers resolving. 
 
Crude dimethylMIDA t-butyl ester (17.13 g, approximately 60 mmol) was charged into a 
200 mL roundbottom flask, followed by formic acid (60 mL). The flask was fitted with a rubber 
112 
 
septum and briefly flushed with nitrogen before being stirred in an 80 °C overnight. The next 
day, TLC (100% EtOAc, KMnO4) showed no remaining starting material and a large smear at 
the baseline (presumably product and formic acid). Formic acid was then removed by rotary 
evaporation in a 50 °C bath, followed by being placed under high vacuum in an 80 °C heat 
block, giving a tacky tan solid. This solid was then taken up in EtOH (~15 mL) with warming via 
heatgun. To this solution was added acetone (75 mL) dropwise with stirring over ~10 minutes, 
causing precipitation of a white solid. The solid was then collected by vacuum filtration and 
washed copiously with acetone (~100 mL). The resulting white crystalline solid was then dried 
under high vacuum overnight to give 8.62 g (88% yield over two steps) of product as a 1:1 
mixture of diastereomers. 
1
H-NMR (500 MHz, DMSO-d6): δ 3.48 (app dq, 2H), 2.28 (app d, 
3H), 1.20 (app dd, 6H). Note: This spectrum is that of the 1:1 mixture of diastereomers—all 
peaks appear to split as “doublets” but its really just the two diastereomers resolving. 
 
A 100 mL Schlenk flask with a stir bar and stoppered with a rubber septum was vac/filled 
three times with nitrogen. Benzyl alcohol (5.2 mL, 50 mmol, 2 eq), THF (50 mL), and pyridine 
(4.05 mL, 50 mmol, 2 eq) were added via syringe while stirring. The reaction was cooled to 0 ⁰C 
in an ice bath, and 2-bromobutyrl bromide (3.02 mL, 25 mmol) was added dropwise to the 
stirring solution over 10 minutes, producing a yellow color. After 1 hour of stirring in the ice 
bath, the reaction was quenched with the addition of water (50 mL) via syringe. The mixture was 
transferred to a separatory funnel, and the aqueous layer was extracted with diethyl ether (3 x 30 
mL). The combined organics were washed with saturated NH4Cl (2 x 25 mL), water (25 mL), 
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saturated NaHCO3 (25 mL) and brine (25 mL). The organics were dried with MgSO4, filtered 
over a pad of Celite, and solvent was removed via rotary evaporation, producing a clear oil (8.80 
g crude). The crude product was dry loaded on Celite and placed atop a silica gel column 
equilibrated with 20 % ethyl acetate in hexanes. A clear oil was obtained (96% yield). 
1
H-NMR 
(500 MHz, CDCl3): δ 7.38 (m, 5H), 5.21 (s, 2H), 4.22 (dd, 1H), 2.13 (dq, J = 14.2, 7.1 Hz, 1H), 
2.03 (dq, J = 14.8, 7.5 Hz, 1H), 1.02 (app t, J = 7.3 Hz, 3H). 
 
A 20 mL vial with a stir bar was charged with potassium carbonate (2.743 g, 19.81 mmol, 
5.86 eq) and methylamine hydrochloride salt (224.5 mg, 3.38 mmol, 1 eq). The vial was capped 
and purged with nitrogen for 10 minutes. Acetonitrile (3.9 mL) and the 2-bromobenzyl ester 
(2.008 g, 7.78 mmol, 2.3 eq) were added subsequently with stirring via syringe. The nitrogen 
inlet was removed and the vial was sealed with Teflon tape. The reaction was heated at 82 ⁰C in 
a heat block for 24 hours. The solvent had evaporated off in the vial, leaving a white paste. The 
mixture was filtered over a pad of Celite and washed with ethyl acetate. The solvent was 
removed via rotary evaporation, producing a pale, yellow oil (1.50 g crude). A gradient silica 
column was run with 7.5-10% ethyl acetate in hexanes. A clear oil was isolated (441.3 mg, 15% 
yield) as a mixture of diastereomers. 
1
H-NMR (500 MHz, CDCl3): δ 7.33 (app m, 10H), 5.04 
(app ddd, 4H), 3.33 (app dt, 2H), 2.50 (app d, 3H), 1.76 (m, 4H), 0.88 (app dd, 6H). Note: This 
spectrum is that of the 1:1 mixture of diastereomers—all peaks appear to split as “doublets” but 
it’s really just the two diastereomers resolving. 
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A 40 mL vial was charged with a stir bar and the DEMIDA dibenzyl ester (441.3 mg, 
1.151 mmol, 1 eq) was added anhydrous methanol (8.1 mL). The vial was capped and purged for 
10 minutes with nitrogen gas bubbling through the solution while stirring. 10% palladium on 
carbon (21.4 mg) was added by replacing the cap. The vial was purged once more with nitrogen 
for 10 minutes. One balloon filled with hydrogen gas was bubbled through the reaction mixture. 
The vial was placed under one balloon of hydrogen for 24 hours with stirring. The balloon was 
removed and the reaction purged for 20 minutes with nitrogen. The reaction was filtered over a 
pad of Celite, and washed with methanol (3 x 30 mL). Solvent was removed via rotary 
evaporation and the compound was placed on the high vacuum, producing a crystalline, white 
solid (242.8 mg, 100% yield) as a mix of diastereomers. 
1
H-NMR (500 MHz, DMSO-d6): δ 3.14 
(app dt, 2H), 2.31 (app d, 3H), 1.58 (app ddq, 4H), 0.83 (app td, 6H). Note: This spectrum is that 
of the 1:1 mixture of diastereomers—all peaks appear to split as “doublets” but it’s really just 
the two diastereomers resolving. 
 
This compound was synthesized in a manner analogous to benzyl 2-bromobutyrate using 
3.96 mL (25 mmol, 1 eq) of 2-bromohexanoyl bromide. A clear oil (6.884 g, 97% yield) was 
isolated. 
1
H-NMR (500 MHz, CDCl3): δ 7.38 (m, 5H), 5.21 (s, 2H), 4.25 (dd, J = 7.8, 7.0 Hz, 
1H), 2.02 (m, 2H), 1.35 (m, 4H), 0.89 (app t, J = 7.0 Hz, 3H). 
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A 20 mL vial with stir bar was charged with potassium carbonate (2.067 g, 14.8 mmol, 
5.86 eq) and methylamine hydrochloride salt (203.6 mg, 3.02 mmol, 1 eq). The vial was capped 
and purged with nitrogen for 10 minutes. Acetonitrile (3.5 mL) and the 2-bromobenzyl ester 
(2.007 g, 7.01 mmol, 2.3 eq) were added subsequently with stirring via syringe. The nitrogen 
inlet was removed and the vial was sealed with Teflon tape. The reaction was heated at 82 ⁰C in 
a heat block for 8 days. The mixture was filtered over a pad of Celite and washed with ethyl 
acetate (3 x 35 mL). The solvent was removed via rotary evaporation, producing a pale, yellow 
oil (1.43 g crude). A gradient silica column was run with 7.5-10% ethyl acetate in hexanes. A 
clear oil was isolated (709.4 mg, 52% yield) as a mixture of diastereomers. 
1
H-NMR (500 MHz, 
CDCl3): δ 7.34 (m, 10H), 5.04 (app ddd, 4H), 3.40 (app dt, 2H), 2.51 (app d, 3H), 1.71 (m, 4H), 
1.26 (m, 8H), 1.84 (td, 6H). Note: This spectrum is that of the 1:1 mixture of diastereomers—all 
peaks appear to split as “doublets” but it’s really just the two diastereomers resolving. 
 
This compound was synthesized in a manner analogous to diethylMIDA using 666.4 mg 
(1.52 mmol, 1.0 eq) of dibutylMIDA benzyl ester. 388.2 mg (99% yield) of a white crystalline 
solid was obtained as a mixture of diastereomers. 
1
H NMR (500 MHz, DMSO-d6): δ 3.20 (app 
dt, 2H), 2.32 (app d, 3H), 1.55 (m, 4H), 1.24 (m, 8H), 0.84 (t, 6H). Note: This spectrum is that of 
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the 1:1 mixture of diastereomers—all peaks appear to split as “doublets” but it’s really just the 
two diastereomers resolving. 
 
A 250 mL Schlenk flask was charged with a stir bar, the 2-bromo acid (6.45 g, 30 mmol, 
1 eq), and DMAP (366.5 mg, 3.0 mmol, 0.1 eq). The flask was sealed with a rubber septum and 
vac/filled three times with nitrogen gas. DCM (110 mL) was added via syringe, producing a 
yellow, clear solution. Tert-butanol (3.5 mL, 36 mmol, 1.2 eq) was added via syringe and the 
flask was cooled to 0 ⁰C in an ice bath for 15 minutes. The septum was removed and EDCI·HCl 
(6.90 g, 36 mmol, 1.2 eq) was added. DCM (10 mL) was used to wash flask, and the septum was 
replaced. The water bath was removed, and the reaction was stirred for 24 hours at room 
temperature. The reaction was quenched with the addition of water (50 mL). The mixture was 
transferred to a separatory funnel, and the aqueous layer was extracted with ethyl acetate (3 x 50 
mL). The organics were washed with brine (50 mL), dried with MgSO4, filtered over a pad of 
Celite, and solvent was removed via rotary evaporation. Column chromatography (2.5-5% 
EtOAc/hexanes) gave 1.734 g (21% yield) of a clear oil. 
1
H NMR (500 MHz, CDCl3) δ 7.48 (dd, 
2H), 7.36 (m, 3H), 5.25 (s, 1H), 1.44 (s, 9H). 
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A 20 mL vial with stir bar was charged with potassium carbonate (3.96 g, 28.66 mmol, 
5.86 eq) and methylamine hydrochloride salt (338 mg, 4.89 mmol, 1 eq). The vial was capped 
and purged with nitrogen for 10 minutes. Acetonitrile (5.6 mL) and the 2-bromo-t-butyl ester 
(3.04 g, 11.25 mmol, 2.3 eq) were added subsequently with stirring via syringe. The nitrogen 
inlet was removed and the vial was sealed with Teflon tape. The reaction was heated at 80 ⁰C in 
a heat block for 24 hours. The mixture was filtered over a pad of Celite and washed with ethyl 
acetate (3 x 35 mL). The solvent was removed via rotary evaporation, producing a pale, yellow 
oil. A silica column was run and the product was isolated (1.29 g, 64% yield) as a mixture of 
diastereomers. 
1
H-NMR (500 MHz, CDCl3): δ 7.48 (app dd, 4H), 7.32 (m, 6H), 4.49 (app d, 2H), 
3.29 (app d, 3H), 1.44 (app d, 18H).  Note: This spectrum is that of the 1:1 mixture of 
diastereomers—all peaks appear to split as “doublets” but it’s really just the two diastereomers 
resolving. 
 
A 20 mL vial was charged with a stir bar, the DPMIDA di-t-butyl ester (1.29 g, 3.12 
mmol, 1 eq), and formic acid (3.1 mL, 82.6 mmol, 26 eq). The vial was capped and stirred at 80 
⁰C overnight. The reaction mixture was cooled, and transferred to a 100 mL RBF. The formic 
acid was removed via rotary evaporation, producing a light brown solid. Methanol (around 4 
mL) was added to the solid, creating a suspension. The suspension was sonicated, and five 
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volumes of acetone (20 mL) were added dropwise to the stirring suspension over 15 minutes. 
The mixture was vacuum filtered over filter paper. The resulting solid was transferred to a 20 mL 
vial and placed on high vacuum for one hour. The diacid was isolated as a white crystalline solid 
(515.7 mg, 55% yield), and as a single diastereomer. 
1
H-NMR (500 MHz, DMSO-d6): δ 7.40 (m, 
8H), 7.33 (m, 2H), 4.51 (s, 2H), 3.33 (s, 18H), 2.03 (s, 3H). 
 
2,6-Pyridinedicarboxylic acid (1.50 g, 9.00 mmol) was placed into a 100 mL recovery 
flask along with MeOH (28 mL). The mixture was then degassed by bubbling nitrogen through it 
with stirring for 10 minutes. Pd/C (150 mg, 10 wt%, wet, Degussa type) was then added in a 
single portion before sealing the flask with a rubber septum and Teflon tape. Hydrogen gas was 
then bubbled through the solution with stirring for ~10 minutes (1 balloon) before being placed 
under an atmosphere of hydrogen (3 balloons simultaneously) and stirred for a total of 48 hours. 
The mixture was then degassed by bubbling nitrogen through it as before (10 minutes) before 
filtering over Celite and washing with MeOH (500 mL). Solvent was removed under vacuum 
and the resulting solid was recrystallized from water to give 851.4 mg (55% yield) of flaky off-
white crystals. 
1
H-NMR (500 MHz, DMSO-d6): δ 3.43 (dd, 2H), 2.03 (m, 2H), 1.79 (m, 1H), 
1.49 (m, 3H). 
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Cis-2,6-piperidinedicarboxylic acid (173 mg, 1.0 mmol) , formalin (5.0 mL) and formic 
acid (75 µL, 2.0 mmol) were placed in a 20 mL vial under ambient atmosphere. This vial was 
sealed and placed in a 100 °C heat block and allowed to stir overnight. The reaction was then 
cooled to room temperature and rinsed into an Erlenmeyer flask with water (5 mL). Acetone (50 
mL) was added with stirring, causing a slight amount of precipitation. Diethyl ether (50 mL) was 
then added with stirring, causing more significant precipitation. The solid was then collected by 
vacuum filtration and dried under high vacuum overnight, yielding 52.1 mg (28% yield) of a 
white crystalline solid. 
1
H-NMR (500 MHz, DMSO-d6): δ 2.79 (dd, 2H), 2.18 (s, 3H), 1.81 (dd, 
2H), 1.74 (m, 1H), 1.49 (qd, 2H), 1.33 (qt, 1H). 
 
To a solution of DIPA (3.22 mL, 23.0 mmol, 2.2 eq) in THF (26 mL) under nitrogen at -
78 ⁰C was added n-BuLi (14.35 mL, 1.6 M in hexanes, 22.96 mmol, 2.2 eq) dropwise over 5 
minutes. The reaction was placed in an ice bath and stirred at 0 ⁰C for 25 minutes, giving a light 
yellow homogenous solution. Substrate was added as a solution in THF (26 mL) over ~15 
minutes. After stirring at 0 °C for 30 minutes, methyl iodide (2.92 mL, 47.0 mmol, 4.5 eq) was 
added dropwise over 5 minutes. The ice bath was then removed and the reaction was warmed to 
room temperature. Precipitate formed and TLC (10% EtOAc/hexanes, KMnO4) showed 
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complete conversion. The reaction was then quenched with NH4Cl solution (25 mL), extracted 
with EtOAc (3 x 50 mL), dried over sodium sulfate, filtered, and concentrated under vacuum to a 
yellow oil with some solids suspended in it. This was taken on to the next step without further 
purification. 
To the crude intermediate from the above reaction was added 10.5 mL 98% formic acid 
while transferring to a capped 40 mL vial. The homogenous solution was stirred at 80 °C 
overnight. The reaction was then concentrated under vacuum to a brown solid. This solid was 
dissolved in ~18 mL water with heating, and this solution was then washed once with 20 mL 
DCM. Residual DCM in the aqueous layer was blown off under a nitrogen stream. In an 
Erlenmeyer flask, 100 mL of acetone was added to this solution to induce crystallization. After 
30 minutes stirring in an ice bath, the solids were collected by filtration and dried under high 
vacuum to give a white solid (1.48 g, 70% yield) over two steps. 
1
H-NMR (500 MHz, DMSO-
d6): δ 2.37 (s, 3H), 1.34 (s, 12H). 
 
 Potassium carbonate (28.53 g, 206.4 mmol, 5.0 eq) and tert butyl alanine ester 
hydrochloride (7.50 g, 41.3 mmol, 1.0 eq) were placed into a 500 mL round bottom flask, 
followed by MeCN (200 mL) and tert butyl 2-bromopropionate (10.36 g, 49.5 mmol, 1.2 eq). A 
reflux condenser was placed was placed on top of the flask and the reaction was purged with 
nitrogen for five minutes before being sealed with a septum pierced with a nitrogen inlet needle. 
The flask was then placed in a 60 °C oil bath and stirred overnight. The next day, the reaction 
was cooled and filtered through Celite, rinsing copiously with EtOAc (2x100 mL). The crude 
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mixture was then loaded onto Celite via rotovap and placed atop a silica gel column equilibrated 
with 5% EtOAc/hexanes. Purified by gradient column (5 to 10 to 15% EtOAc/hexanes, 9 cm 
width by 10 cm height column) to yield 8.31 grams of a colorless oil. 
1
H-NMR (500 MHz, 
CDCl3): 3.24 (app dq, 2H), 2.19 (br s, 1H), 1.44 (app d, 18H), 1.25 (app dd, 6H).  Note: This 
spectrum is that of the 1:1 mixture of diastereomers—all peaks appear to split as “doublets” but 
it’s really just the two diastereomers resolving. 
 
 A 200 mL round bottom flask was charged with potassium carbonate (2.07 g, 15.0 mmol, 
3.0 eq) and tetrabutylammonium iodide (369.4 mg, 1.00 mmol, 0.2 mmol). The flask was then fit 
with a rubber septum and vacuum/N2 filled (3x). DMSO (50 mL) was then added via syringe, 
followed by the amine (1.37 g, 5.00 mmol, 1.0 eq, added via syringe). After stirring briefly, 
crotyl bromide (2.03 g, 15.0 mmol, 3.0 eq) was added dropwise via syringe before placing the 
flask in an 80 °C oil bath and stirring overnight. The next day, the reaction was cooled and 
poured into a separatory funnel containing water (100 mL) and EtOAc (100 mL). After shaking 
and separation, the aqueous layer was extracted with EtOAc (2x100 mL). The combined organic 
layers were washed with water (2x50 mL) to remove DMSO, followed by brine (50 mL). The 
organic layer was then dried over MgSO4, filtered, and concentrated to a viscous pale yellow oil. 
Column chromatography (10 to 20% EtOAc/hexanes) gave the product as a complex mixture of 
diastereomers and E/Z isomers (due to impure crotyl bromide). 1.02 g, 62% yield. 
1
H-NMR (500 
MHz, CDCl3): 5.62-5.54 (app m, 1H), 5.43-5.35 (app m, 1H), 3.59-3.53 (app m, 2H), 3.48-3.33 
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(app m, 2H), 1.68 (app dp, 3H), 1.45-1.44 (app m, 18H), 1.26-1.22 (app m, 6H). Note: This 
mixture is inconsequential for our purposes as the double bond will be hydrogenated and the 
stereocenters will later be made non-stereogenic. 
 
 Wilkinson’s catalyst (197.8 mg, 0.214 mmol, 10 mol%) was massed into a 40 mL vial 
under ambient atmosphere (this batch of catalyst had been stored under air). The vial was then 
vaccum/N2 filled (3x) before adding the substrate (700 mg, 2.14 mmol, 1.0 eq) as a solution in 
toluene (20 mL). Hydrogen gas was then bubbled through the solution via balloon (1 balloons 
worth, ~10 minutes, through a 20 gauge needle). The vial was then placed under a hydrogen 
atmosphere (balloon). Reaction was stirred for five days (for convenience). The solution and vial 
were then purged with nitrogen for 10 minutes before filtering the solution through Celite, 
washing with acetone. The solution was then concentrated and the resulting oil was purified by 
column chromatography (5 to 10% EtOAc/hexanes) to give 368 mg (52% yield) of a colorless 
oil. 
1
H-NMR (500 MHz, CDCl3): 3.52 (app dq, 2H), 2.77 (app ddd, 2H), 1.44 (app s, 18H), 1.37 
(app m, 2H), 1.28 (app m, 2H), 1.23 (app dd, 6H), 0.88 (app s, 3H). Note: This spectrum is that 
of the 1:1 mixture of diastereomers—all peaks appear to split as “doublets” but it’s really just 
the two diastereomers resolving. 
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 A flame dried 50 mL Schlenk flask was charged with THF (5.0 mL) and freshly distilled 
diisopropylamine (445 µL, 3.20 mmol). The flask was then cooled in a ice-water bath for 10 
minutes before adding nBuLi (1.6 M in hexanes, 1.98 mL, 3.17 mmol) dropwise via syringe. 
After stirring for 5 minutes in the ice-water bath, the diester substrate (347.6 mg, 1.05 mmol) 
was added dropwise via syringe as a solution in THF (5.0 mL) over the course of ~10 minutes. 
The reaction was then allowed to stir in the ice-water bath for 30 minutes, taking on a pale 
yellow color. Methyl iodide, neat (395 µL, 6.33 mmol) was then added dropwise via syringe 
over the course of ~ 5 minutes. The reaction was then stirred in the ice-water bath for 2 hours 
before removing the bath and allowing it to stir and warm to room temperature. After stirring 
another hour, TLC indicated complete conversion (10% EtOAc/hexanes). The reaction was then 
quenched by addition of 1:1 water:sat. NH4Cl (10 mL). The mixture was then added to a 
separatory funnel containing EtOAc (10 mL) and water (5 mL). After shaking and separating, the 
aqueous layer was extracted with EtOAc (3x10 mL). The combined organic layers were then 
dried with brine (10 mL), dried over MgSO4, filtered, and concentrated to give a deep orange oil. 
Crude 
1
H NMR indicated the desired product as the primary component (~>90%). This material 
was used in the next step without further purification. 
 The crude orange oil from the previous step was transferred to a 7 mL vial using formic 
acid (2x1.0 mL). The vial was then sealed and placed in a 80 °C heat block and allowed to stir 
overnight. The next day, the mixture was transferred to a 50 mL recovery flask using DCM 
(2x1.5 mL) and was concentrated via rotovap (50 °C water bath, ~1 hour) to a deep brown 
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chunky solid. The flask was then placed on high vac for 3 hours to remove residual formic acid. 
The brown solid was then taken up in a minimum of water with warming via heat gun (~4.0 mL). 
The solution was then cooled to room temperature (some precipitate formed) before being 
washed with DCM (4.0 mL), removing much of the brown color. The aqueous layer was then 
placed on the rotovap to remove residual DCM, before adding 25 mL acetone with vigorous 
stirring, causing precipitation of the product. The mixture was capped and stirred in an ice bath 
for 30 minutes before filtered and washing the solid with acetone (2x10 mL). The solid was 
collected and placed on high vac overnight, giving 154 mg of a white solid (60% yield over two 
steps). 
1
H-NMR (500 MHz, DMSO-d6): 2.75 (app m, 2H), 1.52 (app m, 2H), 1.35 (s, 12H), 1.19 
(app m, 2H), 0.86 (t, J = 7.3 Hz, 3H). 
Boronate Synthesis 
 
General Procedure for the Synthesis of p-tolyl MIDA Boronate Derivatives. Under ambient 
atmosphere, a recovery flask containing a stir bar was charged with p-tolylboronic acid and 
ligand. To this was added a given volume 10:1 solvent mixture of toluene and DMSO before 
fitting the flask with a Dean-Stark trap (prefilled with toluene) and condenser. This flask was 
then stirred in a 110-120 °C oil bath with azeotropic removal of water until TLC indicated 
consumption of starting material. The reaction mixture was then cooled and poured into a 
separatory funnel containing containing water (five times the reaction volume) and EtOAc (five 
times the reaction volume). After shaking and phase separation, the aqueous layer was extracted 
twice with EtOAc (five times the reaction volume). The combined organic layers were then 
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washed sequentially with water, 1:1 water:brine, and brine (five times the reaction volume each), 
dried over MgSO4, filtered, and concentrated in vacuo. The resulting solid was then purified by 
column chromatography, crystallization, or a combination thereof. In the cases where 
diastereomers were possible, the two isomers were separated by column chromatography. 
 
  The general procedure was followed using dimethylMIDA (200 mg, 1.14 mmol, 1.0 eq), 
p-tolylboronic acid (1.2 eq), and 12 mL 10:1 toluene:DMSO. The resulting mixture of product 
diastereomers was purified by two rounds of column chromatography (10% to 20% to 30% 
acetone/hexanes) to give 95.7 mg (30% yield) of the out-out and 107.3 mg (34% yield) of the in-
out diastereomers respectively. 
1
H-NMR (500 MHz, acetone-d6): [out-out diastereomer] δ 7.42 
(d, J = 7.9 Hz, 2H), 7.18 (d, J = 7.7 Hz, 2H), 4.18 (q, J =  7.3 Hz, 2H), 2.46 (s, 3H), 2.32 (s, 
3H), 1.49 (d, J = 7.3 Hz, 6H). [in-out diastereomer] δ 7.40 (d, J = 7.9 Hz, 2H), 7.18 (d, J = 7.8 
Hz, 2H), 4.25 (q, J = 7.1 Hz, 1H), 4.12 (q, J = 7.1 Hz, 1H), 2.47 (s, 3H), 2.32 (s, 3H), 1.60 (d, J = 
7.0 Hz, 3H), 1.56 (d, J = 7.1 Hz, 3H). 
 
The general procedure was followed using diethylMIDA (210.6 mg, 1.04 mmol, 1.0 eq), 
p-tolylboronic acid (211.3 mg, 1.55 mmol, 1.5 eq), and 10 mL of a 95:5 toluene:DMSO solvent 
mixture. Column chromatography (0 to 2% MeOH/DCM) gave 95.8 mg (30% yield) of the out-
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out and 123.4 mg (40% yield) of the in-out diastereomers respectively. 
1
H-NMR (500 MHz, 
DMSO-d6): [out-out diastereomer] δ 7.41 (d, J = 7.9 Hz, 2H), 7.17 (d, J = 7.7 Hz, 2H), 3.90 (dd, 
J = 9.9, 5.5 Hz, 2H), 2.49 (s, 3H), 2.32 (s, 3H), 1.99 (m, 2H), 1.84 (m, 2H) 1.21 (t, J = 7.4 Hz, 
6H). [in-out diastereomer] δ 7.39 (d, J = 7.8 Hz, 2H), 7.17 (d, J = 7.4 Hz, 2H), 3.91 (dd, J = 7.3, 
6.0 Hz, 1H), 3.83 (dd, J = 9.5, 4.3 Hz), 2.50 (s, 3H), 2.32 (s, 3H), 2.13-2.00 (m, 2H), 2.01-1.92 
(m, 2H), 1.33 (t, J = 7.4 Hz, 3H), 1.30 (t, J = 7.4 Hz, 3H). 
 
The general procedure was followed using dibutylMIDA (354.1 mg, 1.37 mmol, 1.0 eq), 
p-tolylboronic acid (278.4 mg, 2.05 mmol, 1.5 eq), and 13 mL of a 95:5 toluene:DMSO solvent 
mixture. Column chromatography (0 to 2% MeOH/DCM) gave 109.5 mg (22% yield) of the out-
out and 265.1 mg (54% yield) of the in-out diastereomers respectively. 
1
H-NMR (500 MHz, 
DMSO-d6): [out-out diastereomer] δ 7.48 (d, J = 7.8 Hz, 2H), 7.29 (d, J = 7.4 Hz, 2H), 3.87 (dd, 
J = 9.2, 6.2 Hz, 2H), 2.44 (s, 3H), 2.42 (s, 3H), 1.84 (m, 6H), 1.48 (m, 6H), 1.02 (t, J = 7.3 Hz, 
6H). [in-out diastereomer] δ 7.40 (d, J = 7.8 Hz, 2H), 7.17 (d, J = 7.2 Hz, 2H), 3.96 (dd, 1H), 
3.86 (dd, 1H), 2.53 (s, 3H), 2.32 (s, 3H), 1.98 (m, 6H), 1.60 (m, 2H), 1.43 (m, 4H), 0.95  (t, J = 
7.4 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H). 
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The general procedure was followed using diphenylMIDA (515.7 mg, 1.72 mmol, 1 eq), 
p-tolylboronic acid (349.6 mg, 2.58 mmol, 1.5 eq), and 16.4 mL of a 95:5 toluene:DMSO solvent 
mixture. Column chromatography (0 to 2% MeOH/DCM) gave the in-out diastereomer (285.6 
mg, 42% yield) as a white crystalline solid. 
1
H NMR (500 MHz, DMSO-d6) δ 7.70 (d, 2H), 7.60 
(m, 1H), 7.52 (m, 4H), 7.23 (m, 3H), 7.04 (m, 2H), 6.37 (d,  2H), 5.75 (s, 1H), 5.64 (s, 1H), 2.35 
(s, 3H), 2.16 (s, 3H). 
 
The general procedure was followed using SchMIDA (49.6 mg, 0.26 mmol, 1.2 eq), p-
tolylboronic acid (30.0 mg, 0.22 mmol, 1.0 eq), and 11 mL of a 10:1 toluene:DMSO solvent 
mixture. Column chromatography (30 to 40 to 50% acetone/hexanes) gave 41.2 mg (65% yield) 
of a white crystalline solid. 
1
H-NMR (500 MHz, acetone-d6): δ 7.49 (d, 2H), 7.32 (d, 2H), 3.89 
(t, 2H), 2.58 (s, 3H), 2.45 (s, 3H), 2.17 (m, 4H), 1.86 (m, 2H). 
 
The general procedure was followed using TIDA (89.4 mg, 0.443 mmol, 1.1 eq), p-
tolylboronic acid (54.4 mg, 0.403 mmol, 1.0 eq), and 4 mL of a 95:5 toluene:DMSO solvent 
mixture. Column chromatography (20 to 40% acetone/hexanes) gave 67.5 mg (55% yield) of a 
white crystalline solid. 
1
H-NMR (500 MHz, acetone-d6): δ 7.45 (d, 2H), 7.16 (d, 2H), 2.67 (s, 
3H), 2.31 (s, 3H), 1.77 (s, 6H), 1.54 (s, 6H). 
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The general procedure was followed using TIDA (402.4 mg, 1.98 mmol, 1.1 eq), 
octylboronic acid (284.5 mg, 1.8 mmol, 1.0 eq), and 19.8 mL of a 10:1 toluene:DMSO solvent 
mixture. Trituation of the crude product with 1:1 diethyl ether:hexanes (3x5 mL) gave 478.1 mg 
(82% yield) of a white solid. 
1
H-NMR (500 MHz, acetone-d6): δ 2.72 (s, 3H), 1.70 (s, 6H), 1.60 
(s, 6H), 1.42 (br m, 2H), 1.30 (br m, 10H), 0.88 (t, J = 6.9 Hz, 3H), 0.63 (m, 2H). Slow 
evaporation from THF in a 7 mL vial covered with a kimwipe gave crystals suitable for single 
crystal x-ray analysis. 
 
The general procedure was followed using TIDA (335.3 mg, 1.65 mmol, 1.1 eq), m-
bromophenylboronic acid (301.2 mg, 1.5 mmol, 1.0 eq), and 16.5 mL of a 10:1 toluene:DMSO 
solvent mixture. Trituration with 1:1 diethyl ether:hexanes (3x5 mL) gave 302.3 mg (55% yield) 
of a white solid. 
1
H-NMR (500 MHz, CDCl3): δ 7.68 (s, 1H), 7.49 (app dd, 2H), 7.22 (t, J = 7.7 
Hz, 1H), 2.50 (s, 3H), 1.79 (br s, 6H), 1.54 (br s, 6H). 
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The general procedure was followed using TIDA (335.3 mg, 1.65 mmol, 1.1 eq), rac-sec-
butylboronic acid (152.9 mg, 1.5 mmol, 1.0 eq), and 15 mL of a 10:1 toluene:DMSO solvent 
mixture. Trituration with 1:1 diethyl ether:hexanes (3x5 mL) gave 183.5 mg (45% yield) of a 
white solid. 
1
H-NMR (500 MHz, CDCl3): δ 2.60 (s, 3H), 1.72 (d, J = 21.2 Hz, 6H), 1.61 (d, J = 
8.9 Hz, 6H), 1.54 (m, 1H), 1.29 (ddt, J = 16.0, 14.1, 7.4 Hz, 1H), 0.93 (app t, 6H), 0.77 (br m, 
1H). 
 
The general procedure was followed using TIDA (335.3 mg, 1.65 mmol, 1.1 eq), 5-
formyl-2-furylboronic acid (209.9 mg, 1.50 mmol, 1.0 eq), and 15 mL of a 10:1 toluene:DMSO 
solvent mixture. Trituration with 1:1 diethyl ether:hexanes (3x5 mL) gave 170.2 mg  of an off-
white solid of ~85% purity (31% yield) by proton NMR. 
1
H-NMR (500 MHz, CDCl3): δ 9.67 (s, 
1H), 7.22 (d, J = 3.5 Hz, 1H), 6.94 (d, J = 3.5 Hz, 1H), 2.62 (s, 3H), 1.79 (br s, 6H), 1.62 (s, 6H). 
 
Under ambient atmosphere, a 40 mL vial was charged with 3-iodo-5-
(trifluoromethyl)phenyl MIDA boronate (500 mg, 1.17 mmol, 1.0 eq) and a stir bar. To this was 
added THF (7.5 mL), followed by aqueous NaOH (1 N, 3.5 mL, 3.5 mmol, 3.0 eq). The vial was 
capped and stirred vigorously for 15 minutes. TLC (20% acetone/hexanes) showed complete 
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conversion, so the reaction was quenched via the addition of sat. NH4Cl (10 mL). The crude 
mixture was then partitioned between EtOAc (20 mL) and water (20 mL). The aqueous layer was 
then extracted with EtOAc (3x20 mL). The combined organics were then washed with brine (20 
mL), dried over MgSO4, filtered, and concentrated. The resulting wet solid was azeotroped with 
toluene (2x20 mL) until a minimum volume of toluene remained with solids suspended within it 
(~3 mL). To this crude solution of boronic acid in a 50 mL recovery flask was added toluene (15 
mL) and DMSO (1.5 mL), followed by TIDA (261.3 mg, 1.29 mmol, 1.1 eq). The flask was then 
fit with a Dean-Stark trap (prefilled with toluene) and a condenser. The flask was then refluxed 
with azeotropic removal of water for 3 hours. TLC (20% acetone/hexanes) showed complete 
conversion. The reaction was then worked up as in the general procedure and the resulting solid 
was triturated with 1:1 diethyl ether:hexanes (3x5 mL) to give 482.0 mg (85% yield) of a white 
solid. 
1
H-NMR (500 MHz, CDCl3): δ 8.07 (s, 1H), 7.95 (s, 1H), 7.75 (s, 1H), 2.50 (s, 3H), 1.81 
(br s, 6H), 1.55 (br s, 6H). 
Hydrolysis Assay 
The following assay was developed based upon conditions previously reported by Knapp et al.
21
 
 To each of twelve 1 mL conical vials equipped with stirring vanes was added 100 µL 
(0.08 M, 0.008 mmol) of a THF-d8 solution of the indicated boronate, followed by 20 µL (3.0 M, 
0.06 mmol, 7.5 eq) of a D2O solution of K3PO4. Each vial was then capped, shaken briefly to 
mix, and then stirred in a 60 °C heat block at 800 RPM. At the indicated times, two vials were 
removed from the heat block, cooled briefly under a stream of air, and then had 680 µL DMSO-
d6 containing 1,4-dimethoxybenzene (~0.008 M) as an internal standard added. The vials were 
then again briefly capped, shaken to mix, and the solutions were then immediately transferred to 
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NMR tubes and spectra were taken (16 scans, d1 = 10 s). Time points were taken at 0, 0.5, 1, 1.5, 
2.0, 4.0, and 6.0 hours. The solutions for the 0 time points were made directly in the NMR tubes, 
shaken, and then had spectra obtained. The percentage boronate remaining was determined by 
average the integration of the aryl protons (which fully resolved from the corresponding aryl 
protons on the parent boronic acid) across the two runs, except in the case of octyl TIDA 
boronate, for which the terminal methyl group of the octyl chain was used. 
 In all cases, each time point represents the average of n=2 experiments, except in the case 
of the N-Cy and N-iPr MIDA, for which n=1. 
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Figure 3.11. Hydrolysis behavior of MIDA derivatives modified at nitrogen 
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Figure 3.12. Hydrolysis behavior of MIDA derivatives modified at the backbone methylenes 
Figure 3.13. Hydrolysis behavior of MIDA, DimethylMIDA, and TetramethylMIDA (TIDA) 
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Coupling Reactions 
 
Under ambient atmosphere, Pd(OAc)2 (5.6 mg, 0.025 mmol, 5 mol%), SPhos (20.5 mg, 
0.05 mmol, 10 mol%), 3-iodo-5-(trifluoromethyl)phenyl TIDA boronate (241.5 mg, 0.5 mmol, 
1.0 eq), and p-tolylboronic acid (81.6 mg, 0.6 mmol, 1.2 eq) were charged into a 40 mL vial 
containing a stir bar. The vial was then sealed with a PTFE-lined septum screw cap and wrapped 
with Teflon tape. The vial was then placed under vacuum and back filled nitrogen three times 
before adding dioxane (7.25 mL). The mixture was then stirred at room temperature for 10 
minutes, giving a deep red homogenous solution. Aqueous K3PO4 (1.25 mL, 3.0 M, 3.75 mmol, 
7.5 eq) was then added via syringe and the vial was placed in a 60 °C heat block and allowed to 
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Figure 3.14. Evidence for phase transfer effects in the hydrolysis of MIDA boronates and derivatives 
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stir for 6 hours. At this point, TLC (20% acetone/hexanes, KMnO4) appeared to indicate no 
conversion; however it was later determined that the starting material and product co-elute. The 
reaction mixture was partitioned between EtOAc (30 mL) and water (30 mL). The aqueous layer 
was extracted with EtOAc (3x30 mL). The combined organics were then washed with brine (30 
mL), dried over MgSO4, filtered, and concentrated under reduced pressure. Crude 
1
H NMR 
showed product as the main component of the resulting solid. The solid was then adsorbed onto 
Celite from an acetone solution and then placed atop a silica gel column equilibrated with 20% 
acetone/hexanes. Column chromatography (20% to 30% to 40% acetone/hexanes) gave 110.7 
mg (50% yield) of a white solid. 
1
H-NMR (500 MHz, CDCl3): δ 7.92 (s, 1H), 7.80 (s, 1H), 7.74 
(s, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.27 (d, 2H, overlaps with solvent), 2.53 (s, 3H), 2.41 (s, 3H), 
1.83 (br s, 6H), 1.57 (br s, 6H). 
 
 On the benchtop, meta chlorophenylTIDA boronate (64.7 mg, 0.20 mmol, 1.0 eq), 
potassium 2-butyltrifluoroborate (49.2 mg, 0.30 mmol, 1.5 eq), potassium carbonate (82.9 mg, 
0.60 mmol, 3.0 eq), and P(tBu)3 third generation Buchwald precatalyst (11.4 mg, 0.02 mmol, 10 
mol%) were weighed into a 7 mL vial. The vial was sealed with a septum cap and vacuum/N2 
filled (3x). Benzene (400 µL) and water (400 µL) were then added via syringe. The nitrogen inlet 
needle was then removed and the septum was covered with electrical tape before placing the vial 
in a 60 °C heat block and stirring for 48 hours. The reaction was then cooled and transferred to a 
separatory funnel containing EtOAc (10 mL) and sat. NH4Cl (10 mL). After shaking and 
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separation, the aqueous layer was extracted with EtOAc (2x10 mL). The combined organic 
layers were dried with brine (10 mL), MgSO4, filtered, and concentrated to give a yellow solid. 
This solid was loaded onto Celite and purified by column chromatography (20 to 30 to 40% 
acetone/hexanes) to give 33.2 mg (48% yield) of a white solid. 
1
H-NMR (500 MHz, CDCl3): δ 
7.38-7.33 (m, 2H), 7.29-7.24 (m, 1H, overlaps with solvent), 7.19-7.15 (m, 1H), 2.57 (app br q, J 
= 7.0 Hz, 1H), 2.47 (s, 3H), 1.79 (br s, 6H), 1.62-1.50 (m, 8H), 1.21 (d, J = 6.9 Hz, 3H), 0.78 (t, 
J = 7.3 Hz, 3H).  
 
 On the benchtop, meta chlorophenylTIDA boronate (64.7 mg, 0.20 mmol, 1.0 eq), 2-
butylMIDA boronate (63.9 mg, 0.30 mmol, 1.5 eq), potassium carbonate (82.9 mg, 0.60 mmol, 
3.0 eq), and P(tBu)3 third generation Buchwald precatalyst (11.4 mg, 0.02 mmol, 10 mol%) were 
weighed into a 7 mL vial. The vial was sealed with a septum cap and vacuum/N2 filled (3x). 
Benzene (400 µL) and water (400 µL) were then added via syringe. The nitrogen inlet needle 
was then removed and the septum was covered with electrical tape before placing the vial in a 60 
°C heat block and stirring for 48 hours. The reaction was then cooled and transferred to a 
separatory funnel containing EtOAc (10 mL) and sat. NH4Cl (10 mL). After shaking and 
separation, the aqueous layer was extracted with EtOAc (2x10 mL). The combined organic 
layers were dried with brine (10 mL), MgSO4, filtered, and concentrated to give a yellow solid. 
This solid was loaded onto Celite and purified by column chromatography (20 to 30 to 40% 
acetone/hexanes) to give 17.5 mg (25% yield) of a white solid. 
1
H-NMR (500 MHz, CDCl3): δ 
7.38-7.33 (m, 2H), 7.29-7.24 (m, 1H, overlaps with solvent), 7.19-7.15 (m, 1H), 2.57 (app br q, J 
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= 7.0 Hz, 1H), 2.47 (s, 3H), 1.79 (br s, 6H), 1.62-1.50 (m, 8H), 1.21 (d, J = 6.9 Hz, 3H), 0.78 (t, 
J = 7.3 Hz, 3H). 
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